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The selectin family of molecules (L-, P- and E-selectin) mediate the adhesive
interactions between leukocytes and endothelial cells and are required for recruitment of
leukocytes to inflammatory sites. At sites of inflammation, soluble E-selectin is
upregulated by proinflammatory mediators and is released into the bloodstream and
underlying tissues. Elevated soluble E-selectin levels act to promote neutrophil
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P2 integrin-mediated adhesion by prolonging calcium (Ca ) mobilization.
In this thesis I have investigated the functional consequences of soluble E-selectin upon
neutrophil responses to proinflammatory mediators, the effects of soluble E-selectin on
Ca2+ signalling, and the signalling events regulating this. Specifically, I have
investigated the mechanism by which soluble E-selectin acted to prolong intracellular
Ca2+ ([Ca2+]j). Soluble E-selectin alone was unable to initiate Ca2+ signalling but it
allowed store operated calcium entry (SOCE) to occur following stimulation with
platelet activating factor (PAF) and 1 have termed this effect permissive SOCE. This
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increase in [Ca ]; in response to soluble E-selectin and PAF was shown to act through a
G-protein coupled receptor (GPCR) coupled to pertussis toxin-insensitive Gq/n. Using
pharmacological approaches to define the ion channels involved it was demonstrated
that this effect was mediated by canonical transient receptor potential channels (TRPC)
due to its sensitivity to specific inhibition by a store operated channel inhibitor,
MRS1845 and a TRPC inhibitor, Gd3+. RT-PCR and western blotting analysis
demonstrated that TRPC6 was the principal TRPC family member expressed by human
neutrophils. In terms of mechanism, soluble E-selectin activated Src family tyrosine
kinases, an effect that was upstream of PI 3-kinase in a signalling pathway that regulates
permissive SOCE following exposure of neutrophils to PAF. I have also shown a
regulatory role for protein kinase C in control of the soluble E-selectin mediated
prolongation of elevated Ca2+.
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Soluble E-selectin induced alterations in TRPC channel function acts to promote
adhesion, reduce migratory capacity and augment neutrophil destructive potential and
neutrophil survival. Soluble E-selectin was demonstrated to bind via the lectin domain,
presumably through a putative E-selectin receptor present on neutrophils. Ligation of
CD66 with antibodies caused prolonged PAF-induced Ca2+ mobilization in a similar
manner to that caused by soluble E-selectin. In summary, this thesis describes studies
which provide the first evidence for communication between an adhesion receptor and
inflammatory mediator at a molecular level. Selectin receptor ligation allows permissive
SOCE to occur following PAF stimulation of human neutrophils.
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CIF Calcium Influx Factor
COPD Chronic Obstructive Pulmonary Disease
CRAC Ca2+ release-activated Ca2+
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ROS Reactive oxygen species
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SOC Store Operated Channel
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STIM1 Stromal interaction molecule 1
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TBS Tris-buffered Saline
TNFa Tumour necrosis factor-a
TRPC Canonical Transient Receptor Potential Channels







Table of Contents 9-12
Chapter 1: Introduction 13-34
1.1 The Neutrophil 13-16
1.1.1 Neutrophil Characteristics 15-16
1.2 Neutrophil Receptors 17-23
1.2.1 Adhesion Receptors 17-18
1.2.2. Immunoglobulin Superfamily Receptors 19-20
1.2.3 Lectin-Like Receptors 21
1.2.4 Chemoattractant/7TMReceptors 21-23
1.3 Neutrophil Recruitment at Sites of Inflammation 23-29
1.3.1 Phagocytosis 27-28
1.3.2 Apoptosis 28-29
1.4 Regulation ofNeutrophil Function 30-32
1.4.1 Priming 30-31
1.4.2 Co-operative Signalling in Neutrophils 31 -32
1.5 Neutrophil Signalling 33-41
1.5.1 Intracellular Ca2+ Signalling 33-35
1.5.2 TRPC 35-36
1.5.3 Role ofIntracellular Ca2+ Signalling 37-38
1.5.4 PhospholipidSignalling 38-40
1.5.5 Tyrosine Phosphorylation 40
1.5.6 Tyrosine kinases in Signalling by Adhesion 40-41
1.6 Selectins and their Receptors 41-47
9
1.6.1 Regulation ofSelectins 44-45
1.6.2 Selectins and Disease 45-47
Aims 48
Chapter 2: Materials & methods 49-68
2.1 Antibodies and other reagents 49-50
2.2 Mononuclear and Polymorphonuclear Leukocyte Isolation 50
2.3 Quality Control for Cell Isolation 51
2.4 Neutrophil Culture 51
2.5 Characterisation ofNeutrophil Apoptosis by Flow Cytometry 51
2.6 Measurement of [Ca2+]j 54-55
2.7 Superoxide Assays 54
2.8 Adhesion Assays 56
2.9 Migration Assays 56-57
2.10 Electrophysiology 57
2.11 Biotinylation ofCell Surface 57
2.12 Whole Cell Lysis Method 58
2.13 Immunoprecipitation 58
2.14 Cytoskeletal and Cytoplasmic Lysates 59
2.15 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 59-60
2.16 Western Blotting 60-61
2.17 RNA Isolation and RT-PCR 61-62
2.18 PCR 62-63
2.19 Expression of E-selectin 63-65
2.20 Purification of E-selectin 65-67
2.21 Amplification of Virus Stocks 68
2.22 Flow Cytometry Software 68
2.23 Statistical Analysis 68
Chapter 3: Identification of Store Operated Calcium Entry in Neutrophils .. 69-107
3.1 Introduction 69-73





Soluble E-selectin Prolongs PAF-induced Ca2+ Mobilization 74-78
Specificity ofSoluble E-selectin Effects 78-80
E-selectin permits PAF-induced Ca2 Influx 80-81
Store operated or Receptor Operated Ca2+ Influx? 81 -84
E-selectin causes Ca2+ influx through a TRPC 83,85,86
TRPC expression in PMN 85,88,89
Identification ofSTIMl and CRACMl 87&90
DAG does not cause Ca2 influx 87&92
Priming the channel allows Ca2+ influx to be induced by DAG 91&93
Patch Clamp Channel Recordings 94-97
3.3 Discussion 98-107
Chapter 4: Regulation of E-selectin mediated SOCE 108-136
4.1 Introduction 108-111
PKC Activation 108-109
Phosphorylation ofTRPC channels 110-111
4.2 Results 112-128
E-selectin-induced SOCE is regulated by Src andPI 3-Kinase 112-115
PKC negatively regulates E-selectin mediated SOCE 116-120
TRPC6 channels are phosphorylated by PKC 120-123
PKC isoform activation 123-128
4.3 Discussion 129-136









Recombinant E-selectin supports neutrophil adhesion 141-142
Soluble E-selectin inhibits neutrophil chemotaxis towards PAF 141&143
SOCE inhibition reverses E-selectin chemotaxis inhibition 144-145
Tyrosine phosphorylation reverses E-selectin effects on chemotaxis .... 144&146
Soluble E-selectin augments neutrophil respiratory burst 147-148
Soluble E-selectin induced SOCE is not involved in neutrophil
Priming 147-150
Soluble E-selectin augments PAF-induced neutrophil survival 150-152
Role ofE-selectin induced SOCE in PAF-mediated augmentation
ofapoptosis 152-153
Role ofsignalingpathways in neutrophil apoptosis 152-155
CD66 is a potential E-selectin counter-receptor 155-157
Identification ofE-selectin counter-receptors 157-160
5.3 Discussion 161-171
Chapter 6: Summary & Future Directions 172-181
6.1 Summary 172-173
6.2 Why is this work important? 174-177
6.3 Future directions 177-181





In vertebrates, recruitment of blood-borne leukocytes represents a key event in the
body's defence against invading micro-organisms following injury or infection. The
polymorphonuclear leukocytes, which include neutrophils, eosinophils and basophils are
critical effector cells in both innate and humoral immunity. In particular, neutrophils are
capable of internalisation of micro-organisms via phagocytosis which together with
production and release of reactive oxygen radicals, digestive enzymes and antimicrobial
peptides allow the elimination of infectious micro-organisms. However, these same
processes can cause host tissue injury if they are engaged inappropriately or not tightly
controlled.
In view of this potential for neutrophil-mediated tissue destruction, there are multiple
levels of control for adhesion processes to ensure that inappropriate recruitment of
neutrophils does not occur. Neutrophils have been implicated in the pathogenesis of a
number of disease states including respiratory distress syndromes, rheumatoid arthritis
and asthma (Malech and Gallin, 1987; Kerstjens and Timens, 2003; Caramori and Papi,
2004). In experimental models of acute inflammation, blockade of neutrophil adhesion
is associated with a reduction in tissue damage (Albelda et al., 1994), raising the
possibility that perturbation of neutrophil recruitment patterns may alter progression of
inflammatory responses, leading to generation of chronic inflammatory conditions,
fibrosis and loss of organ function. Although deployment of the neutrophil armoury of
degradative enzymes and toxic oxidant species is essential for the elimination of
invading pathogens and initiation of tissue repair processes, if neutrophil destructive
potential is triggered inappropriately, host tissue damage may occur with pro¬
inflammatory consequences. Excessive inflammatory cell recruitment or inappropriate
cell activation may contribute to the development of chronic inflammatory conditions.
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Neutrophils are the most abundant white blood cell type present in the circulation,
accounting for 70% of all white blood cells (leukocytes). They are derived from
pluripotent stem cells in the bone marrow which undergo proliferation and
differentiation under the influence of three major haematopoietic cytokines G-CSF, GM-
CSF and 1L-3 (Berliner, 1998; Boneberg and Hartung, 2002), allowing them to
differentiate and mature into fully functional neutrophils. There appear to be several
recognisable morphological stages including myeloblast, primary myeloblast, myelocyte
and metamyelocyte stages with subsequent formation of non-segmented (band)
neutrophils before fully functional segmented neutrophils acquire their characteristic
primary (azurophil), secondary (specific) and tertiary granules. The mature neutrophil is
distinguished also by a lobulated chromatin dense nucleus.
Neutrophils are released from the bone marrow into the circulation in the healthy adult,
at a rate of 1 x 1011 neutrophils per day (Cannistra and Griffin, 1988). During acute
inflammation, release of neutrophils from the bone marrow is thought to increase to
more than 1 x 1012 per day (Cannistra and Griffin, 1988). Neutrophils are short lived
cells and in the circulation have an estimated half life of only 4-6 hrs. The intravascular
pool of human neutrophils is composed of one compartment which is circulating and
another that is marginated to the vascular endothelium. Marginated neutrophils are
mature neutrophils that leave the circulating bloodstream and are delayed along the
walls of microvessels, forming a sequestered or "marginated" pool that can be rapidly
mobilized back into the circulation (ATHENS et al., 1961; Hogg, 1987). Marginated
pools of neutrophils exist in the liver, spleen and lung, where they can live for 1 to 2
days (Bicknell et al., 1994) before they are cleared by apoptosis. A dynamic equilibrium
exists between the circulating pools and marginated pools, allowing exchange with each
other (Berkow and Dodson, 1987). Stress, such as physical exercise, catecholamine
infusion or injury, increases the circulating leukocyte counts by mobilizing this
marginated pool (Muir et al., 1984; Foster et al., 1986; Shephard, 2003).
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1.1.1 Neutrophil Characteristics
Neutrophils have a mean diameter ~ 7 pm and are characterised by a multilobed
chromatin-dense nucleus and a large number of intracellular granules. Initially
neutrophil granules were simply divided into two categories, namely peroxidase positive
(azurophil or primary) and peroxidase negative (specific or secondary). However, an
additional two further granule subgroups can be defined, namely tertiary/gelatinase
granules and secretory vesicles (Borregaard and Cowland, 1997). The importance of
neutrophil granules is demonstrated in Chediak-Higashi syndrome in which an apparent
inability to mount a proper inflammatory response leads to congenital abnormality in
neutrophil granule formation (Davis and Douglas, 1972; Kjeldsen et al., 1998).
The azurophil or primary granules vary in size and have an oval or round morphology
(Bainton, 1976; Borregaard, 1997). They contain a wide variety of agents believed to be
involved in bacterial killing and are primarily released into the phagolysosomal
compartment during phagocytosis. Regulated secretion of granule contents is required
to avoid detrimental effects upon host tissue. Amongst the many antimicrobial
constituents of azurophil granules, one of the most important for effective bactericidal
killing is myeloperoxidase (MPO) (Klebanoff, 1999). The enzymatic activity of MPO is
responsible for the conversion of hydrogen peroxide to hypochlorous acid, providing the
neutrophil with a highly effective microbial capacity. Azurophil granules also contain
antimicrobial peptides called defensins, which form a large proportion of the proteins
contained in azurophil granules (Chertov et al., 2000). These small antimicrobial
peptides are highly toxic to a wide variety of bacteria, fungi and some viruses. Other
important constituents include serine proteases such as elastase and cathepsin G, which
are involved in hydrolytic degradation of many substrates including bacterial cell walls
(Chertov et al., 2000). The second category of granules is specific granules, which are
round, oval or elongated in shape and are slightly larger than gelatinase granules. In
contrast to azurophil granules, it is thought that specific granule contents can be released
extracellularly. They characteristically contain the iron sequestering protein lactoferrin,
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important for preventing the growth of ingested bacteria by depriving them of this vital
growth nutrient (Spitznagel et al., 1974; Ellison, III, 1994). Specific granules are also an
intracellular source of receptors for the small complement fragment iC3b (Sengelov et
al., 1994b), laminin (Singer et al., 1989) and N-formylmethionyl-leucyl-phenylalanine
(fMLP) (Sengelov et al., 1994a). It is not clear if these receptors are fully functional
when they become translocated to the plasma membrane following degranulation. A
further important constituent of specific granules is cytochrome b558, a component of
the NADPH oxidase, responsible for the generation of superoxide anion (Calafat et al.,
1993).
Gelatinase (or tertiary) granules are smaller than specific granules and are principally
composed of the protease gelantinase which may be involved in digestion of the vascular
basement membrane, allowing the extravasation of neutrophils (Dewald et al., 1982).
Similarly to specific granules, gelatinase granules also contain cytochrome b558 and
several acid hydrolases but do not contain lactoferrin.
1.2 Neutrophil Receptors
The interaction of the neutrophil with the local micro-environment occurs through the
cell surface receptors that are expressed at the plasma membrane. During the
recruitment process and before reaching sites of inflammation the neutrophil alters its
cell surface receptor repertoire, increase their metabolic rate and acquire a state of
alertness referred to as 'priming'. Many of the key molecular mediators of adhesion,
migration and phagocytosis are maintained within intracellular granule compartments, in
the azurophil and specific granules. In response to exposure to a variety of stimuli
derived either from pathogens (e.g. fMLP) or from the host (a range of cytokines and
growth factors), the neutrophil is able to rapidly mobilise these granule contents to the
plasma membrane. Coupled with this, the neutrophil can control the levels of surface
receptor expression through the rapid and specific proteolytic 'shedding' of the ecto-
domain of specific receptors through the action of metalloproteases. Together these
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processes combine to generate a very different receptor profile that is optimal for
destructive capacity.
The functional capacity of neutrophils, including adherence, reorganization ofmicrobial
pathogens and response to inflammatory stimuli, migration, phagocytosis and generation
of cytokines are mediated by a large variety of surface receptors. Many of these
receptors are involved in neutrophil activation, including chemokine receptors (such as
e.g. IL-8), immunoglobulin Fc receptors (FcRs), complement receptors (CRs) and
multiple receptors for adhesion molecules (selectins, integrins), as well as receptors for
bacteria and microbial products, such as Toll-like receptors, lipopolysaccharide (LPS)
and fMLP. Through these receptors, neutrophils can be activated and they migrate from
the circulation into the local tissue. Expression of these receptors is essential for
neutrophil functions such as chemotaxis, phagocytosis, reactive oxygen species (ROS)
production and release of cytokines, chemokines and growth factors that potentiate
innate immune and inflammatory responses. In general, these receptors can be divided
into four main groups according to their biological function: adhesion receptors;
chemotactic receptors; phagocytic receptors and cytokine receptors.
1.2.1 Adhesion Receptors
Integrins are transmembrane cell surface proteins that bind intracellularly to cytoskeletal
proteins and communicate extracellular signals (Berton and Lowell, 1999). Each
integrin consists of a noncovalently linked, heterodimeric a and P chains. The p2
subfamily of integrins is composed of four family members: CD1 la/CD 18 (lymphocyte
function-associated antigen-1, LFA-1), CDllb/CD18 (Mac-1), CDllc/CD18 and
CDlld/CD18, which are heterodimers composed of a unique a (CD11) subunit
complexed to a common p2 (CD 18) subunit. These integrins have crucial roles in
various neutrophil functions that are required for the containment and elimination of
infection. They are present in an inactive state on circulating leukocytes, however,
following stimulation of neutrophils with various cytokines, a G-protein-coupled
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receptor (GPCR) agonist and high valency ligands, they undergo a rapid conformational
change that results in their activation, which is required for optimal integrin function.
Active p2 integrins mediate leukocyte adhesion and transmigration across the
endothelium, through interactions with ICAM-1 on the activated endothelium. The {32
integrins, Mac-1 and CDllc/CD18 also promote the phagocytosis of microbes into
phagosomes and recognise many pathogens directly (Ross, 2000). The biological
importance of p2 integrins is highlighted in patients that have mutations in the p2 subunit
(Roos and Law, 2001). These patients, referred to as leukocyte adhesion deficiency I
(LADI) patients, exhibit increased susceptibility to infections and peripheral blood
neutrophilia (Wehrle-Haller and Imhof, 2003). Several studies showed that neutrophils
in LAD patients roll normally but do not transmigrate as efficiently through tissues to
sites of inflammation and fail to adhere firmly and spread poorly in vitro ((Harris et al.,
2001; Bunting et al., 2002). LAD patients suffer from recurrent infections of soft tissues
and often die before they are more than a few years old.
Human neutrophils were once thought to express only p2 integrins. However, in 1990
evidence emerged that demonstrated human neutrophils possess both Pi and p2 classes of
integrins and that both mediate polymorphonuclear leukocytes (PMN) adherence
(Bohnsack et al., 1990). Specifically the integrin 014P1 has been shown to be involved in
mediating firm adhesion and transendothelial migration (Kubes et al., 1995). The Pi
integrins share CD29 as their common p subunit (Hemler, 1990). This widely
distributed family of integrins contains a series of cellular receptors for extracellular
matrix proteins including fibronectin, collagen, laminin and vitronectin. a4pi (VLA-4,
CD49d/CD29) has also been shown to be involved in lymphocyte, monocyte,
eosinophil, basophil and natural killer cell adhesion to cytokine-activated endothelial
cells (Morris and Ley, 2004; Zhang et al., 2004).
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1.2.2. Immunoglobulin Superfamily Receptors
The structural unit of the immunoglobulin superfamily members is the Ig domain. Ig
superfamily members that have been identified in neutrophil recruitment include: CD31
(PECAM1), ICAM-1 (CD54) and ICAM-3 (CD50). CD31 is organized into an
extracellular amino-terminal domain containing 6 immunoglobulin (Ig)-like repeats, a
short hydrophobic transmembrane domain, and a long cytoplasmic tail (Newman et al.,
1990). Studies in vivo and in vitro have demonstrated a role for CD31 in neutrophil
transendothelial migration (Muller, 1995). Experiments using mAbs and recombinant
CD31 proteins can inhibit neutrophil migration through blood vessels by blocking at the
stage of interaction with the basement membrane (Wakelin et al., 1996). CD31
facilitates the diapedesis of leukocytes both in vitro and in vivo (Muller et al., 1993;
Vaporciyan et al., 1993; Bogen et al., 1994), acts as a trigger for up-regulating integrins
on leukocytes (Tanaka et al., 1992; Piali et al., 1993; Leavesley et al., 1994; Berman and
Muller, 1995), and thus appears to play a role in cell-cell interactions during an
inflammatory response.
ICAM-1, a cell-surface protein with five immunogloblulin-like domains, plays an
important role in transendothelial migration of leukocytes (Smith et al., 1988; Yang et
al., 2005) through its expression on vascular endothelium and binding to P2 integrins
(Marlin et al., 1990). Immunoglobulin domains 1 and 2 of ICAM-1 are involved in
binding to LFA-1 (Staunton et al., 1990; Casasnovas et al., 1999), while
immunoglobulin domain 3 mediates binding to Mac-1 (Diamond et al., 1991). ICAM-1
is upregulated through synthesis of protein in vivo or in vitro in response to
inflammatory cytokines (Rothlein et al., 1988), phorbol esters (Rothlein and Springer,
1986) or lipopolysacharides (Jersmann et al., 2001). Integrin binding to ICAM-1 is
particularly important for firm attachment and migration across the endothelial surface;
for example, migration of human neutrophils through a monolayer of umbilical vein
endothelium was inhibited >85% by anti-ICAM-1 blocking monoclonal antibodies
(mAbs) (Smith et al., 1988). ICAM-3 is unique in the ICAM adhesion protein family in
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that ICAM-3 is expressed only on leukocytes and also regulates neutrophil adhesion by
binding to LFA-1 and Mac-1. Both ICAM-1 and -3 mediate binding to the P2 integrins,
LFA-1 and Mac-1, and expression of these receptors is of particular importance in
regulating neutrophil behaviour in inflammatory responses.
Fc receptors have been identified as a family of receptors that bind to the Fc portion of
immunoglobulin molecules and have been proven to be essential for phagocytosis. The
interaction of antibody-antigen complexes with cells of the immune system results in a
wide range of responses, ranging from effector functions such as antibody-dependent
cytotoxicity and phagocytosis to immunomodulatory signals such as regulating
lymphocyte proliferation. All these interactions are initiated through the binding of the
Fc domain of antibodies of immune complexes to Fc receptors. FcRs exist for every
antibody class: FcyR bind IgG, FcaR bind IgA, FceR bind IgE, FcpR bind IgM and
Fc5R bind IgD (Ravetch and Bolland, 2001).
Human neutrophils constitutively express two distinct FcyRs: FcyRIIa (CD32) and
FcyRIIIb (CD 16). FcyRs are critical participants in inflammation and in the immune
response by providing an important link between the humoral and cellular immune
systems. FcyRIIa is a transmembrane receptor that can initiate many neutrophil
inflammatory responses including degranulation and the generation of reactive oxygen
intermediates. FcyRIIIb is a glycosylphosphatidylinositol (GPI)-linked protein that can
also initiate a number of neutrophil inflammatory responses including antibody-
dependent cellular cytotoxicity. FcaRl (CD89) an IgA receptor, is also expressed on
neutrophils and FcaRI activation has been shown to initiate several neutrophil responses
including phagocytosis, cytotoxicity, respiratory burst, cytokine release and antigen
presentation (Morton et ah, 1996; Hellwig et al., 2001; Shen et ah, 2001).
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1.2.3 Lectin-Like Receptors
L-selectin (CD62L), the lymphocyte homing receptor, and CD44, the hyaluronan
receptor, are two of the major adhesion molecules expressed by leukocytes of both
lymphoid and myeloid origin (Yong and Khwaja, 1990). L-selectin (CD62L) mediates
the initial tethering and rolling of leukocytes on endothelial surfaces, which is a
prerequisite for leukocyte extravasation from the blood into tissues and also contributes
to recruitment of leukocytes from the blood to areas of inflammation (Tedder et al.,
1995). PSGL-1 (CD 162) is the major P-selectin ligand on neutrophils. This interaction
mediates the tethering and rolling of these cells on endothelial cells under physiological
flow, an important initial step in leukocyte extravasation (McEver et al., 1995).
Interactions between PSGL-1 and L-selectin can mediate neutrophil-neutrophil
interactions, which may amplify neutrophil extravasation (Walcheck et al., 1996).
CD44 is a transmembrane glycoprotein which contributes to the adhesion of neutrophils
to endothelial cells (Lesley et al., 1993). The principal ligand for CD44 is hyaluronan
(HA), an extracellular matrix glycosaminoglycan (Lesley et al., 1993). The interaction
between cell-surface CD44 and HA has been implicated in leukocyte extravasation at
inflammatory sites (DeGrendele et al., 1997). CD44 on the surface of activated
leukocytes can function as an adhesion receptor that initiates the attachment of these
cells to HA on microvascular endothelium (DeGrendele et al., 1996). In a fashion
similar to the interaction between selectins and their carbohydrate ligands, binding of
leukocyte CD44 to vascular HA tethers leukocytes to the vessel wall and supports their
rolling adhesion (DeGrendele et al., 1996).
1.2.4 Chemoattractant/7TM Receptors
Neutrophils are attracted to inflammatory sites and/or sites of infections through the
production at these sites of chemoattractant mediators, for example the bacterial peptide
fMLP, leukotriene B4 (LTB4), C5a, PAF. Many of these chemoattractants bind to a
heptahelical G-protein coupled cell surface receptor on neutrophils. Human neutrophils
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express fMLP receptors (FPRs), C5a-, LTB4- and PAF receptors. As a result of
chemoattractant receptor activation, neutrophils are stimulated to move, adhere and de-
adhere, rearrange their cytoskeleton and ultimately to phagocytose infectious
micororganisms, secrete granules containing degradative enzymes and antimicrobial
agents (Flaribabu et al., 2000). The signalling mechanisms and responses used by
chemoattractant receptors are thus of major importance in determining how neutrophils
will respond to any given biologic situation. For example, N-formyl peptides interact
with the fMLP receptor to induce neutrophil chemotaxis, phagocytosis, production of
superoxide radicals and release of proteolytic enzymes from intracellular granules (Bae
et al., 2003). The PAFR and LTB4R are known to be involved in regulating adhesion to
endothelial cells and chemotactic responses. C5a is a strong chemoattractant and is
involved in the recruitment of inflammatory cells such as neutrophils, eosinophils,
monocytes, and T lymphocytes, in activation of phagocytic cells and release of granule-
based enzymes and generation of oxidants, all of which may contribute to innate
immune functions or tissue damage (Guo and Ward, 2005). The receptor for C5a plays
a critical role in numerous inflammatory conditions (Guo and Ward, 2005). Another
characteristic that all these chemoattractant receptors have in common is their ability to
induce rises in intracellular calcium ([Ca2+]j) in neutrophils (Fruman et al., 1991). The
binding of fMLP, C5a, LTB4 and PAF to the appropriate receptor activates
phospholipase C (PLC), via a G-protein. The resulting production of diacylglycerol
(DAG) and phosphoinositides induces the activation of protein kinase C (PKC) and
mobilization of [Ca2+]j, which affects several neutrophil functions.
Chemoattractant receptors are G protein coupled-receptors that span the membrane
seven times. Ligand binding to the GPCR is coupled to exchange of GDP for GTP
bound to the associated G protein heterotrimer and results in the activation by the G
protein a and (3y subunits of signalling effectors. The Ga subunits of the ai class are
ADP-ribosylated and irreversibly inactivated by pertussis toxin. In neutrophils PAF,
fMLP, C5a and LTB4 work through distinct G protein coupled receptors, PAF and C5a
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signal via a pertussis toxin-insensitive G-protein pathways (Gq) and fMLP and LTB4
through pertussis toxin-sensitive pathways (Gj).
1.3 Neutrophil Recruitment at Sites of Inflammation
Recruitment of neutrophils to sites of tissue injury or infection is the hallmark of the
acute inflammatory response. Efficient neutrophil extravasation at sites of inflammation
requires a coordinated cascade of adhesive and signalling events (Springer, 1995; Smith,
2000). Molecular specificity in the targeting of neutrophils to sites of inflammation is
mediated by selectins, integrins and the immunoglobulin gene superfamily. Based on in
vitro and in vivo observations, neutrophil recruitment may be described as a sequential
process having at least three distinct adhesive events (tethering, rolling and firm
adhesion), as shown in Figure 1.1. Neutrophils are captured from the bloodstream by
tethering via constitutively expressed L-selectin that recognises glycoprotein ligands on
adjacent neutrophils and those upregulated in cytokine activated endothelium (Abbassi
et al., 1993). Neutrophil rolling is supported by E-selectin and P-selectin that are
upregulated on the endothelial plasma membrane in response to cytokine or thrombin
and histamine stimulation, respectively (Lawrence and Springer, 1993; Jones et al.,
1993). The carbohydrate and epitope specificity of selectin recognition has been
determined by blocking adhesion with mAbs to each selectin, recombinant soluble
selectins and fucosylated polysaccharides (Kansas, 1996). These interventions are
effective at blocking tethering and rolling in vitro and they can inhibit the accumulation
of neutrophils at sites of inflammation in animal models of acute inflammation (Kansas,
1996). The P-selectin glycoprotein ligand-1 (PSGL-1) is a dimeric mucin-like
glycoprotein found on neutrophil surfaces has also been proven to promote cell adhesion
by binding to P- and L-selectin (Yang et al., 1999).
The requirement for selectins in primary cell capture and rolling has also been confirmed
in transgenic mice deficient in L-selectin, E-selectin, P-selectin and PSGL-1 (Mayadas
et al., 1993; Kunkel and Ley, 1996; Xia et al., 2002). It is clear from this literature that
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selectins provide for a redundant molecular recognition system that supports both
capture and rolling of neutrophils in blood vessels in which the shear rate is high (>100
s"1) and the collisional contact duration with the endothelium is brief (<25ms) (Simon
and Goldsmith, 2002). Rolling along the endothelium is thought to allow sufficient time
and elicit the activation of neutrophil integrins that then bind to their counter receptors,
resulting in firm adhesion (Simon et al., 1998; Chen and Springer, 1999). The selectins
will be discussed in greater details in section 1.6.
A critical step in the transition from neutrophil rolling to arrest is the development of
firm adhesion, which is predominantly mediated by the activation of membrane
expressed |3i and Pi-integrins. Their participation is required for stable shear resistant
and prolonged adhesion (Hynes, 1992; Taylor et al., 1996). Following activation by
chemoattractant agents, such as 1L-8 or PAF, the neutrophil upregulates adhesion
receptors such as CDllb/CD18. Consequently, firm adhesion to the endothelium is
secured via binding through LFA-1 or Mac-1 with endothelial cell ligands such as
ICAM-1 (Ley, 1992; Carlos and Harlan, 1994; Springer, 1994; Wang and Doerschuk,
2002).
Completion of the process of neutrophil recruitment follows the development of strong
interactions between integrins and Ig-superfamily members. Firmly adherent
neutrophils are able to migrate over the luminal surface of endothelium by reversible
adhesion, which involves the cycling of integrin receptor avidity (Dustin and Springer,
1989). For example, transmigration of neutrophils across the endothelial barrier
involves an interaction between leukocyte integrins and endothelial ICAM-3 and CD31
ligation which is associated with (L integrins (Berman and Muller, 1995; Berman et al.,
1996). CD31 is localised in the intracellular junctions of endothelial cells (Muller et al,
1993) and is crucial to the process of leukocyte transmigration through intercellular
junctions of vascular endothelial cells. A monoclonal antibody to CD31, or recombinant
soluble CD31, blocks transendothelial migration ofmonocytes by 70-90% (Muller et al.,
1993). Recent studies have shown that CD99, a type I transmembrane protein, also
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plays a profound role in the transmigration of neutrophils (Lou et al., 2007). CD99
appears to act at a step downstream of CD31 during diapedesis and blocking both
molecules has an additive effect, blocking almost all neutrophil and monocyte
transmigration (Lou et al., 2007).
Diapedesis of neutrophils through the endothelium is then followed by migration to the
site of infection along a chemotatic gradient (Figure 1.1). The invading microorganisms
themselves may produce chemoattractants such as fMLP, involved in recruiting
neutrophils to the site of infection. Other chemotactic agents such as IL-8 may be
released from the local phagocytes following initial interactions with infectious agents
(Hachicha et al., 1998). This allows an amplification of the preliminary inflammatory




















Figure 1.1 Schematic representation of the mechanism involved in neutrophil
recruitment
Neutrophil recruitment is controlled by a cascade of multiple molecular interactions.
Initial tethering of neutrophils involves reversible binding to the endothelium through
selectins on the endothelium and their carbohydrate ligands on the neutrophils. This
enables neutrophils to roll along the blood vessel wall and to sense activating factors
such as chemokines that are deposited on the endothelial surface. This leads to the
activation of neutrophil integrins (CDlla, CDllb) and ICAM-1 which mediate firm
adhesion, a prerequisite for directed migration of neutrophils on the endothelial cell
surface. Tight binding arrests the rolling and allows the neutrophil to transmigrate
across the endothelium and enter the site of infection. Finally, the neutrophil migrates
along a concentration gradient of chemokines secreted by the cells at the site of
infection. IXXI = Stop signal.
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1.3.1 Phagocytosis
Once a neutrophil has migrated into the tissue, its primary purpose is to recognise and
destroy pathogens. Phagocytosis is a process utilised by neutrophils to ingest and clear
large particles (>0.5um), including infectious agents and cellular debris. Neutrophils
may phagocytose microbes through direct binding of lectins (Sharon and Ofek, 1995).
However, in many instances effective phagocytosis and clearance of infectious agents
additionally requires the availability of opsonins, to facilitate the adherence of the
bacteria and other microbes to opsonin receptors on the surface of the neutrophil.
Opsonisation with antibodies or complement components may allow phagocytosis
mediated through Fc receptor recognition of the Fc portion of antibodies binding on the
bacterial or viral cell surface or via complement receptors binding to C3b (Scribner and
Fahrney, 1976). Following recognition and pathogen binding, a phagosome forms
containing engulfed micro-organisms. This then fuses with the intracellular granules,
allowing the neutrophil to release a variety of antimicrobial agents into a contained
microenvironment.
During phagocytosis a substantial increase in oxygen consumption is observed, called
the respiratory burst activity, which requires translocation and assembly of the cytosolic
components of the NADPH oxidase enzyme system with membrane-bound
flavocytochrome, cytochrome b558. This process, through the reduction of oxygen by
NADPH oxidase, allows the generation of toxic reactive oxygen intermediates (ROI)
such as superoxide anions and via the activity of superoxide dismutase, generation of
hydrogen peroxide. Further reduction leads to the production of more toxic oxygen
radicals such as hydroxyl radical (OH) from H2O2, in a reaction catalysed by Fe2+ or the
production of hypochlorous acid, through the action of myeloperoxidase. These
substances have highly powerful antimicrobial activities, the importance of which is
illustrated in chronic granulomatous disease (CGD). CGD is characterized by various
genetic defects in essential NADPH oxidase components and reults in an inactive
oxidase. Patients with CGD experience severe, recurrent life-threatening bacterial and
27
fungal infections and often develop granulomas formed by the fusion ofmonocytes and
macrophages that have phagocytosed bacteria, but are unable to destroy them as a result
of a defective NADPH oxidase (Heyworth et al., 2003).
1.3.2 Apoptosis
The majority of neutrophils do not migrate from inflamed sites but are cleared locally by
neighbouring cells or by macrophages. However, in order for neutrophils to be removed
from sites of inflammation they must first undergo apoptosis. Apoptosis is a genetically
regulated form of cell death, which is important for normal development and cell
turnover in adult organisms. Neutrophil apoptosis is crucial for the successful resolution
of inflammation and the balance between neutrophil apoptosis and necrosis in inflamed
tissues is an important determinant of the degree of tissue injury. The phagocytic
removal of intact, apoptotic neutrophils prevents them from releasing their cytotoxic
content into the extracellular milieu that would occur if the cells died by necrosis. Death
by apoptosis and safe removal by phagocytic cells thus helps to limit tissue damage
during resolution of inflammation. Dysregulation of apoptosis affects many
pathological conditions. Accelerated apoptosis is evident in acute and chronic
degenerative diseases, immunodeficiency, whereas insufficient apoptosis or defective
apoptotic cell clearance can cause cancer and autoimmunity (Fadeel et al., 1999).
When neutrophils become apoptotic, a chain of highly regulated molecular events occur
that result in distinct structural, morphological and biochemical phenotypes. Apoptotic
neutrophils tend to be smaller but more vacuolated as a result of cytoplasmic changes
and the typical multi-lobed nucleus seen in non-apoptotic neutrophils fuses into one or
sometimes several distinct, visually disconnected nuclear lobes. The nuclear chromatin
condenses into dense, crescent shape structures with the nucleolus becoming more
prominent. Endogenous endonuclease activation is responsible for internucleosomal
cleavage into characteristic DNA fragments of 180-200 base pairs of the chromatin
(Majno and Joris, 1995). Major cell surface changes occur in neutrophils undergoing
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apoptosis (Hart et al., 2000). For example, the distribution of plasma membrane (PM)
phospholipid changes dramatically. Phosphatidylserine, normally located on the inner
leaflet of the PM of non-apoptotic cells, flips onto the external surface of apoptotic cells
(Fadok et al., 1998). Neutrophils also shed FcyRIII (CD 16) and L-selectin when
undergoing apoptosis (Dransfield et al., 1994; Dransfield et al., 1995; Akgul et al.,
2001).
Importantly, as neutrophils become apoptotic their ability to respond to agonists (e.g.
fMLP) is dramatically reduced so that they are no longer capable of undergoing
chemotaxis and degranulation and their phagocytic abilities are impaired (White et al.,
1993). In vitro, significant numbers of neutrophils become apoptotic within 18 hours of
culture, which is coupled to downregulation of neutrophil functions. In vivo, this
process might limit their destructive potential before their clearance by macrophages
(Savill et al., 1989). The execution of the apoptotic pathway in neutrophils is mediated
by caspases. Caspases are the central components of the apoptotic response (Shi, 2002),
responsible for morphological changes of apoptotic cells. They are a conserved family
of enzymes that irreversibly commit the cell to die. Eleven casapases have been found
in humans. Caspase-1, 4, 5 and 13 are involved in cytokine activation and inflammation
but not in apoptosis. Of the caspases involved in apoptosis, there are two main types:
initiator caspases (caspase-2, 8, 9, 10) and effector caspases (caspases-3, 6 and 7).
Initiator caspases are the first to be activated and these cleave and activate the effector
caspases. The primary function of effector caspases is the cleavage of key proteins that
leads to the characteristic features of apoptotic cells (Nicholson, 1999). Having both
initiator and effector caspases means apoptosis is tightly regulated as it involves the
coordinated action ofmultiple caspases.
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1.4 Regulation of Neutrophil Function
1.4.1 Priming
It is well recognised that there are complex regulatory mechanisms in place to allow
neutrophils to respond to infection when required. The magnitude of neutrophil
responsiveness to infection or tissue injury may be influenced by several agents which
may allow neutrophils to acquire a state of preactivation, allowing enhanced
responsiveness to microbial infection termed 'priming'. Priming agents include PAF,
cytokines such as granulocyte-macrophage colony-stimulating factor (GM-CSF),
granulocyte-colony stimulating factor (G-CSF), tumour necrosis factor-a (TNFa) and
bacterial products such as LPS (Pitrak, 1997). For example, exposure of neutrophils to
large concentrations of LPS does not induce oxidative burst but will greatly potentiate
the oxidative burst in response to another stimulus such as fMLP or C5a (Haslett et al.,
1985). This regulatory mechanism of priming is vitally important for generating a more
rapid and powerful neutrophil response, following the initial microbial insult (Condliffe
et al., 1998). As a consequence, neutrophil functions such as agonist (e.g. fMLP, C5a)
induced degranulation (Fittschen et al., 1988), the respiratory burst (Guthrie et al., 1984)
and production of lipid mediators (Doerfler et al., 1989; Doerfler et al., 1994) is greatly
enhanced. It has become increasingly apparent that regulation or neutrophil function is
also determined by the ability of neutrophils to produce a variety of mediators, which
can act in an autocrine manner. This is in contrast to previously held beliefs that
neutrophils already possess all mediators necessary to participate in the inflammatory
response and have little synthetic capacity. However, neutrophils are known to be
capable of producing a large variety of inflammatory mediators such as bioactive lipids
and cytokines, which can participate and influence the inflammatory response.
Through metabolism of arachadonic acid, neutrophils produce leukotrienes and
prostaglandins such as LTB4 (McColl et al., 1991) and PGE2 (Tolone et al., 1977).
Futhermore they can secrete a wide variety of cytokines such as IL-8 (Cassatella et al.,
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1992), IL-6 (Cicco et al., 1990), TNFa (Dubravec et al., 1990; Djeu et al., 1990) and IL-
1 (Tiku et al., 1986; Scapini et al., 2000). Thus, the role of the neutrophil is not only
determined by their ability to respond to agents in the extracellular milieu, but also by
their capacity to direct and influence the inflammatory response.
1.4.2 Co-operative Signalling in Neutrophils
An emerging theme in neutrophil adhesion research is that selectin-mediated cell
tethering and rolling alone is not sufficient to enable cells to become firmly adherent but
is synergistic with signalling via chemokine ligation in activation of integrins to bind
adhesion molecules more efficiently under shear flow. Neutrophil activation occurs in
response to signalling molecules that are recognized by receptors on their plasma
membranes, including members of the G-protein coupled receptors that recognise PAF,
TNFa and GM-CSF and others (Ben-Baruch et al., 1995). Traditionally, these
chemotactic factors were thought to be supplied by cells outside of the vascular system,
at sites relatively distant from the initial contact between endothelial cells and
neutrophils. However, it is now known that inflamed endothelial cells express signalling
factors for neutrophils. This is a powerful mechanism for spatially localising the
activation response of the target neutrophil and one which eliminates the need for the
release of signalling factors in solution, which can have deleterious consequences
(Zimmerman et al., 1993). For example, PAF can act as a signalling molecule, as PAF
is rapidly synthesized by stimulated endothelial cells but its expression on their surfaces
is transient; thus there are mechanisms that control its signalling action (Prescott et al.,
1984). PAF induces inside-out signalling of P2-integrins on the neutrophils and other
activation responses and blocking the PAF receptor on neutrophils inhibits these events
at the endothelial surface (Zimmerman et al., 1990; Lorant et al., 1991). In addition,
exogenous PAF induces the relevant signalling events and does so when neutrophils are
tethered to P-selectin (Lorant et al., 1993). Engagement of the ligand for P-selectin on
neutrophils appears to facilitate inside-out signalling of P2 integrins (Lorant et al., 1991).
The tethering of neutrophils by P-selectin to the surface of the endothelium is known to
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be essential in allowing PAF to interact with its receptor and thereby induce neutrophil
activation/adhesion. Thus, P-selectin and PAF act in a complementary fashion. Such
coordinated action of tethering and signalling factors is likely to be a general mechanism
of adhesion-dependent signalling in the vascular system and elsewhere.
PAF initiates signalling cascades in neutrophils that are associated with the endothelial
plasma membrane (Zimmerman et al., 1990). Thus, it acts in a juxtacrine fashion
(Zimmerman et al., 1993; Lorant et al., 1993; Bosenberg and Massague, 1993). One
consequence of juxtacrine activation of neutrophils by PAF is functional upregulation of
CD11/CD18 integrins on the PMN. These integrins bind to counter receptors on the EC,
enhancing the avidity of adhesion over that provided by P-selectin alone. Juxtacrine
signalling adds another level of precision to spatially localised information transfer
between cells and is particularly well-suited for inflammatory and vascular interactions,
where tightly localised cellular activation is frequently required. In endothelial cell
interactions with neutrophils, E-selectin may act as a juxtacrine signalling molecule and
IL-8 and other chemokines may signal while localised at the endothelial cell surface
(Zimmerman et al., 1993). For example, Ruchaud-Sparagano et al. (2000) showed that
exposure of neutrophils to soluble E-selectin and PAF in combination induced a
synergistic effect upon p2-integrin-mediated adhesion and demonstrated that E-selectin
specifically prolonged elevation of [Ca2+], in response to PAF. Thus, combinations of
tethering and signalling molecules regulate neutrophil adhesive interactions with EC and
the time-dependent expression of different patterns of tethering and signalling molecules
by EC provides a general mechanism for differential adhesion and activation.
Combinations of such molecules also regulate other functional responses of the
neutrophils that are important in inflammation.
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1.5 Neutrophil Signalling
Chemokines and chemoattractants are known to initiate several intracellular signal
transduction cascades that lead to neutrophil activation and altered functional responses.
The main pathways activated are intracellular Ca2+ signalling, phospholipid signalling
and tyrosine phosphorylation.
1.5.1 Intracellular Ca2+ Signalling
Signals for increases of the [Ca2+]j are generated by chemokine receptors that are
activated by chemoattractants such as fMLP and PAF. Chemoattractants alone are
known to induce Ca2+mobilization through the release of Ca2+ from intracellular stores,
which occurs through activation of the GPCR. Receptor activation leads to PLC
activation, which cleaves the PM minor phospholipid phosphatidylinositol (4,5)-
bisphosphate (PIP2) to generate the second messengers inositol (l,4,5)-trisphosphate
(IP3) and DAG. IP3 then binds to an IP3 receptor located on the endoplasmic reticulum
(ER) and causes the release of Ca2+ which floods into the cytoplasmic compartment.
When agonists such as PAF bind to a GPCR, the interaction of IP3 with its receptor in
the ER results in rapid Ca2+ release from ER stores. This release of Ca2+ from
intracellular stores can result in a subsequent activation of Ca2+ influx across the PM by
mechanisms generally referred to as store-operated calcium entry (SOCE), see figure
2.1.1 (Putney, Jr., 1986).
As neutrophils are electrically non-excitable, store-operated Ca2+ channels (SOCs) rather
than voltage-operated Ca2+ channels (VOCCs) provide the major mechanism for Ca2+
influx. SOC is defined as a channel that opens in response to depletion of the internal
Ca2+ stores. SOC is activated when IP3 discharges Ca2+ from intracellular stores in the
ER or sarcoplasmic reticulum (SR) (Hoth and Penner, 1992).
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Ca
Figure 1.5.1 - Schematic Model of Store Operated Calcium Entry (SOCE)
An agonist binds to G-protein coupled receptor (GPCR) resulting in activation of PLC,
which cleaves P1P2 and generates diacylglycerol (DAG) and inositol (1,4,5)-
trisphosphate (IP3). Binding of IP3 to its receptor (IP3R) on the endoplasmic reticulum
(ER) causes release of Ca2+ into the cytoplasm. Intracellular Ca2+ store depletion
communicates with store-operated channels (SOC) in the plasma membrane leading to
the activation of store-operated Ca2+ entry (SOCE). SOCE is Ca2+ entry via SOCs.
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During the past 20 years, identification and characterization of SOC and evaluation of its
function have become one of the key goals of Ca2+ research. Recent studies suggest that
alterations in the activities of SOCs may be at the heart of several inflammatory diseases
(Nilius et al., 2005; Ma et al., 2006). Thus, understanding the regulation of SOCs may
prove to be important in developing specific drugs targeted to SOC.
1.5.2 TRPC
The molecular basis of Ca2+ influx in neutrophils is not well understood (Li et al., 2002).
• • • 2"l"
However, the transient receptor potential (TRP) family of non-voltage activated Ca
channels are thought to represent a key potential regulator ofCa2+entry in myeloid cells.
Overexpression of the TRP family enhanced SOCE, while reduction of TRP expression
using antisense strategies decreases SOCE uptake (Zhu et al., 1996; Birnbaumer et al.,
1996).
TRP channels have six putative transmembrane spanning regions with a pore domain
between regions 5 and 6 and have been subdivided into seven major subgroups based on
their amino acid sequence homology; (1) TRPC (classical or canonical), (2) TRPV
(vanilloid), (3) TRPM (melastatin), (4) TRPP (polycystin), (5) TRPML (mucolipin), (6)
TRPA (ankyrin) and (7) TRPN (NOMPC).
TRP channels are activated by multiple stimuli including intra- and extracellular
messengers, ligand activation, receptor activation, chemical, mechanical and osmotic
stress (Putney, 2005). Little was known about TRP expression and function in
neutrophils until recently. Table 1.5.2 summarises current data relating to the TRPC
family in myeloid cells. Several groups have demonstrated that TRPC6 and TRPC3
were present in human neutrophils (Heiner et al., 2003; Itagaki et al., 2004; McMeekin
et al., 2006). Itagaki et al. (2004) also confirmed that multiple TRPC proteins expressed










































































N No model reported
Table 1.5.2 Properties of TRPC Channels
E = Eosinophil, N = Neutrophil, M = Monocyte, P = Platelet.
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1.5.3 Role of Intracellular Ca2+ Signalling
Elevation of [Ca2+]j is a ubiquitous mechanism of signalling that initiates a wide variety
of physiological processes through the activation of enzymes that alter protein function.
Important cellular responses in neutrophils that are mediated or essentially regulated by
the [Ca2+]j include production and release of arachidonic acid products (Krump et al.,
1995), degranulation (Nusse et al., 1998) and respiratory burst (Thelen et al., 1993;
Granfeldt et al., 2002). Ca2+ has also been shown to be important for chemotaxis, in
particular for activation of P2-integrins (van et al., 1993) allowing the firm adhesion to
the endothelial lining of blood vessels and for the recycling of integrins in migrating
neutrophils (Lawson and Maxfield, 1995). These functional responses, which are
important for host defence are regulated by exogenous mediators, including cytokines,
chemokines, bacterial peptides and growth factors. It is now becoming clear that tight
spatio-temporal regulation of Ca2+ concentrations following exposure to these mediators
represents a key mechanism for initiation and control of neutrophil responses. For
example, SOCs can mediated spatially confined Ca2+ signals as seen during neutrophil
phagocytosis, where Ca2+ influx signals have two temporally and spatially separate
components associated with phagocytic cup formation and triggering of the oxidative
• • 9+ • •
burst respectively (Tian et al., 2004). The concentration of Ca inside the cell is
required to be finely tuned by a complex interplay between ion channels, transporters,
pumps and binding proteins.
Recent exciting reports suggest that disruption of the underlying control mechanisms of
SOCE in neutrophils may lead to inappropriate cell activation, contributing to
development of major life threatening disease including atherosclerosis, rheumatoid
arthritis, chronic obstructive pulmonary disease (COPD) and allergic reactions (Lee et
al., 2005; Steinckwich et al., 2007). Several groups have also demonstrated that SOCE
is required for the activation of neutrophil functions seen in an inflammatory context
(Kuhns et al., 1998; Adams et al., 2001) and clinical data (Hauser et al., 2000) suggests
that neutrophil dysregulation following injury and inflammation involves abnormally
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enhanced SOCE. Therefore, the pivotal role of Ca2+ signalling in the control of
neutrophil cell function and their impact on disease processes may also lead to the
identification ofnew therapeutic targets.
1.5.4 Phospholipid Signalling
The interaction of chemoattractants with their GPCR receptor expressed on neutrophils
triggers multiple second messengers through the activation of PLC, phospholipase D
(PLD) and phospholipase A2 (PLA2) and rapidly stimulates phosphatidylinositol-3-
kinase (PI 3-kinase), as well as activating tyrosine phosphorylation. The second
messengers resulting from the GPCR activation act on various intracellular kinases,
including PKC and mitogen-activated protein kinases (MAPKs). The activation of these
signal transduction pathways is known to be responsible for various biochemical
responses which contribute to physiological defence against bacterial infection and cell
disruption.
Fundamental studies in developmental biology, cellular biology and immunology have
established critical roles for PI 3-kinase signal transduction pathways in cellular
chemotactic responses, proliferation, apoptosis and survival. Structurally, PI 3-kinases
exist as heterodimeric complexes, consisting of a pi 10 catalytic (classified a, (3, y, and 5)
and a p55, p85, or plOl regulatory subunit (Vanhaesebroeck et al., 1997; Wymann and
Pirola, 1998). These enzymes can be further divided into 2 subclasses; class 1A (PI3-
kinase a, p and 5) and class IB (PI 3-kinase y) on the basis of their mechanism of
activation. Class 1A PI 3-kinases are stimulated by recruitment of regulatory subunits to
activated growth factor, cytokine and antigen receptors, while Class IB is stimulated by
direct binding of the catalytic subunit to activated GPCRs, such as chemokine receptors
(Okkenhaug and Vanhaesebroeck, 2003; Wymann and Marone, 2005). Activation of
both Class 1A and IB PI 3-kinases may be facilitated by catalytic subunit association
with activated Ras family GTPases. The resulting generation of phosphorylated lipid
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metabolites recruits and stimulates proteins containing PH (pleckstrin homology)
domains.
PI 3-kinases are known to play a pivotal role in the ability of neutrophils to undergo
chemotaxis, as the lipid products they generate, such as PIP3, are critical for promoting
asymmetric F-actin synthesis and thus cell polarization (Wymann et al., 2000; Rickert et
al., 2000; Fruman and Cantley, 2002). Their function, however, is not limited to directed
migration, as they are also required for phagocytosis and the ability of neutrophils to
generate oxygen radicals in response to chemoattractants such as fMLP (Wymann and
Arcaro, 1994; Ninomiya et al., 1994; Sasaki et al., 2000b; Cadwallader et al., 2002).
The ability of PI 3-kinases to regulate these processes relies on PIP3-mediated
recruitment of two lipid-binding protein kinases, phosphoinositide-dependent protein
kinase 1 (PDK1) and protein kinase B/Akt, both of which can interact with this
phosphoinositide derivative via their pleckstrin homology domains. Association of these
kinases with P1P3 at the plasma membrane brings them into close proximity, facilitating
the phosphorylation and activation of Akt by PDK1 (Cantley, 2002). PDK1, which is
thought to be constituently active, phosphorylates Akt at T308, leading to stabilization
of the activation loop in an active conformation. T308 phosphorylation is a requirement
for the kinase activation, but phosphorylation of the residue located at the hydrophobic
C-terminal region is also required for full activation of the kinase. This Akt S473 kinase
(PDK2) has not been identified as yet; however, findings from several recent studies
suggest a role for protein kinase integrin-linked kinase (ILK) in the activation process,
but it remains unknown whether or not ILK directly phosphorylates Akt at S473 (Persad
et al., 2001; Viniegra et al., 2005). These proteins are, in turn, responsible for many of
the downstream signalling events associated with PI 3-kinase activity.
Neutrophils express all 4 members of PI 3-kinases and their involvement in cell
migration is supported by the ability of nonselective PI 3-kinase inhibitors, such as
LY294002 and wortmannin, to mitigate neutrophil chemotaxis. Moreover,
demonstration that inhibition of a specific isoform of these lipid kinases may alter
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neutrophil extravasation into inflamed tissues has been suggested by the partial
reduction in chemoattractant-directed migration of these cells in mice deficient in the
pi 10 catalytic subunit (Hirsch et al., 2000; Li et al., 2000; Sasaki et al., 2000a;
Hannigan et al., 2002). Thus, these observations have triggered considerable interest in
the development of specific small molecule inhibitors to PI 3-kinases that may prevent
undesirable neutrophil accumulation in certain inflammatory disease states in humans
(Stein and Waterfield, 2000).
1.5.5 Tyrosine Phosphorylation
An increase in protein tyrosine phosphorylation is one of the earliest events after
stimulation of neutrophils, with a wide variety of stimuli inducing activation of selective
cell responses. Many studies have shown that neutrophil responses to chemoattractants
can be blocked with inhibitors of tyrosine phosphorylation, proving that tyrosine
phosphorylation plays an important role in chemoattractant signalling (Welch et al.,
1996). The Src family tyrosine kinases have been implicated in a number of GPCR
signalling pathways in leukocytes. Stimulation of many GPCRs directly increases the
enzymatic activity of Src family kinases (Ptasznik et al., 1995; Luttrell et al., 1996). In
neutrophils, the Src family kinases have been implicated in fMLP signalling as treatment
of neutrophils with Src family kinase inhibitors or use of cells from hck~/~fgr~/~lyn^~/_
mutant mice blocks degranulation responses to this agonist (Mocsai et al., 1999; Mocsai
et al., 2000). Together, these reports would suggest that the overall dominant role for Src
family kinases, and specifically for Src family members in neutrophils, is a positive
function in which the kinases propagate downstream signalling pathways after
chemokine stimulation.
1.5.6 Tyrosine Kinases in Signalling by Adhesion
As described earlier (1.3) adhesion to endothelial counter-receptors represents an
essential requirement for neutrophil transmigration into inflamed tissues. Additionally,
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neutrophil interaction with extracellular matrix proteins or tissue cells regulates their
secretion of proinflammatory and toxic compounds. Signalling by both selectins and
integrins plays a critical role in neutrophil functions and has been demonstrated to
involve tyrosine kinases. The signalling capacity of neutrophil L-selectin (Laudanna et
al., 1994) is blocked by tyrosine kinase inhibitors (Waddell et al., 1995). Additionally,
engagement of the selectin ligand PSGL-1 triggers tyrosine phosphorylation and
tyrosine kinase-dependent interleukin-8 secretion by neutrophils (Hidari et al., 1997).
Integrin signalling is also strictly dependent on tyrosine kinases in neutrophil and
macrophages, and substantial progress has been made in the identification of the tyrosine
kinases that are implicated in integrin signal transduction (Berton and Lowell, 1999).
Tyrosine kinases implicated so far in integrin signaling in neutrophils are Src-family
tyrosine kinases (Berton et al., 1994; Yan et al., 1995; Lowell et al., 1996), spleen
tyrosine kinase (Syk) (Yan et al., 1997; Fernandez and Suchard, 1998), and focal
adhesion kinase (Fak) (Fernandez et al., 1997). Studies using mice deficient in the
major Src family kinases present in neutrophils have demonstrated that the primary
positive signalling role for these enzymes is in the integrin pathway (Lowell and Berton,
1999; Lowell, 2004). Deficiency of Hck and Fgr renders neutrophils and macrophages
nonresponsive to adhesion-mediated activation after crosslinking of pi, P2, or p3
integrins.
1.6 Selectins and their Receptors
Studies in vitro and in vivo have revealed the critical role of the selectin family of
molecules in the initial capture and subsequent rolling on vascular endothelial ligands
(Lawrence and Springer, 1991) before their firm adhesion and diapedesis at sites to
tissue injury and inflammation. The selectins are three closely related cell-surface
molecules with differential expression by leukocytes (L-selectin), platelets (P-selectin)
and vascular endothelium (E & P-selectin). Each receptor contains an amino-terminal
domain related to those in Ca2+-dependent (C-type) lectins, followed by an epidermal
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growth factor (EGF)-like motif, a series of consensus repeats similar to those in
complement-regulatory proteins, a transmembrane domain and a cytoplasmic tail. The
lectin domain is directly involved in mediating cell-cell contact through Ca2+-dependent
interactions with cell-surface carbohydrates (Bevilacqua and Nelson, 1993; Bouyain et
al., 2001).
With respect to neutrophil recruitment at sites of inflammation, an emerging
generalization is that P and L-selectin function in the earliest phases of acute response,
whereas E- and possibly L-selectin are critical during later stages (Rosen and Bertozzi,
1994; Ley et al., 1995). Much recent investigation has focused on the identification and
characterization of glycoconjugate ligands for the selectins (Rosen and Bertozzi, 1994;
Sperandio et al., 2006). In particular, it has been demonstrated that the tetrasaccharide
sialyl Lewis x (sLex) and related terminal sugars expressed by neutrophils, monocytes
and some lymphocytes can act as ligands for E-selectin. sLex is also recognised by P-
selectin and L-selectin, although affinity of binding may differ substantially (Bevilacqua
and Nelson, 1993; Sperandio et al., 2006). These findings have been confirmed in
studies of leukocyte recruitment in mice deficient in both E- and P-selectins (Frenette et
al., 1996; Kakkar and Lefer, 2004) and in patients with leukocyte adhesion deficiency
syndrome type II (LADII) who lack the ability to produce appropriately glycosylated
selectin ligands (Phillips et al., 1995; Hidalgo et al., 2003).
The vascular selectins are recognized by neutrophil receptors which carry the
carbohydrate ligand for the selectins, sLex. The best characterized selectin ligand is P-
selectin glycoprotein ligand-1 (PSGL-1) which is found on leukocytes and platelets.
PSGL-1 binds to P-, E- and L-selectin in vitro and represents an important functional
ligand for all of these molecules. P-selectin appears specifically to recognize PSGL-1
whereas E-selectin recognizes a much wider range of sLex-carrying proteins and lipids.
For example, the carcinoembryonic antigen (CEA) subfamily of the Ig superfamily have
been implicated in recognition and as adhesion-supporting molecules and for neutrophils
CD66 antigens have been shown to mediate adhesion to E-selectin (Kuijpers et al.,
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1992). Recently there have also been reports that CD44 could bind to E-selectin
(Dimitroff et al., 2001) and that CD44 is a physiological E-selectin ligand on mature
human and mouse myeloid cells (Katayama et al., 2005). HCELL, which is a
specialised sialofucosylated glycoform of CD44, is highly expressed on neutrophils and
is also known to be a potent E-selectin ligand (Dimitroff et al., 2001; Dagia et al., 2006).
One potential PSGL-1 independent ligand for E-selectin is E-selectin ligand-1 (ESL-1),
an N-glycosylated protein that may be oligomerized to enhance binding avidity,
compensating for its relatively low binding (Xia et al., 2002). ESL-1 binds specifically
to E-selectin but not to P-selectin (Levinovitz et al., 1993) and is expressed by a wide
variety of cell types, although the glycoform that binds to E-selectin has only been found
in myeloid cells (Vestweber and Blanks, 1999). ESL-1 has been described in murine
leukocytes but its function and expression in human cells is uncertain.
The question of how the selectins achieve high affinity and selectivity in vivo has caused
tremendous interest. Affinity, as well as selectivity, could also derive from distinctive
features of the carbohydrate chains or the protein core. There is growing evidence
indicating that sulphation is a critical feature for at least two classes of selectin ligands,
L- and P-selectin (Feizi, 2001). Two enzymes catalyzing carbohydrate sulphation N-
acetylglucosamine 6-O-sulfotransferase [(GlcNAc6ST)-l and -2)] were found to be
involved in the generation of 6-sulfo sLex which is important for L-selectin ligand
activity on HEV (Uchimura et al., 2005; Kawashima et al., 2005). In the case of P-
selectin, early experiments with selenate (a salt of selenic acid and a metabolic inhibitor
of sulphation) suggested the potential importance of sulphation for neutrophil ligands
(Aruffo et al., 1991). Furthermore, sulphation of tyrosine residues at the N-terminus of
PSGL-1 has been reported to significantly influence binding of P-selectin to PSGL-1
(Ramachandran et al., 1999). Thus, both L- and P-selectin recognise sulphated ligands.
In addition both L- and P- but not E-selectin can bind sulphated molecules such as
heparin and sulfatides (Norgard-Sumnicht et al., 1993). Therefore, sulphation is
important in L- and P-selectin ligand interactions but E-selectin recognition of ligands
appears to differ from these two classes of selectins. These findings suggest that each
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selectin preferentially interacts with very specific ligand structures. Although selectins
bind with moderate affinity to sialylated, fucosylated and (in some cases) sulphated
carbohydrate ligands, typified by the sLex, preferred natural ligands are more complex
glycoconjugates. If neutrophils use multiple receptors to bind selectins, this may
provide an opportunity to selectively inhibit specific effects of selectins upon neutrophil
function.
1.6.1 Regulation of Selectins
As contact formation between most leukocytes and endothelium is initiated by selectins,
the regulation of their presence on the cell surface is important for the control of
leukocyte extravasation. The two endothelial selectins, E- and P-selectin, are absent
from the cell surface of non-activated endothelial cells and become induced upon
exposure of the endothelium to various pro-inflammatory stimuli. This ensures that
these selectins are only present on endothelium in proximity to inflamed tissues. L-
selectin in contrast, is constitutively expressed on leukocytes, but is shed by proteolytic
cleavage following cellular activation (Bevilacqua and Nelson, 1993). Proteolytic
shedding occurs on neutrophils within minutes and can be induced by a variety of
chemoattractants and activating factors such as C5a, fMLP, LTB4, IL-8, TNFa,
granulocyte-macrophage colony stimulating factor (GM-CSF), and calcium ionophores
(Griffin et al., 1990). Thus, the function of L-selectin in the initiation of leukocyte-
endothelial contacts in inflamed areas is controlled by the regulated appearance of its
ligand(s).
Temporal differences in E- and P-selectin expression on vascular endothelium observed
in response to tissue injury indicate distinct roles for these molecules in the recruitment
of leukocytes. E-selectin expression is limited to endothelium and principally to
endothelium in response to inflammatory stimuli such as interleukin-1 (IL-1), TNF-a or
bacterial LPS. The loss of E-selectin from the surface of activated endothelial cells is
most likely caused by a combination of factors. Firstly, E-selectin gene transcription is
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sharply downregulated within 6 to 9 hours after induction (Bevilacqua et al., 1989) and
the E-selectin mRNA has a short half life (Ghersa et al., 1992). Secondly, E-selectin is
rapidly internalized and degraded in lysosomes (Subramaniam et al., 1993). Endothelial
cells have also been shown to shed E-selectin into the microcirculation following in vitro
activation (Pigott et al., 1992; Newman et al., 1993). The combination of these
processes collectively ensures that the expression of E-selectin at the surface of
cytokine-stimulated endothelium is transient and the activity of the selectins is likely to
be controlled in large part by regulation of their appearance and disappearance from the
cell surface.
1.6.2 Selectins and Disease
The neutrophil plays an essential role in host defence however there is accumulating
evidence that dysregulation of neutrophil function can result in injury to healthy tissue
and is associated with the pathogenesis of a large number of inflammatory conditions.
In many diseases such as rheumatoid arthritis, vasculitis and glomerulonephritis, the
neutrophil is thought to contribute to disease progression (Weissmann and Korchak,
1984; Heinzelmann et al., 1999). In acute respiratory distress syndrome (ARDS),
neutrophils may cause injury through enhanced production of reactive oxygen species
(McGuire et al., 1982). Influx of neutrophils and subsequent activation is also thought
to be involved in ischemia-reperfusion injury (Jordan et al., 1999).
The inappropriate or abnormal sequestration of neutrophils at specific sites is a central
component in the development of a variety of autoimmune diseases and pathologic
inflammatory disorders. Therefore, therapeutic agents that block neutrophil-endothelial
interactions have a dramatic effect on the progression of inflammatory responses in a
number of animal models (Albelda et al., 1994). The restricted role of the selectins in
directing leukocyte interactions with vascular endothelium makes these molecules
extremely attractive targets for intervention by therapeutic agents (Etzioni, 1994).
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The function of selectins in vivo, as well as their expression patterns in vivo, points to
their involvement in a wide variety of human diseases including atherosclerosis,
ischemia-reperfusion injury, acute lung injury, rheumatoid arthritis, graft rejection and
various cancers. E-selectin has been shown to be expressed on activated endothelium at
sites of active inflammation (Panes et al., 1999). In animal models of acute lung injury,
antibodies against E-selectin were protective against lung damage induced by several
stimulants (Mulligan et al., 1993). In a primate model of extrinsic asthma, antibody
blocking data has suggested that E-selectin plays a major role in neutrophil influx
associated with late phase airway obstruction (Gundel et al., 1991). In animals sensitive
to antigen, a single inhalation exposure induced the rapid expression of E-selectin and
exclusively on vascular endothelium that correlated with influx of neutrophils into the
lungs and the onset of late-phase airway obstruction. A monoclonal antibody to E-
selectin blocked both the influx and the late-phase airway obstruction. The authors
concluded that in primates the late phase response was due to E-selectin dependent
neutrophil influx and that regulation of E-selectin expression may provide a novel
approach to control the acute inflammatory response in diseases such as asthma.
Recent data suggest that E- and P-selectin may participate in neutrophil mediated
damage associated with ischemia reperfusion injury to the heart (Kakkar and Lefer,
2004). It has also been demonstrated that E-selectin is upregulated in the mouse
myocardium following ischemia reperfusion (Jones et al., 2000) and that genetic
deficiency of E-selectin conferred cardioprotection with a reduction in myocardial
infarct size owing to attenuation of neutrophil accumulation (Sligh, Jr. et al., 1993).
Selectin-carbohydrate interactions are also being studied in relation to hematogenous
metastasis of cancer cells. E-selectin has been shown to support the adhesion of human
colon and breast cancers (Tozeren et al., 1995; Gout et al., 2006). sLea and sLex are the
representative oligosaccharides involved in E-selectin binding both of which are
expressed in abundance in human colon and breast cancers (Kim and Varki, 1997).
Elevated plasma levels of soluble E-selectin are associated with various chronic
inflammatory conditions. For example, soluble E-selectin levels were found to be
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increased in ARDS patients (Ruchaud-Sparagano el al., 1998) and elevated soluble E-
selectin levels have been detected in burn patients (Ljunghusen et al., 1996) and breast
and gastric cancer patients (O'Hanlon et al., 2002; Alexiou et al., 2003). Levels of
soluble E-selectin have also been reported to be significantly higher in rheumatoid
arthritis and systemic sclerosis patients (Ates et al., 2004). Soluble E-selectin levels
have also shown marked elevations in sepsis, in one study a 20 fold increase over
normal range was reported (Newman et al., 1993). Soluble E-selectin appears to
correlate with disease severity and/or outcome in several of these diseases as higher
levels of persistent elevation are often associated with greater mortality (Gearing and
Newman, 1993). Therefore, serum levels of E-selectin may provide a useful additional
marker for disease activity or disease severity in patients with inflammatory diseases and
measurement of these selectins may increase our understanding of the relationship
between in vivo endothelial activation and inflammation.
Based on studies like these many laboratories are trying to identify novel anti¬
inflammatory compounds. These efforts involve antibody-, peptide-, and carbohydrate-
based approaches to block selectin-dependent adhesion directly. Selectin antagonists
may prove to be effective therapeutics agents alone or may complement drugs designed
to block the expression and the function of other adhesion molecules.
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Aims
The primary aim of this thesis was to investigate the nature of the intracellular signals
generated following exposure of neutrophils to soluble E-selectin. Soluble E-selectin
levels are elevated in many chronic inflammatory conditions and soluble E-selectin has
been shown to promote neutrophil destructive function and potentially influence the
progression of inflammation. Therefore, understanding the mechanisms by which
selectins influence intracellular signalling pathways could reveal new therapeutic targets
for the treatment of inflammatory disease.
Specifically, 1 wished to:
1. Define the signalling pathways involved in E-selectin-mediated prolongation of
intracellular calcium levels and identify the calcium channel involved.
2. Determine the mechanisms involved in the regulation of E-selectin-mediated store
operated calcium entry.
3. Study the functional consequence of E-selectin-mediated store operated calcium
entry.
4. Identify the glycoprotein ligands for E-selectin on neutrophils that mediated altered
store operated calcium entry.
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Chapter 2 - Materials and Methods
2.1 Antibodies and other reagents
Reagents
Reagents were obtained from Sigma-Aldrich (www.sigmaaldrich.com) unless otherwise
stated. Hanks' balanced salt solution (HBSS) was obtained from Invitrogen
(www.invitrogen.com.). Dextran T500 was purchased from Amersham Pharmacia
Biotech (wwwl.amershambiosciences.com). Express-five serum free media was
obtained from Invitrogen and High Five cells were a kind gift from Dr Gavin Nicoll,
Edinburgh University. Recombinant E-selectin was obtained from R&D Systems
(www.rndsystems.com). MRS 1845 and ruthenium red were purchased from Tocris
(www.tocris.com). PAF, OAG, thapsigargin, U73122, U73343, LY294002
hydrochloride, LY303511 Fura2-AM, PP2, PP3, SB203580, SB202474, PD98059, 2-
APB, R59949 and Ro-31-8220 were purchased from Calbiochem
(www.merckbiosciences.co.uk). EZ-Link, Sulfo-NHS-Biotin Reagent was obtained
from Pierce (www.piercenet.com). Streptavidin horseradish peroxidise was purchased
from Dako (www.dako.com). Enhanced chemiluminescence (ECL) Western blotting
detection reagents were obtained from Amersham Pharmacia Biotech. All PCR reagents
were purchased from Promega (www.promega.com) unless otherwise stated.
Antibodies
All antibodies were mouse monocolonal IgG unless otherwise stated. Mouse anti-
human CD16:RPE and mouse anti-human CD 162 clones PL-1 and PL-2 were obtained
from Serotec (www.serotec.com). Mouse anti-human E-selectin F(ab)2 (ENA2) was
purchased from Abeam (www.abcam.com). Rabbit polyclonal anti-TRPC3 and TRPC6
were purchased from Alamone Labs (www.alomone.com). Rabbit polyclonal IgG anti-
phospho-Src family (Tyr416) and rabbit phospho-(Ser) PKC substrate antibody were
purchased from Cell Signalling (www.cellsignal.com) and anti-phospho-Aktl/PKBa
(Ser473), clone 11E6 was obtained from Upstate (www.upstate.com). PKC sampler kit
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(DGK0, PKCa, P, y, 8, e, r|, 0, i, X & RACK1) was obtained from BD Biosciences
(www.bdbiosciences.com). LFA-1 antibody was a kind gift from Dr JE Hildreth.
Monoclonal anti-P-actin antibody was purchased from Sigma-Aldrich. Polyclonal goat
anti-mouse immunoglobulin and goat anti-rabbit immunoglobulin horseradish
peroxidase-conjugated antibodies were obtained from Dako (www.dako.com).
2.2 Mononuclear and Polymorphonuclear Leukocyte Isolation
Human peripheral blood was taken from healthy volunteers and collected into tubes
containing 4ml of 3.8% sodium citrate (Phoenix Pharmaceuticals Ltd., Gloucester, UK)
to a final volume of 40ml and then centrifuged at 350 x g for 20 min. All steps were
carried out at room temperature. The resulting upper platelet rich plasma (PRP) layer
was removed and autologous serum was prepared by adding 10ml of PRP to 220pl of
1M CaCl2 and incubated for 1 hour (h) at 37°C in glass serum tubes. Leukocytes were
separated from erythrocytes in the cell pellet by dextran sedimentation using 2.5ml of
6% (w/v) dextran T500 per 10ml of packed cells, made up to 50ml with 0.9% saline and
then left for 30 min at room temperature to sediment. The resulting leukocyte-rich upper
layer was then collected and centrifuged at 350 x g for 6 min to pellet the leukocytes.
Polymorphonuclear leukocytes were then separated from mononuclear leukocytes using
discontinuous isotonic Percoll gradients. Percoll was made isotonic by preparing a 90%
solution using lOx PBS. The isotonic Percoll was then used to make 81%, 68% and
55% layers using lx PBS without CaCU or MgCl2. Gradients were prepared by layering
3ml of 68% onto 3ml or 81% Percoll. The cell pellets were then mixed with 3ml of 55%
layer and layered onto the gradient. The Percoll gradients were then centrifuged at 720x
g for 20 min. Polymorphonuclear leukocytes and mononuclear leukocytes were
harvested from the 68%/81% and the 55%/68% interfaces, respectively. Leukocytes
were then washed twice in PBS without CaCl2 and MgCl2 before cell culture.
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2.3 Quality Control for Cell Isolation
Cells collected from each layer of the gradient were subject to flow cytometry analysis
by forward and side scatter (Figure 2.3.1). The PMN fraction was labelled with mouse
anti-human CD16:RPE and analyzed using the FL-2 detector, to check the percentage of
neutrophils (Figure 2.32). The percentage eosinophils were checked by cytopsin. The
PMN used in all experiments were >95% neutrophils, with less than 5% eosinophils
present and are hereafter referred to as neutrophils.
2.4 Neutrophil Culture
Neutrophils were resuspended at 4xl06/ml in Iscove's DMEM + 10% autologous serum
and incubated for 20 h at 37°C and 5% CO2 in 96 well flat bottom flexible plates
(www.bdbiosciences.com) to induce apoptosis.
2.5 Characterisation ofNeutrophil Apoptosis by Flow Cytometry
Following in vitro culture, neutrophils were labelled with FITC-conjugated annexin V
and propidium iodide (PI). Annexin V was diluted 1/500 in annexin V buffer (Ca2+ and
Mg2+ free PBS + 5mM CaCl2) and 280pl was then added to a tube containing 20pl of
neutrophils of 4xl06/ml and incubated on ice for 10 min. Immediately prior to analysing
the sample, lpl of lmg/ml PI was added to the cells. Annexin V and PI binding were
measured using FL1 and FL2 detectors respectively.
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Figure 2.3.1 Flow Cytometry profiles for PMN and monocyte-rich layers Percoll
gradient isolation.
Mononuclear and polymorphonuclear (PMN) cells were isolated from peripheral blood
and separated by Percoll gradients. Representative flow cytometry FS and SS profiles
are shown for (A) the PMN fraction and (B) the mononuclear cell fraction. Gates were









Figure 2.3.2 Flow Cytometry histograms for unlabelled and CD16 labelled PMN's
Fc(gamma)RlIlb (CD16) is a glycosyl phosphatidylinositol (GP1) anchored low-affinity
IgG receptor, expressed by human neutrophils. Representative histogram plots are
shown for (A) unlabelled PMN fraction showing that eosinophils present in the cell
preparation have an increased autofluoresecence compared with neutrophils and (B)
CD 16 labelled PMN fraction.
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2+2.6 Measurement of [Ca ]j
Freshly isolated neutrophils were resuspended at 107/ml in HBSS (Ca2+and Mg2+ free),
and were incubated with 2pM Fura2-AM at 37°C for 30 min in the dark. The cells were
then washed twice to remove extracellular Fura2-AM and resuspended at 4 x 107/ml in
• • 2+ 2+ •HBSS (containing Ca and Mg ). Intracellular calcium was monitored by Fura-2
emission fluorescence at 510nm using 340/380nm dual wavelength excitation in a
Perkin Elmer luminescence spectrometer at 37°C with constant stirring. [Ca2+]j was
calculated from the 340/380nm fluorescence ratio as described (Grynkiewicz et al.,
1985) using the equation: [Ca2+]f = Kd x B x [(r -rmin)/(rmax -r)], where r is the measured
Fura-2 fluorescence ratio between 340 and 380 nm. rmax, the maximum 340/380 nm
ratio, was obtained by lysing cells with lOOpl 0.1% (v/v) Triton XI00. rmjn, the
minimum 340/380 ratio, was obtained by adding lOmM EGTA. Kd is the dissociation
constant of the Fura-2/Ca2+ complex (224 nM), and B is the ratio of fluorescence at 380
nm at 0 and saturating Ca2+ concentration (Figure 2.6.1).
2.7 Superoxide Assays
Determination of release of superoxide anions by freshly isolated neutrophils was
performed as described previously (Condliffe et al., 1996). Briefly, neutrophils were
preincubated with inhibitors as described in figure legends prior to addition of TNF or
PAF, in the presence of cytochrome c (1 mg/ml), for 15 min at 37°C. Following this, the
reaction was stopped by centrifugation (300 g, 5 min, 4°C) and the superoxide
dismutase-inhibitable reduction of cytochrome c was determined for each supernatant by
measuring the peak absorbance between 535 and 635 nm using a scanning
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Figure 2.6.1 Measurement of [Ca +]j
2_|_
[Ca' ]j was monitored by FURA-2 emission fluorescence at 510nm using dual 340/380
wavelength excitation (A). Calibration was performed after each experiment using 0.1%
Triton XI00 to obtain the Rmax and lOmM EGTA to calculate Rmin (B). [Ca2+]j was
calculated from the 340/380nm fluorescence ratio and (C) shows a representative
calcium trace showing the changes in [Ca2+]j.
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2.8 Adhesion Assays
Recombinant E- and P-selectin and fetal calf serum (FCS) in 0.1 M bicarbonate (pHlO.O)
were absorbed to 96 well plates (CoStar) at a concentration of lpg/ml overnight at 4°C.
FCS was heat-inactivated by heating it at 56°C for 30 min. Plates were then blocked
with 10% (v/v) heat-inactivated fetal calf serum (HI-FCS) in HEPES-buffered saline for
2 h at 4°C before use in adhesion assays. For adhesion blockade using CD62E, wells
were pre-incubated with 1:50 dilution of ENA2 F(ab)2 for 30 min at 4°C. Neutrophils
were resuspended at 3 x 106/ml in HEPES-buffered saline containing 4mM CaCh (assay
medium) and were incubated (lOOpl per well) at 4°C for 30 min with gentle agitation
using a rocking platform. Plates were then washed six times in assay medium alone and
fixed in 3% paraformaldehyde. Adhesion of neutrophils was viewed under a Zeiss
Axiovert microscope, with images captured using AppleMac OpenLab image capture
system.
2.9 Migration Assays
Neutrophil chemotaxis was measured using the sub-agarose methods (Chenoweth 1991)
with some modifications. Clean glass microscope slides were dipped in 0.5% gelatine in
PBS, rinsed and then dried. 5ml of molten 1% agarose (Indubiose) /0.25% gelatine in
medium 199 supplemented with 1% BSA was then slowly poured using a 5ml pipette
onto the slide and was finally cut with a pattern-former giving one set of three wells per
slide. The neutrophils (8pl at 5 x 107/ml in medium 199) were added to the central wells
and 8pl aliquots of medium 199 plus or minus fMLP/PAF (final concentration 10~7M,)
were added to the outer well. The slides were incubated for 2h at 37°C, fixed overnight
in 2.5% glutaraldehyde and stained with Diff-Quik Staining set
(www.baxterhealthcare.co.uk). Migration distances of duplicate samples were measured
by determining the leading edge of neutrophil mobility for both directed and random
migration using a Zeiss Axiovert si00 with lOx magnification. Chemotactic response
was defined as the specific migration towards the chemoattractant fMLP or PAF.
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2.10 Electrophysiology
Before electrophysiological recording the neutrophils were plated onto glass coverslips
coated with Sigmacote™. Neutrophils were plated directly onto clean coverslips and
allowed to adhere for 5-10 min.
Human neutrophils were visualized using a water immersion objective (40x, Carl Zeiss
Ltd, Welwyn Garden City, UK) and Nomarski differential interference contrast optics.
Recording pipettes were made from thin-walled borosilicate glass capillaries (GC150TF,
www.harvardapparatus.com) using a patch-pipette puller (Narishige PP-83,
www.intracel.co.uk). The patch-pipette was coated with sylgard to reduce capacitance.
For whole-cell voltage clamp experiments, the standard extracellular bath solution
contained 140mM NaCl, 1.2mM MgC^, 1.2mM CaCh, 5mM KC1 and lOmM Hepes;
the pH was adjusted to 7.4 using KOH. The pipette solution contained 145mM caesium
glutamate, 8mM NaCl, 2mM MgCU, lOmM caesium-EGTA, lOmM Hepes; pH 7.2
(CsOH). Cells were held at a potential of -60 mV. Current-voltage (I—V) relationships
were obtained from voltage ramps from -90 to +60 mV, applied over 200 ms. The
experiments were performed at room temperature.
Off-line analysis was performed using a CED1401+ interface (www.ced.co.uk), personal
computer and Signal software (www.ced.co.uk).
2.11 Biotinylation of Cell Surface
Fresh neutrophils were resuspended in PBS (containing Ca2+ and Mg2+) at 5xl06/ml and
biotin (EZ-Link, Sulfo-NHS-Biotin Reagent) was added to a final concentration of
0. lmg/ml and left for 1 h on ice. Neutrophils were then washed 3 times in PBS
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(containing Ca2+ and Mg2+) and the cells were lysed as described in whole cell lysis
section 2.12
2.12 Whole Cell Lysis Method
Neutrophils (5 x 106 cells/ml per sample), were lysed, following stimulation as detailed
in figure legends, in lysis buffer containing 100 mM Tris HC1 (pH 8.0), 100 mM NaCl ,
2 mM EDTA, 1% v/v Nonidet NP-40, 5 mM Na3V(>4, 50 mM NaF & protease inhibitor
cocktail for 30 min at 4°C. Samples were centrifuged for 20 min at 15,000 rpm at 4°C
and supernatants were incubated with electrophoresis sample buffer under reducing
conditions which contained 0.25M Tris HC1 (pH 6.8), sodium dodecylsulphate (8%
w/v), p-mercaptoethanol (10% w/v), glycerol (30% v/v) and bromophenol blue (0.02%
w/v).
2.13 Immunoprecipitation
Lysates of freshly isolated neutrophils were made as detailed in whole cell lysis method.
lpg-3pg of immunoprecipitation antibody was added to each lysate and left on ice for
one hour. A conjugated Sepharose resin was used to pull out the antibody as appropriate
and left to spin for 2 h at 4°C. The samples were then centrifuged to pellet the
Sepharose and washed four times in whole cell lysis buffer and resuspended to 25pi in
whole cell lysis buffer. The samples were then incubated with reducing sample buffer
and boiled at 95°C for 5 min. Each sample was loaded onto a 7.5% SDS-poIyacrylamide
gel and run and blotted using the western blotting protocol.
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2.14 Triton X-100 Fractions
Neutrophils (5 x 106 cells/ml per sample) were lysed, following stimulation as detailed
in figure legends, in 200pl of 2X cytoskeleton stablisation (CSK) buffer (50mM PIPES,
8M glycerol, 2mM MgCl2, 0.4% Triton X-100, 4mM EGTA, 4mM EDTA) + 500pl
whole cell lysis buffer per 500pl of 2X CSK used and lysed for 10 min at 4°C. The
samples were centrifuged at 14,000g for 10 min at 4°C. Supernatants were removed and
these samples were called the Triton X-100 soluble fractions. The pellets were washed
once for 3 min in IX CSK buffer and then resuspended to 200pl in
Radioimmunoprecipitation (R1PA) buffer (25mM Tris-HCL, 150mM NaCl, 1% Triton
X-100, 0.1% SDS, 1% sodium deoxycholate) and left to lyse for 30 min at 4°C to obtain
the Triton X-100 insoluble fraction. Both the soluble and insoluble Triton X-100
fractions were resuspended in reducing sample buffer and boiled at 95°C for 5 min prior
to analysis by SDS-PAGE and western blotting as described in the relevant sections.
2.15 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
SDS-PAGE was used to separate proteins by running samples through an acrylamide
gel. There are two gels, the running gel and the stacking gel. The stacking gel is of very
low acrylamide concentration and is used to form the wells into which the protein is
loaded. The low acrylamide concentration also allows most proteins to be concentrated
at the dye front, so that dilute protein samples can be compared to concentrated samples
on the same gel. The higher the acrylamide concentration in the running gel the slower
the proteins migrate through the gel. On lower percentage gels proteins go faster,
therefore the percentage of the gel was chosen so that the protein of interest would be
found in the running gel. After cell lysis samples were loaded onto SDS-PAGE gels
which were made up of the following solutions:
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Running Gel Solution - 1 running gel (7.5mls)
7.5% 10.0%
Acrylamide/Bisacrylamide Mix 1.88mls 2.5mls
Separating Buffer (1.5M Tris pH8.8) 1.88mls 1.88mls
h20 3.71mls 3.09mls
10% SDS lOpl 10(ol
10% Ammonium Persulfate (APS) 30pl 30pl
Temed 6(0.1 6(0.1
Stacking Gel Solution - 1 stacking gel (2.5mls)
Acrylamide/Bisacrylamide Mix 375(0.1






Cell lysate samples were loaded onto a SDS-polyacrylamide gel, the samples were then
run at 80V through the stacking gel and 120V through the running gel. Following
electrophoresis, the gels were electrophoretically transferred to nitrocellulose by passing
a current of 80V through the gel to the membrane in transfer buffer (25mM Tris, 0.2M
glycine pH8.3, 20% methanol) for 1 h. The membranes were then blocked for 1 h in 5%
w/v dried milk diluted in Tris-buffered saline pH7.6 containing 0.1% v/v Tween 20
(TBST) and probed with primary antibody overnight in TBST (see figure legends).
After washing four times with IX TBST, blots were incubated with goat anti-mouse
immunoglobulin HRP conjugate (1:2500) or with goat anti-rabbit immunoglobulin HRP
conjugate (1:2500) antibodies diluted in TBST for 1 h at room temperature. After four
times washing in TBST the membranes were incubated with ECL reagent, placed under
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BioMax MS-1 X-ray sensitive film, and processed through an X-ray developer
(www.xograph.com).
2.17 RNA Isolation and RT-PCR
Freshly isolated neutrophils (25 x 107/sample) were pelleted and resuspended in 1ml
Trizol and incubated for 5 min at room temperature. 0.2ml of chloroform per 1ml of
trizol was added to lyse the cells and the tubes were shaken vigorously by hand for 15 s,
followed by an incubation at RT for 3 min. The tubes were then centrifuged at 12000g
for 15 min at 4°C. The supernatants settled out into an upper RNA rich phase, an
interphase of protein and a lower phase of DNA and protein. The upper phase was
removed and collected into fresh tubes and 0.25ml of isopropanol was added to each
tube and the RNA incubated on ice for 10 min. After centrifugation at 12000g for 10
min at 4°C, a pellet formed which was washed once with 70% ethanol and then
centrifuged at 7500g for 5 min at 4°C. The ethanol was then removed and the pellet air
dried for 10 min, after which it was dissolved in 20pl ofRNase free water and incubated
at 55°C for 10 min.
RNA was then DNAse treated to remove any contaminating DNA using a DNAse kit
(www.ambion.com). 0.1 volume (of the RNA) of lOx DNAse 1 buffer and lpl of
DNAse 1 enzyme was added to the RNA and mixed gently and incubated at 37°C for 30
min. 5jul DNAse inactivation buffer beads were then added to each tube of RNA and
incubated at 37°C for 2 min and centrifuged at lOOOOg for 1 min to pellet the
inactivation buffer beads. The supernatant containing the RNA was then transferred to
fresh tubes and stored at -80°C.
The isolated RNA was then reverse transcribed to generate cDNA. The RNA was first
assessed for purity and yield by measuring absorbance at 260nm and 280nm. An
absorbance reading of 1 unit at 260nm corresponds to 40pg/ml RNA in RNase free
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water. The concentration of RNA (pg/ml) = 40 x A260. The ratio of the readings at
260nm and 280nm (A260/A280) provides an estimate of the purity of the RNA.
1 pi of oligo DT and 2pg ofRNA was made to a final volume of 12pl by the addition of
dFEO and then incubated at 70°C for 10 min. 4pl of 1st strand buffer, 2pl of 0.1 M DTT,
0.5pl of 20mM dNTP and 0.5pl of RNAse inhibitor mix was then added and incubated
at 42°C for 2 min to equilibrate the mix, after which lpl of superscript enzyme was
added and the mix incubated at 42°C for 50 min and then at 70°C for 15 min. The
cDNA was then stored at -20°C until required.
2.18 PCR
PCR reactions were carried out using the following reaction mix for 25pl sample: 19pl
RNase free water, 2.5pl of lOx reaction buffer, 0.5pl of lOmM dNTP, 0.75pl of 50mM
MgCl2, 0.5pl of 20pmol/pl forward and reverse primer, lpl of cDNA and 0.25pl Taq
polymerase. Each time a PCR reaction was run, a positive control reaction using
GAPDH primers and a negative control reaction without template cDNA was run, to
confirm any product was derived from the cDNA.
Two pairs of specific primers each were used to detect TRPC1, 3, 4 & 6 and one primer
pair was used for TRPC2, 5 & 7, primers were synthesised by MWG Biotech
(www.mwg-biotech.com). The sequence of the primer pairs used along with the
predicted size of their expected amplicons are as follows:
TRPC1: Forward 5'-ATGTATACAACCAGCTCTATCTTG-3' &
Reverse 5'-AGTCTTTGGTGAGGGAATGATG-3' (525bp);
TRPC2: Forward 5'-TCTGGACCATGTTCGGTATG-3' &
Reverse 5'-GCTACCTCGCTTTGCAGTC-3' (565bp)
TRPC3: Forward 5'-CTGCAAATGAGAGCTTTGGC-3' &
Reverse 5'-AACTTCCATTCTACATCACTGTC-3' (388bp).
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The PCR conditions were: 95°C for 10 min, followed by 35 cycles, each consisting of
denaturation at 95°C for 1.5 min, annealing at 63°C for 2 min and extension at 72°C for
2 min and a final extension at 72°C for 10 min. After PCR amplification, the reaction
mixtures were applied to 1% (w/v) agarose gel for electrophoresis and DNA fragments
were detected by ethidium bromide staining.
2.19 Expression of E-selectin
Recombinant fusion proteins of E-selectin were obtained using a baculovirus expression
construct kindly provided by Dr Mike Bird, GlaxoSmithKline, Stevenage, U.K.
Recombinant human E-selectin, lacking the last two consensus repeats, was produced in
a baculovirus insect cell expression system as a C-terminal chimera with two protein A
domains in tandem (Figure 2.19.1). High five cells (BT1-TN-5B1-4 cell line,




Figure 2.19.1 Recombinant E-selectin Structure
The extracellular portion of E-selectin contains an amino terminal domain homologous
to C-type lectin domain and an adjacent epidermal growth factor like domain (EGF).
These are followed by six consensus repeat domains (CRD) (numbered circles) and a
transmembrane sequence (grey recentangle) and a short cytoplasmic sequence is at the
carboxyl terminus. Recombinant E-selectin is comprised of the N-terminal C-type lectin
domain, an epidermal growth factor domain and four of the CRDs with two protein A
domains (grey diamonds) inserted in tandem at the C- terminal.
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High five cells were cultured in Express Five serum-free media supplemented with L-
glutamine and penicillin/streptomycin. High Five cells (9xl06/75cm2 flask) were seeded
into cell culture flasks and left to adhere for 20 min. After attachment of the cells, the
medium was removed and the cells were infected with recombinant virus at 2 PFU/cell.
Three hours later, the medium was replaced with fresh medium. After 72 h incubation at
27°C, the culture supernatant was collected and stored at 4°C for further purification
(Figure 2.19.2).
2.20 Purification of E-selectin
Recombinant proteins were then purified from High Five Insect cell culture supernatants
using IgG affinity column chromatography utilising the protein A domains in the
recombinant protein. A column (0.7cm x 10cm) containing IgG-agarose was
equilibrated with 5 column volumes of 0.1M phosphate buffer pH 8.0. The supernatant
from infected High Five cells was applied to the affinity column and the column was
then washed with 2 column volumes of 0.1M phosphate buffer before elution with
lOOmM glycine in 500pl fractions. Fractions were analyzed by SDS-PAGE
electrophoresis for protein content (Figure 2.20.1). The eluted proteins were then
dialyzed against PBS (Ca2+and Mg2+ free) overnight. A typical yield was 1.5-2.0mg of
protein per 250ml supernatant.
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Figure 2.19.2 Expression of E-selectin
Uninfected High Five cells (A), these cells continue to divide and form a confluent
monolayer. High Five cells infected with E-selectin baculovirus, after 72 h incubation
(B), these cells stop dividing and enlarge and produce E-selectin into the supernatant.
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Figure 2.20.1 Purification of E-Selectin
Coomassie blue gel of the different stages of the E-seleetin purification process. Soluble
E-selectin is approximately 70 KDa in size and recombinant E-selectin (rE-sel)
purchased from R&D Systems was used as a positive control. S= E-selectin transfected
High Five cell culture supernatant, FT= Flow Through and P = Purified soluble E-
selectin.
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2.21 Amplification of Virus Stocks
High Five cells were infected at cell concentration of lxlO6 cell/ml at a MOl of between
0.01-0.1 PFU/cell and incubated at 27°C with constant agitation between 90-110rpm.
During infection 5% (v/v) HI-FCS was added to the culture. Cells were counted the
following day and if necessary were diluted to maintain a cell concentration of 2x106
cells/ml. The cell concentration was monitored and maintained at 2x106 until it was
observed that cell growth had stopped. The culture was then left for a further 3 days.
The virus was harvested from cell culture supernatant by centrifugation at 2000 x g for
30 min and the virus was stored at 4°C in the dark.
2.22 Flow Cytometry Software
All flow cytometry data collected was analysed using the Becton Dickinson Cell Quest
software package.
2.23 Statistical Analysis
Data was analysed using the GraphPad Prism statistical package. When more than two
conditions were compared, data was analysed by repeated ANOVA with post t-test
(Tukey-Kramer Multiple Comparisons Test).
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Chapter 3: Identification of Store Operated Calcium Entry in
neutrophils
3.1 Introduction
Inflammatory processes expose neutrophils to a wide variety of agonists that can attract,
prime, or activate neutrophils via heterotrimeric GPCRs. Neutrophil GPCRs activate a
variety of signal transduction pathways including increasing cytosolic Ca2+
concentration and phosphorylation of proteins for example MAP kinase and PLC (Chen
et al., 2005; Selvatici et al., 2006). Increases in [Ca2+]j have profound effects on
neutrophils, including the initiation of cytoskeletal changes, degranulation, presentation
of adhesion molecules, and triggering the oxidative burst. The magnitude and duration
of [Ca2+]j signal responses to G protein-coupled chemoattractants are clearly important
(Parekh and Penner, 1997), but the mechanisms by which they are regulated are
incompletely understood.
Selectins function not only in shear-dependent tethering and rolling of leukocytes but
can also transduce signals that can be involved in cell adhesion, transmigration and
release of pro-inflammatory cytokines and proteases. Upon ligation and cross linking
they specifically activate neutrophil adhesion (Crockett-Torabi, 1998). The response of
neutrophils to various inflammatory stimuli is largely determined by their previous
exposure to agents such as cytokines (TNFa), lipid mediators (e.g. PAF) or bacterial
products (fMLP). At physiological concentrations these agonists elicit cell polarization,
recruitment and activation of p2-integrins and enhance or 'prime' neutrophil responses
(e.g. respiratory burst activation) to other secondary agonists.
Selectin-dependent alterations in neutrophil function have been suggested to require co-
stimulation with other agents, e.g. PAF (Lorant et al., 1991; Ostrovsky et al., 1998),
fMLP (Kuijper et al., 1996) and TNFa (Carlos and Harlan, 1994). The functional
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alterations induced by agents that activate neutrophils appear distinct from those caused
by "priming" agents. Early studies have suggested that E-selectin and PAF signalling
acts cooperatively to induce neutrophil adhesion to the endothelium.
PAF induces Ca2+mobilization
PAF alone is known to induce Ca2+ mobilization through the release of Ca2+ from
intracellular stores which occurs through activation of the G protein-coupled PAF
receptor. G-protein activated PLC produces two secondary messengers: DAG and IP3.
IP3 production results in the activation of IP3RS in the ER which causes Ca2+release and
the opening of surface membrane channels which leads to Ca2+ influx into the
cytoplasmic compartment (Figure 3.1 A). These rapid events produce a characteristic
Ca2+ "spike" that rapidly decays due to the action of Ca2+ ATPases pumping Ca2+ out of
the cytosol back into stores and/or out of the cell (Figure 3.1 B & C). PAF induces an
increase in [Ca2+]j which occurs primarily through Ca2+ release from IP3 sensitive
• • 9 I
intracellular stores followed by an influx of extracellular Ca via receptor-operated
channels expressed in the plasma membrane. Depletion of intracellular Ca2+ stores can
• 2+also induce Ca influx across the PM through SOCs.
SOCE
• 7 I
The molecular basis of Ca influx is not well understood (Berridge et al., 2000).
Through an unknown mechanism, the depletion of internal Ca2+ stores activates SOCs
present in the PM. Ca2+ influx via SOCs (also known as SOCE) causes a sustained
• • 9+ •
increase in [Ca ]j, which mediates longer term cytosolic calcium signals and provides a
















Figure 3.1 PAF induces Ca2+ mobilization
(A) Schematic Model of PAF induced Ca2+ entry. PAF binds to G-protein coupled
receptor (GPCR) resulting in activation of PLC, which cleaves PIP2 and generates
diacylglycerol (DAG) and inositol (l,4,5)-trisphosphate (IP3). Binding of IP3 to its
receptor (IP3R) on the endoplasmic reticulum (ER) causes release of Ca2+ into the
cytoplasm resulting in the initial rapid increase of intracellular Ca2+ (B&C). The second
phase of the PAF response, shows a rapid decay in [Ca2+]j as Ca2+ is being pumped back
into intracellular stores and out of the cell.
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Although the molecular identity of SOCs has not been determined, several studies
implicate the Ca2+ release-activated Ca2+ (CRAC) channel as one form of SOC and
certain members of the transient receptor potential (TRP) family of cation channels in
SOC-channel activity (Parekh and Penner, 1997; Montell, 2001; Lewis, 2007). The two
prevailing coupling scenarios to activate SOCs, involve either a diffusible chemical
messenger e.g. calcium influx factor (CIF) (Bolotina and Csutora, 2005) or physical
interactions between ER and PM (Parekh and Putney, Jr., 2005). However, the nature of
the ER-derived signal to activate SOCs remains unresolved.
Recently, a new mechanism of regulation has been suggested following identification of
a novel protein termed, stromal interaction molecule (STIM1), which was proposed to
act as a Ca2+ sensor for the ER and may play a key role in communication with channels
in the plasma membrane. This latest model of SOCE regulation may bring us a
significant step closer to understanding the intricate complexities involved in SOCE.
ST1M1 contains a signal sequence and a single transmembrane EF-hand domain and is
located in intracellular compartments in the ER at rest. Upon store depletion, STIM1
redistributes from the ER to distinct puncta close to, or within, the plasma membrane
(Spassova et al., 2006). Ca2+ binding to the EF hand domain of ST1M1 within the lumen
of the Ca2+ store keeps CRAC channels in plasma membrane closed. Mutation of the EF
hand motif of STIM1 was found to cause localisation to the plasma membrane, allow
basal Ca influx to be elevated and caused the CRAC channel current (Icrac) to operate
in a constitutively active, Ca2+ store independent manner. (Liou et al., 2005; Spassova et
al., 2006). Although the presence or translocation of ST1M1 is not sufficient to mediate
SOC channel activity (Zhang et al., 2005), it may act as a novel Ca2+ sensor in the
regulation of SOCE (Liou et al., 2005).
Another regulator of SOCE is CRAC modulator 1 (CRACM1), also known as Orail
(Feske et al., 2006). Structural analysis of the CRACM1 protein revealed a structure
with four proposed transmembrane regions, localisation to the plasma membrane and
both N- and C-termini are intracellular (Feske et al., 2006). Overexpression of STIM1
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and CRACM1 in HEK293 cells, results in significant amplification of store-operated
currents and electrophysiological analysis of channel activity has indicated that these
currents are similar to Icrac (Soboloff et ah, 2006). CRACM1 may represent a
regulatory protein of a multimeric complex that can influence CRAC channel activity.
At present, although the role of these proteins in myeloid cells remains to be defined,
altered CRAC channel activity is associated with many immune disorders for example
patients with severe combined immunodeficiency (SC1D) have a severe defect in CRAC
channel activation (Feske et ah, 2005), suggesting that they could represent important
targets for therapeutic manipulation and intervention.
Recent Studies
Ruchaud-Sparagano et ah (2000) demonstrated that soluble E-selectin caused increased
adhesion to p2-integrin ligands (albumin-coated latex beads) treated with PAF. Their
study also showed soluble E-selectin and PAF induced p2-integrin-mediated adhesion
required PAF-induced Ca2+ mobilization from ^-sensitive intracellular stores
suggesting that soluble E-selectin might act to alter Ca2+ mobilization within neutrophils
in response to PAF. Further investigation showed preincubation of neutrophils with
2~e • *soluble E-selectin did not affect the initial increase of [Ca ]j in response to PAF (Figure
1C) but caused a subsequent sustained increase in [Ca2+]j (Ruchaud-Sparagano et ah,
2000). However, the mechanism for this prolonged Ca2+ response was not defined.
In this chapter experiments will be carried out to investigate the signalling pathways
involved in E-selectin's prolongation of PAF induced Ca2+ mobilization and data will be
shown from experiments aimed at identifying the calcium channel involved.
Biochemical evidence will also be provided for molecular cross-talk between these
structurally distinct receptor pathways.
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3.2 Results
Soluble E-selectin Prolongs PAF-induced Ca2+ Mobilization
Incubation of human neutrophils in the presence of soluble E-selectin did not induce
o I
^
Ca mobilization (Figure 3.2). However, in agreement with our previous studies
(Ruchaud-Sparagano et al., 2000), pre-incubation of neutrophils with soluble E-selectin
caused a subsequent sustained increase in [Ca2+]j in response to PAF without affecting
the initial increase of [Ca2+]j (Figure 3.2). To facilitate comparison of experimental data,
we have calculated the area under the Ca2+ curve to provide a measure of the Ca2+
mobilization observed. Inhibition of soluble E-selectin interaction with neutrophils by
ENA2, an anti-E-selectin monoclonal antibody that binds to the lectin domain of E-
selectin, inhibited the sustained Ca2+ levels without affecting the initial rapid rise in
[Ca2+]j observed in response to PAF treatment (Figure 3.3A&B). These data
demonstrate that binding of soluble E-selectin via the lectin domain to a counter receptor
• • 9-F •
present on neutrophils is required for the prolongation of Ca mobilization in
neutrophils in response to PAF.
The optimum concentration of soluble E-selectin required for the prolongation of Ca2+
mobilization in response to PAF was determined by pre-incubating neutrophils with
various concentrations of soluble E-selectin before stimulation with PAF. Figure 3.2C
shows that 5pg/ml of soluble E-selectin gave the optimal effect. Using a range of pre¬
incubation times with soluble E-selectin, it was demonstrated that the effects of soluble
E-selectin on prolongation of [Ca2+]j in neutrophils were maximal by 15 min (Figure
3.4A), suggesting that downstream signalling pathways may be required to induce
9+
prolonged Ca mobilization in response to PAF rather than a rapid physical interaction
that exerted direct effects e.g. via conformational changes. Therefore, in all the
experiments in this thesis neutrophils were pre-incubated with 5pg/ml soluble E-selectin


















Figure 3.2 Soluble E-selectin prolongs PAF-induced Ca mobilization
(A) Freshly isolated neutrophils were loaded with Fura2-AM (2pM) for 30 min at 37°C
in Ca2+ and Mg2+-free HBSS, then washed and resuspended in HBSS containing Ca2+
and Mg2+ and then pre-incubated with or without soluble E-selectin (E-sel, 5pg/ml) for
15 min at 37°C as indicated. Neutrophils were stimulated with PAF (lOOnM) after
recording "baseline" Ca2+ levels for 60 s. Data is shown as a representative trace of ten
separate experiments showing similar results and is expressed as % of peak [Ca2+]j
following PAF stimulation (typically from 50nM control levels to 2.5pM following
stimulation). (B) Traces from A have been integrated to calculate area under each curve
using GraphPad Prism software (www.graphpad.com) in order to compare the effects of
various inhibitors. * Statistically different (P<0.5) from PAF treated controls. (C)
Freshly isolated neutrophils were loaded with Fura2-AM and preincubated with various
concentrations of soluble E-selectin for 5 min. The cells were then stimulated with PAF.



























Figure 3.3: Lectin domain of E-selectin required for prolonged Ca2+ mobilization
(A) For blockade of CD62E, ENA2 (1:50) and soluble E-selectin were preincubated for
1 h. Freshly isolated neutrophils were loaded with Fura-2-AM (2pM) and preincubated
with the E-selectin/ENA2 mixture for 15 min prior to stimulation with lOOnM PAF. (B)
Bar graph representing area under the curves of the graph in panel A plus other control
conditions not included in graph A, calculated using Graph Pad Prism software. Data
shown are expressed as mean + SEM from 3 separate experiments that were performed.
* Statistically different (P<0.05) from PAF-treated control. Data shown are expressed as
mean area under the curve + SEM from 3 independent experiments. * Statistically
different (P<0.05) from untreated controls.
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Figure 3.4: Effect of soluble E-selectin is time-dependent
(A) Freshly isolated neutrophils were loaded with Fura2-AM (2pM) as for Figure 1 and
pre-incubated with E-selectin (5ug/ml) for various times as indicated. The cells were
then stimulated with lOOnM PAF after 60 s of recording. Data from three separate
experiments that were performed are expressed as mean area under the curve ± sem. *
Statistically different (P<0.05) from PAF-treated controls. (B) Freshly isolated
neutrophils were pre-incubated with soluble E-selectin and samples were either washed
to remove E-selectin (WO) or used after 15 min incubation. Data shown are expressed
as mean area under the curve ± sem from three independent experiments.
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Furthermore, "wash-out" experiments where soluble E-selectin was removed by
washing after the 15 min incubation period clearly indicated that the effects of soluble
E-selectin upon prolongation of [Ca2+]i levels were maintained in the absence of
extracellular soluble E-selectin (Figure 3.4B). These data indicate that the effects of
soluble E-selectin are unlikely to be attributed to non- specific effects such as
sequestration or buffering of extracellular Ca2+ or changes in associated molecules that
affect Ca2+ ion movements. One interpretation of these results would be that soluble E-
selectin triggers intracellular signalling pathways to modulate Ca2+ entry.
Specificity of Soluble E-selectin Effects
In contrast to the effects of soluble E-selectin, pre-incubation of neutrophils with soluble
P-selectin had no effect on [Ca2+]j response to PAF, suggesting that the effect of soluble
E-selectin upon Ca2+ mobilization is specific (Figure 3.5B). We next examined the
ability of soluble E-selectin to prolong Ca2+ mobilization in response to other agonists
that act via distinct G-protein coupled receptors. As shown in Figure 3.5, in contrast
with the effects of PAF, changes in [Ca2+]j following stimulation with either LTB4 or
fMLP were not affected by pre-incubation with soluble E-selectin. These data are in
agreement with previously published results which showed a similar lack of effect with
LTB4 and fMLP-induced Ca2+ mobilization (Ruchaud-Sparagano et al., 2000).
PAF, fMLP and LTB4 work through distinct G protein coupled receptors and we decided
to investigate whether these GPCRs coupled to the same G protein by the use of
pertussis toxin. Pretreatment of neutrophils with pertussis toxin, which ADP-ribosylates
Gj and G0, was found to inhibit fMLP- and LTB4-induced Ca2+ mobilization but had no
effect on PAF-induced Ca2+ responses (Figure 3.6A). These results suggest a role for a
pertussis toxin-insensitive Gq protein in mediating the effects of PAF and for a pertussis
toxin-sensitive G0 or Gj proteins in mediating the effects of fMLP and LTB4.
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Figure 3.5 Soluble E-selectin effect upon Ca2+ mobilization is specific to PAF
Freshly isolated neutrophils were loaded with Fura-2-AM (2 pM) and preincubated with
or without E-selectin (5pg/ml) or P-selectin (5pg/ml) for 15 min before measuring
[Ca2+]i. 60 s after recording, the cells were stimulated with PAF (A&B), LTB4 (C), or

























Figure 3.6 Soluble E-selectin specifically modulates Gq agonist induced
mobilization
(A) Freshly isolated neutrophils were incubated with Pertussis toxin (2pg/ml) for 1 h,
washed and then loaded with Fura2-AM (2pM) for 30 min at 37°C prior to stimulation
with lOOnM PAF. Data shown is expressed as mean area under each curve ± sem from
three separate experiments. * Indicates statistically different (P<0.05) from PAF/LTB4
or fMLP-treated controls. (B) EGTA (1.25mM) was added 10 min before stimulation
with lOOnM PAF. A representative Ca2+ trace from three separate experiments that were
performed.
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E-selectin permits PAF-induced Ca2+ Influx
In a series of experiments in which extracellular Ca2+ was chelated by EGTA the E-
selectin-mediated prolongation of [Ca2+], was found to be sensitive to blockade whereas
PAF-induced Ca2+ release from stores was unaffected, indicating that soluble E-selectin
affected Ca2+ influx rather than release from an intracellular store (Figure 3.6B). PAF-
induced Ca2+ mobilization was dependent on activation of phospholipase C and release
of IP3 as this response was sensitive to complete inhibition by U73122, a specific
phospholipase C inhibitor and 2-APB, a specific inhibitor of IP3-induced Ca2+ release
(Figure 3.7). Our previous studies also demonstrated that the initial PAF-induced [Ca2+]j
spike was abolished by TMB-8, which blocks Ca2+ release from intracellular stores and
SKF 96365, a receptor-operated channel inhibitor blocked the PAF-induced extracellular
Ca2+ influx (see figure 3.IB). However, Ca2+ mobilization in the presence of soluble E-
selectin was relatively insensitive to SKF 96365, suggesting that soluble E-selectin-
induced Ca2+ mobilization occurs through distinct ion channels rather than influx of
2+extracellular Ca through SKF 96365-sensitive receptor-operated channels.
Store operated or Receptor Operated Ca2+ Influx?
SOCs can be activated by the depletion of intracellular Ca2+ stores causing a sustained
increase in calcium via Ca2+ influx. Depletion or emptying of intracellular Ca2+ stores
and activation of SOCE can be achieved in a number ofways including inhibition of the
Ca2+ ATPase pumps of the ER. Thapsigargin, a Ca2+ ATPase pump blocker, inhibits ER
Ca2+ uptake directly and as intracellular stores are 'leaky' this results in depletion of the
intracellular stores that are involved in agonist-induced Ca2+ mobilization. Thus,
thapsigargin prevents activation of SOCs and prevents SOCE. To confirm that E-selectin
prolonged PAF-induced Ca2+ mobilization was SOC mediated rather than ROC we
pretreated neutrophils with 2pM thapsigargin.
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Figure 3.7 Ca2+ influx requires PLC activity
(A) U73122 (5pM) was added 5 min before stimulation with lOOnM PAF. A
representative Ca2+ trace from three separate experiments that were performed. (B) Bar
graph representing area under the curves of the graph in A, calculated using GraphPad
Prism software. Data shown are expressed as mean ± sem from three separate
experiments is shown. * Indicates statistically different (P<0.05) from PAF treated
controls. (C) 2-APB (lOOpM) was added 5 min before stimulation with lOOnM PAF. A
2"b
representative Ca trace from three separate experiments that were preformed. (D) Bar
graph representing area under the curves of the graph in C, calculated using GraphPad
Prism software. Data shown are expressed as mean ± sem from three separate
experiments is shown. * Indicates statistically different (P<0.05) from PAF treated
controls.
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Thapsigargin-treated neutrophils alone did not induce SOCE (data not shown) and
Figure 3.8A shows that when thapsigargin-treated neutrophils are stimulated with PAF,
it does not induce calcium influx from plasma membrane stores.
These data confirm that PAF induced Ca2+ release is from intracellular stores and
suggests that store depletion alone or store depletion and a GPCR signal are not
sufficient for SOCE to occur. Flowever, we found that pre-incubation of thapsigargin-
treated neutrophils with soluble E-selectin before stimulation with PAF significantly
attenuated store-operated calcium entry. Figure 3.8B shows that the E-selectin and PAF
induced Ca2+ increase in neutrophils pre-treated with thapsigargin was sensitive to
blockade by chelation of extracellular Ca2+ by EGTA confirming that it was Ca2+ influx
from SOC rather than Ca2+ release from an intracellular store. These results suggest that
E-selectin 'primes' a special SOC but alone does not allow Ca2+ influx to occur as it
requires a G protein-derived signal which comes from a Gq receptor such as the PAF
receptor.
E-selectin causes Ca2+ influx through a TRPC
We therefore sought to further define the molecular mechanism by which soluble E-
selectin induced prolonged elevation of [Ca2+]j. Neutrophils treated with ruthenium red,
an inhibitor of Ca2+-induced Ca2+ release from ryanodine-sensitive stores, were found to
• < • 9+
mobilize Ca in response to PAF in the presence of soluble E-selectin in a similar way
to those under control conditions (Figure 3.9B). These results further suggest that
9+
soluble E-selectin was most likely mediating Ca influx through the plasma membrane
rather than from an intracellular store. Depletion of intracellular Ca2+ stores is known to
communicate with and activate SOCs in the plasma membrane, leading to SOCE. The
initial elevation of [Ca2+]j in response to PAF, known to be due to release of Ca2+ from
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Figure 3.8 Store operated or receptor operated channel?
(A) Thapsigargin (TG) (2pM) was pre-incubated with or without 5pmg/ml E-selectin for
5 min before recording started and cells were stimulated with lOOnM PAF at 10 min.
The Ca2+ trace shown is representative of three separate experiments that were
performed with similar results.
(B) Thapsigargin (2pM) was pre-incubated with or without 5pg/ml E-selectin for 5 min
before recording started and 1.25mM EGTA was added at time zero before stimulation
with lOOnM PAF at 10 min. A representative Ca2+ trace from three separate
experiments that were performed.
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Interestingly, the soluble E-selectin-induced sustained [Ca2+]j increase following
stimulation with PAF was inhibited by MRS 1845 (Figure 3.9B), indicating that PAF-
induced Ca2+ store-emptying was required for E-selectin activation of a store-operated
channel, an effect we have termed 'permissive' SOCE.
As certain members of the transient receptor potential family of cation channels (TRPC)
display properties similar to those of SOCs, experiments were carried out to test whether
gadolinium (III) chloride (Gd3+), a specific TRPC inhibitor, would affect the soluble E-
selectin-induced [Ca2+]j response to PAF. As shown in Figure 3.9A, the prolonged rise
in [Ca2+]j observed in the presence of soluble E-soluble was sensitive to Gd3+ which
would be consistent with a role for TRPC in this response.
TRPC expression in PMN
To determine the profile of TRPC expression in human neutrophils, multiple specific
primer pairs were used to screen for the presence of TRPC 1-TRPC7 mRNA species in
highly purified human neutrophils. The expression profile for members of the TRPC
family is illustrated in a representative gel of RT-PCR products shown in Figure 3.1 OA.
PCR products for TRPC6 were found in all neutrophil samples (n=10) whereas TRPC3
was only found in 20% of samples. We did not observe signals for TRPC1, 2, 4, 5 and 7
in any of the preparations, despite positive RT-PCR controls demonstrating that these
PCR reaction conditions were optimal. Monocytes were used a positive control for
TRPC1, 3, 5 and 6 (Figure 3.1 OB). To confirm TRPC6 protein expression, we assayed
crude membrane preparations from freshly isolated human neutrophils using western
blotting techniques. A specific antibody for TRPC6 revealed a strong band in the
appropriate 90-100KDa range (Figure 3.11A), which could be blocked by a TRPC6
blocking peptide (Figure 3.1 IB), confirming the presence of protein and the RT-PCR
data. However, we could not detect TRPC3 at a protein level (Figure 3.1 IB), suggesting


























Figure 3.9 TRPCs mediate soluble E-selectin prolongation of PAF-induced Ca
mobilization
(A) Calcium traces showing the effect of calcium channel inhibitor, Gd3+, on the
prolonged [Ca2+]j elevation induced by soluble E-selectin. Ga3+Cl3 (lOpM) was added 3
min before stimulation with lOOnM PAF. The calcium trace shown is representative of
three separate experiments with similar results. (B) Ruthenium Red (RR, 20nM) or
MRS 1845 (2pM) were added 5 min and Gd3+ (lOpM) was added 3 min before
stimulation with lOOnM PAF. Bar graph representing area under the curves of graph C
plus curves obtained for the other channel inhibitors used in the same experiment,
calculated using GraphPad Prism software. Data shown is expressed as mean ± sem
from three separate experiments that were performed. * Indicates statistically different
(P<0.05) from PAF/E-selectin treated controls.
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Identification of STIM1 and CRACM1
The precise mechanism of SOCE has remained elusive but identification of
STIM1/CRACMI interactions has recently emerged as the most likely candidate for the
missing link between Ca2+ store depletion and SOC influx. ST1M1 has recently been
proposed to be a novel Ca2+ sensor involved in the regulation of store-operated Ca2+
entry, serving as a calcium sensor that translocates upon store depletion to the plasma
membrane to activated SOCs (Baba et al., 2006; Wu et al., 2006). Therefore we looked
at expression of the calcium sensors, STIM1 and CRACM1, in human neutrophils. The
expression profile for STIM1 and CRACM1 is illustrated in a representative gel of RT-
PCR products shown in Figure 3.12. Bands of PCR products of the expected size were
consistently obtained for ST1M1 and CRACM1 and for the positive control GAPDH in
all neutrophil samples (n=5). These results raise the possibility that STIM1 and
CRACM1 may also be involved in the SOCE pathway in human neutrophils and have a
role in soluble E-selectin prolonged PAF induced Ca2+ mobilization.
1+
DAG does not cause Ca influx
Recent studies have shown that TRPC channels can be directly activated by increases in
intramembrane DAG (Hofmann et al., 1999; Venkatachalam et al., 2003). Hofmann et
al. (1999) proved that the TRPC subgroup: TRPC3, TRPC6 and TRPC7 can be activated
in response to DAG through a mechanism independent of PKC. Therefore, studies
investigating the effect of the cell permeable DAG analogue, 1-oleoyl-2-acetly-sn-
glycerol (OAG), which directly activates PKC were carried out. Figure 3.13A shows
that neutrophils did not mobilise Ca2+ upon addition of lOOpM OAG, a concentration
which several other groups have reported to activate TRPC3, TRPC6 and TRPC7
channels (Hofmann et al., 1999; Beck et al., 2006).
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Figure 3.10 TRPC6 expression in human neutrophils
(A) Expression of TRP family members in isolated human neutrophils. Representative
results of RT-PCR analysis with mRNA from a single isolation and cDNA preparation
of neutrophils with each of the indicated primers are given and GAPDH was used as a
positive control. RT-PCR was carried out on ten different cDNA preparations. (B)
Expression of TRPC family members in monocytes. Representative results of RT-PCR
analysis with mRNA from a single isolation and cDNA preparation of monocytes with
each of the indicated primers are given and GAPDH was used as a positive control.
Lanes are indicated as M, markers; 1, TRPC1; 2, TRPC2; 3, TRPC3; 4, TRPC4; 5,
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Figure 3.11 TRPC6 expression in human neutrophils
Western blotting of neutrophil (N) or mononuclear cell (M) membrane preparations
stained with anti-TRPC6 antibody (1:400) (A) or anti-TRPC3 antibody (1:400) (B)
revealed a strong band at the predicted molecular weight (lOOkDa) as indicated.
Specificity was demonstrated by incubation of the TRPC6 antibody with a four-fold
excess of the antigenic peptide exhibited no signal. Non-specific binding was assessed
using an IgG control stained with rabbit anti-lgG antibody (1:400). Representative







Figure 3.12 Identification of STIM1 & CRACM1 in human neutrophils by RT-
PCR
Expression of STIM1 and CRACM1 in isolated human neutrophils. Representative
results of RT-PCR analysis with mRNA from a single isolation and cDNA preparation
of neutrophils with each of the indicated primers are given and GAPDH was used as a
positive control. RT-PCR was carried out on five cDNA preparations and all
experiments gave similar results. M = markers.
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Priming the channel allows Ca2+ influx to be induced by DAG
Although neutrophils did not respond to the addition ofOAG alone, prior store depletion
using thapsigargin before the addition in OAG resulted in a Ca2+ influx. Figure 3.13B
shows that the OAG induced Ca2+ influx in neutrophils pre-treated with thapsigargin
was sensitive to blockade by EGTA-mediated chelation of extracellular Ca2+ confirming
that it was Ca2+ influx from SOCE rather than Ca2+ release from an intracellular store.
Figure 3.8A shows that when thapsigargin-treated neutrophils are pre-incubated with E-
selectin, it did not induce Ca2+ influx but when thapsigargin-treated neutrophils are
incubated with E-selectin and activated by PAF calcium influx occurs as it requires a G
protein-derived signal. The thapsigargin/OAG data may suggest that OAG needs
another signalling event to prepare the channel for activation by OAG. Figure 3.14
shows OAG causes a small Ca2+ influx in neutrophils pre-incubated with soluble E-
• • "2.1selectin. However, OAG did not affect soluble E-selectin-induced modulation of Ca
influx following stimulation of neutrophils with PAF (Figure 3.14B). These results
suggest that the TRPC involved requires to be 'primed' before OAG activation or direct
DAG activation independent of PKC, as it requires another signal which comes from






Figure 3.13 DAG alone does not directly activate TRPCs present in human
neutrophils
(A) Freshly isolated neutrophils were loaded with Fura-2-AM (2pM) before incubation
with lOOpM OAG. Before stimulation with PAF, neutrophils were preincubated with
lOOpM OAG for 15 min. (B) Thapsigargin (TG) (2 pM) was added at 0 min, lOOpM
OAG was added after 8 min. For EGTA experiments, 1,25mM EGTA was added after 2
min before addition of OAG at 8 min. Graphs are representative Ca2+ traces from three
separate experiments performed.
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Figure 3.14 E-selectin 'primes' channel for DAG activation
(A) Neutrophils were preincubated with or without soluble E-selectin (5pg/ml) for 15
min before stimulation with lOOpM OAG or lOOnM PAF. 1.25mM EGTA was added
10 min before stimulation with 1 OOpM OAG. A representative Ca2+ trace from three
separate experiments that were performed. (B) Bar graph representing area under curves
of the graph in A and an E-sel/PAF/OAG treated control, calculated using GraphPad
Prism software. Data shown are expressed as mean + sem from three separate
experiments. * Indicates statistically different (P<0.05) from PAF treated controls.
93
Patch Clamp Channel Recordings
As there are few specific TRPC pharmacological inhibitors that are cell permeable, we
decided to carry out several whole cell patch clamp experiments to further investigate
the role of TRPC channels. Whole-cell patch-clamp is a technique for measuring
currents passing across either the whole-cell membrane or through single membrane
channels. A small patch of membrane is sealed to the tip of a micropipette and a patch is
created. For the whole-cell recording technique this patch is then ruptured thereby
allowing electrical continuity with the inside of the cell and thus permitting current flow
across the total cell membrane to be measured. This is a very difficult and technically
demanding technique and before experiments could be started buffers had to be designed
which were suitable for TRPC channel recording and would not activate neutrophils. A
surface to which neutrophils would attach to but not adhere to and become activated was
then identified. By coating glass cover slips with Sigmacote, this allowed us to attach
recording pipettes to non-activated neutrophils and prevented the neutrophils from
firmly adhering to the glass cover slips.
In order to determine the identity and biophysical properties of the TRPC channel in
human neutrophils which are modulated by soluble E-selectin and PAF whole-cell,
patch-clamp recordings were carried out. Figure 3.15B shows membrane currents
obtained from a resting neutrophil using the whole-cell recording configuration. The
neutrophil was voltage-clamped at -55 mV and then stepped briefly to a range of
potentials indicated by the corresponding voltage commands shown in Figure 3.15A. As
can be seen from the amplitude of the responses, current flow across the cell membrane
is very small suggesting very few channels are open under these conditions. This would
be expected as a caesium based internal pipette solution which blocks K+ channels was
used. Figure 3.15C shows the current-voltage relationship for this neutrophil. The slope
of the current-voltage relationship obtained by linear regression gives a whole-cell
conductance of 0.58nS. The conductance is an indication of the number of channels
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Figure 3.15 Whole-cell patch-clamp recording from a resting neutrophil
(A) Whole-cell current responses to voltage step commands shown in (B) obtained from
a neutrophil in normal external solution. The neutrophil was voltage-clamped at -55mV.
(C) Current-voltage relationship obtained from the records shown in A and B. The line
has been fitted by linear regression and indicates a resting whole-cell conductance of
0.58nS.
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This is useful because it allows you to quantify any changes observed as a consequence
of drug action, for example an increase in conductance (as indicated by an increase in
the slope of the I-V plot) indicates channels opening.
Under the same experimental conditions as described above OAG, a derivative of DAG
which is known to activate TRPC channels, was bath-applied to a different neutrophil
(Figure 3.16C). Current-voltage relationships were generated before and during OAG
(100 pM) application (Figure 3.16C) using a voltage ramp protocol illustrated in Figure
3.16A. OAG caused a large increase in conductance from 1.02nS to 4.53nS indicating
the opening of channels in the cell membrane. The control and OAG current-voltage
plots intersect at 8mV. This represents the reversal potential for the current modulated
by the drug and gives an indication of the ions flowing through the open channels. PAF
was also bath-applied to a different neutrophil, under the same experimental conditions
(Figure 3.16B). Current-voltage relationships were generated before, during PAF
(lOOnM) and after (washout) of PAF using a voltage ramp protocol illustrated in Figure
3.16B.
PAF caused a significant increase in conductance from 0.47nS to 1.19nS indicating the
opening of channels in the cell membrane. The washout current-voltage plot gave a
conductance of 0.72nS indicating the PAF response is reversible and is unlikely to be an
artefact. The control and PAF current-voltage plots also intersect at 8mV, which
represents the reversal potential of the current induced by the drug. Reversal potentials
of 8mV after the addition of PAF or OAG suggest a non-selective cation channel has
been opened. This could include permeability to Ca2+ though further extensive work






Figure 3.16 Activation of membrane currents by PAF & OAG
Current responses were obtained using the ramped voltage protocol shown in (A). The
voltage was ramped from -85 to +60 mV at a rate of 210mV/s. (B) Current-voltage
relationships obtained from a resting neutrophil before (Control), during (PAF) and after
(Washout) bath-application of PAF (lOOpM). (C) Current-voltage relationships obtained
from a resting neutrophil before (Control), and during (OAG) bath-application of OAG
(100pM). (D) Current-voltage relationship showing the OAG sensitive current obtained
by subtracting the current-voltage plot obtained in the absence of the OAG from that
obtained in presence of OAG. The reversal potential ofOAG is 8mV.
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3.3 Discussion
The selectin family of receptors are critical for the appropriate recruitment of neutrophils
to sites of infection or tissue injury and the initiation and progression of the
inflammatory response. Soluble E-selectin acts to promote integrin-mediated neutrophil
adhesion, inhibit migration and amplify destructive responses, raising the possibility that
elevated levels of soluble E-selectin in patients with inflammatory diseases such as
rheumatoid arthritis and being associated with tumour growth may have pro¬
inflammatory effects (Koch et al., 1993). Importantly, a requirement for the lectin-
binding domain of E-selectin implies that a putative E-selectin receptor is most likely
involved in mediating these responses. Ligation of selectin receptors has been reported
• • • 9+ • •
to transduce intracellular signals resulting in altered PAF Ca mobilization and P2
integrin-mediated adhesion (Ruchaud-Sparagano et al., 2000). Here we show
prolongation of PAF induced Ca2+ mobilization by soluble E-selectin is maintained
following 'wash-out' suggesting that soluble E-selectin induces activation of signalling
pathways.
In leukocytes, PAF acts through its specific G protein-coupled receptor to induce
chemotaxis. Neutrophil activation by PAF has been shown to be pertussis toxin-
insensitive implicating Gq, whereas stimulation by LTB4 and fMLP are pertussis toxin-
sensitive, suggesting G0 or Gj involvement in mediating these responses (Lad et al.,
1985; Powell et al., 1996; M'Rabet et al., 1999). In neutrophils, P2 integrin-mediated
adhesion to albumin-coated latex beads induced by PAF but not fMLP and LTB4 was
promoted by soluble E-selectin (Ruchaud-Sparagano et al., 2000). Furthermore, we
have also shown that soluble E-selectin specifically prolongs elevation of [Ca2+], in
response to PAF but not fMLP or LTB4 (Ruchaud-Sparagano et al., 2000). Our data
shows that pertussis toxin does not affect PAF-induced Ca2+ mobilization but abolishes
fMLP and LTB4-induced Ca2+ mobilization. Several other Gq-coupled agonists
including Par2 and thrombin were examined to determine whether they could replicate
the E-selectin prolonged Ca2+ mobilization response in response to PAF. However, no
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other Gq-coupled agonist that either was present on neutrophils or produced a large
enough Ca2+ response to measure the difference between soluble E-selectin treated and
untreated neutrophils. Taken together, this would indicate that only signals from a
pertussis toxin-insensitive Gq-coupled receptor such as the PAF receptor are able to
communicate with E-selectin receptor to affect [Ca2+]; signalling.
This study has further defined the molecular mechanism of action of soluble E-selectin
on modulating Ca2+ influx in human neutrophils following stimulation with PAF.
Stimulation of neutrophils with PAF caused activation of PLC through a GPCR, release
of IP3 and mobilization of Ca2+ from intracellular stores and Ca2+ influx through a
receptor-operated ion channel, but did not typically cause SOCE. Importantly, soluble
E-selectin alone does not cause release of Ca2+ from intracellular stores or Ca2+ influx,
but modulates the Ca2+ signals induced by PAF in a novel manner by allowing
'permissive' SOCE to occur, i.e. where E-selectin permits PAF-induced signals to
communicate with and activate SOCE. Temporally, PAF-induced release of Ca2+ from
lP3-sensitive stores is an essential event that precedes soluble E-selectin-mediated
SOCE, suggesting that PAF and E-selectin are not binding to an ion channel and
influencing channel regulation or opening directly. In addition, soluble E-selectin is not
acting directly on ryanodine-sensitive Ca stores or sensitizing these stores to PAF-
induced activation signals. Inhibition of E-selectin-mediated prolongation of PAF-
induced Ca2+ signals was achieved with MRS 1845 and Gd3+, indicating that this occurs
through a store-operated channel of the TRPC family.
Experiments using thapsigargin (Figure 3.8) confirmed that soluble E-selectin was
mediating Ca2+ influx through a SOC. They also suggest that soluble E-selectin primes
a SOC but alone does not allow influx to occur which confirms our previous data that
soluble E-selectin alone does not induce Ca2+ release. These experiments also prove that
this 'priming' requires a G protein-derived signal from a Gq-coupled receptor via
activation of the PAF receptor as thapsigargin-treated neutrophils pre-incubated with
soluble E-selectin do not cause Ca2+ influx. We also confirmed that a Ca2+ influx
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occurred when both PAF and E-selectin were present as EGTA inhibited the increase in
[Ca2+]j (Figure 3.8B) demonstrating that this was due to Ca2+ influx. The SOC requires
• • • 2~F • • •
signals from both E-selectin and Gq receptor when intracellular Ca is increased in
order to be activated and allow Ca2+ influx.
These observations suggested that soluble E-selectin was acting to promote a novel
mechanism of molecular cross-talk that permits PAF-induced signalling pathways to
regulate a TRPC in the plasma membrane that is usually inaccessible to activation by
PAF, thus permitting SOCE to occur. It is unclear to date whether soluble E-selectin
acts to sensitize TRP channels to the signals which mediate SOCE such as calcium
influx factor (C1F) and calcium sensors, that recruitment of a regulatory protein to TRP
channels occurs as a result of soluble E-selectin-induced signals which permits SOCE or
that soluble E-selectin promotes physical interaction between IP3 channels in the ER
with a TRP channel in the plasma membrane. Physical interactions between IP3 channel
and the TRP could be investigated using confocal microscopy or immunoprecipitation
techniques. Flowever, to study the role of CIF and calcium sensors on TRP channel
activity, experiments would have to be carried out in a relevant transfection expression
system.
• • 2+Proteins homologous to the Drosophila transient receptor potential gene (trp) Ca
channels that assemble into heterodimeric ion channels are known to be involved in the
generation of SOCE. The TRPC family is composed of at least 7 non-selective ion
channels (TRPC 1-7), encoded for by separate mammalian genes. These family members
have been divided into four subgroups (TRPC1; TRPC4 and 5; TRPC3, 6 and 7; and
TRPC2) based upon sequence and functional similarities (Clapham et al., 2001). Our
RT-PCR studies found that only TRPC3 and TRPC6 mRNA were expressed in PMN
(Figure 3.1 OA), in agreement with Heiner et al. (2003). TRPC6 appears to represent the
principal TRPC family member present, being detected at both the level of mRNA and
protein. It has recently been shown that TRPC6 is externalized to the plasma membrane
by the stimulation of a Gq protein coupled receptor (Cayouette et al., 2004), and it has
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2+also been shown that expression of TRPC6 in COS cells increase Ca entry in response
to stimulation of a Gq-protein-coupled receptor (Boulay et al., 1997). Several
preliminary experiments using immunofluorescence microscopy were carried out to
image TRPC6 localisation in neutrophils. However, these were unsuccessful as there are
only a few commercially available antibodies for TRPC6 all of which only recognise the
intracellular epitopes of TRPC6. For detection of translocation of TRPC6 to the plasma
membrane upon stimulation, an antibody that would recognise the extracellular domain
to see the appearance of TRPC6 at the plasma membrane was required. The TRPC6
antibodies tested are also only recommended for use in western blotting and
immunohistochemistry and have not been characterized for use in immunofluorescence
analysis. However, once an appropriate antibody is available it would be interesting to
investigate whether soluble E-selectin pre-incubation leads to the up-regulation of
TRPC6 on the cell surface and establish whether this is sensitive to activation via Gq-
coupled receptor-induced signals specifically.
The precise mechanism of SOCE has remained elusive but identification of
STIM1/CRACM1 interactions has recently emerged as the most likely candidate for the
missing link between Ca2+ store depletion and SOC influx. ST1M1 and CRACM1 have
recently been proposed to act as Ca2+ sensors involved in the regulation of store-
operated Ca2+ entry (Zhang et al., 2005; Roos et al., 2005; Peinelt et al., 2006). Our RT-
PCR studies found that both ST1M1 and CRACM1 mRNA were expressed in human
neutrophils. Preliminary experiments found that STIM1 was detected at a protein level
by western blotting (personal communication with Dr Trevor Walker). However, there
2~E
is currently no commercially available antibody for CRACM1. Upon depletion of Ca
from lP3-sensitive ER, STIM1 has been reported to oligomerise at both the ER
membrane and in the plasma membrane, potentially close to SOC and form a protein-
protein bridge between the two membranes (Draber and Draberova, 2005). This would
allow communication to occur through protein/protein interactions and may involve
adaptor proteins to recruit other signalling molecules. One study has shown that STIM1
can activate TRPC1, suggesting that STIM1 may be able to activate or regulate the
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activity of TRPC channels (Huang et al., 2006). STIM1/CRACM1 may be activating or
interacting with TRPC6 following stimulation of neutrophils with soluble E-selectin and
PAF but single cell imaging and confocal microscopy would need to be carried out to
determine the localisation of ST1M1 and CRACM1 in neutrophils following incubation
with E-selectin and PAF.
The recent finding that DAG directly activates TRPC3 and TRPC6 may represent an
alternative mechanism for activation of these channels via phospholipase C-linked
receptors (Hofmann et al., 1999), allowing regulation to occur independently of Ca2+
mobilization from intracellular stores. However, figure 3.13 shows that OAG, a DAG
analogue, does not directly activate TRPC channels in neutrophils using Fura 2-AM to
record [Ca2+]i measurements. OAG has been found to be a relatively poor activator of
TRPC6 (Estacion et al., 2006), as OAG caused only a small current in stably transfected
TRPC6 HEK cells compared to other groups who had reported a robust activation of
TRPC3 and TRPC6. Channel recordings seem to be dependent on the conditions the
cells are recorded in, as OAG has varying degrees of activation in every study carried
out. Studies with heterologously overexpressed TRPC6 channels indicate that PLC-
dependent agonists activate channels, probably in a DAG-independent manner
(Hofmann et al., 1999; Zhang et al., 2006). However, under these experimental
conditions, the number of channel units present is presumably much higher than in the
case of endogenous channels and whereas the expression of a channel protein subunit
probably results in the formation of homomeric channels, the native channels may be
constituted by different protein subunits and have different properties (McKay et al.,
2000). There are also several other possible explanations as to why OAG does not
appear to activate TRPCs in neutrophils; OAG may cause a very small current in
neutrophils that is not detectable under our measuring Fura-2AM conditions. Whole cell
patch clamp experiments did show that OAG causes a significant influx of divalent ions
although further work needs to be carried out to confirm this was Ca2+ influx from a
TRPC channel. The lack of OAG effect might also be explained as there being a
divergence in function of the permeant DAG analogue from the function of the authentic
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endogenously generated DAG. OAG may also exert its effect by changing the local
lipid environment which allows the channel to open more readily rather than directly
activate the channel itself.
Experiments using thapsigargin-treated neutrophils (Figure 3.14) suggest that store
depletion primes a SOC for OAG activation but alone does not allow influx to occur.
OAG application also resulted in a small Ca2+ influx in neutrophils pre-incubated with
soluble E-selectin. We confirmed that a Ca2+ influx occurred when both E-selectin and
thapsigargin were present with OAG, as EGTA inhibited the increase in [Ca2+]j (Figure
3.14) demonstrating that this was due to Ca2+ influx. These results suggest that the
TRPC involved requires to be 'primed' before OAG activation or direct DAG activation,
as it requires another signal which comes from soluble E-selectin or store depletion for
Ca2+ influx to occur.
To definitively identify which channels were present in neutrophils and influenced by E-
selectin, electrical recording of patch clamp experiments were carried out. It was
necessary to spend time developing a method and buffers (in collaboration with Dr
Larkman), which were suitable for measuring channel recordings in neutrophils without
damaging or affecting the neutrophil's channel activity. We were successful in
recording from a resting neutrophil and using TRPC agonists which showed there was
detectable channel activity, despite their small size. Due to time constraints and the
technical difficulties of patch clamp recording, we were unable to more fully investigate
the effects of soluble E-selectin on this channel activity or confirm that a TRPC channel
was involved using pharmacological inhibitors. Future experiments include
investigation of the identity and biophysical properties of the TRPC channels in human
neutrophils which are modulated by E-selectin and PAF and definitive identification of
the channel involved in the prolongation of PAF induced Ca2+ mobilization by soluble
E-selectin. Patch clamp recording is able to distinguish between ion channels as each
channel family have their own unique properties, for example each channel has a
different single channel conductance, ion permeability and reversal potential. Ion
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channels are also activated by different agonists. There are numerous pharmacological
tools which can be combined with patch clamp recording to confirm the channel
identity. There are several inhibitors of TRPC channels available, however these show
varying degrees of specificity. For example, the non-specific cation channel blocker
flufenamate can differentiate between the TRPC3, TRPC6 and TRPC7 subfamily
members as flufenamate reversibly enhances TRPC6 currents but inhibits both TRPC3
and TRPC7 currents. Therefore, in order to definitively identify the channel involved
the combined use of pharmacological blockers with studies examining the conductance
and permeability of the channel to different ions. Comparison of the results obtained
from these experiments with the properties of expression of a cloned TRPC6 channel. If
the profile of the channel obtained in neutrophils matched or was a very close match to
the profile of the cloned TRPC6 channel you could definitively say it was a TRPC6
channel involved. This approach would be carried out in parallel with
immunohistological studies and/or studies using transgenic animals in which the channel
is question has been deleted.
Neutrophils isolated from the bone marrow of TRPC6_/" mice could be used to confirm
the role ofTRPC6 in E-selectin mediated Ca2+ prolongation. TRPC6 neutrophils would
be pre-incubated with murine E-selectin and we would expect that E-selectin would
have no effect on PAF-induced Ca2+ mobilization. This technique could also be used to
confirm that E-selectin and PAF cause permissive SOCE in neutrophils from mice, in
the same way as human neutrophils. Inflammatory neutrophils isolated after migration
to an inflammatory site could be used to test if transmigration across soluble E-selectin
primes SOCE. Inflammatory neutrophils would be prepared from mouse peritoneal
neutrophils which are isolated 4 hours after a peritoneal injection of thioglycollate
solution which causes neutrophil activation. However, the use of murine neutrophils
may not be a suitable technique as typical yields from bone marrow neutrophil and
peritoneal neutrophil (inflammatory neutrophils) preparations are approximately 1-2
million neutrophils, which is equivalent to the amount of neutrophils required for one
[Ca2+]j experiment.
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All [Ca2+], spectrofluormetry experiments carried out in this thesis show the mean
[Ca2+]j release of a population of neutrophils. In order to examine that neutrophil
2"l"
responses are similar across the cell population and there are synchronous free Ca
changes in individual neutrophils stimulated by PAF, single cell imaging experiments
could be carried out using confocal to perform real-time fluorescent imaging. Ca2+
signals can be monitored in individual neutrophils using ratio imaging of Fura-2AM.
This technique has already been used to show how individual neutrophils respond to
fMLP and LTB4(Davies et al., 1991). A suitable experiment would be to record Fura-2-
AM fluorescence levels over a time period of 2 minutes, with an image being taken
every 20 seconds in approximately 30 individual cells each time. Changes in
24-
intracellular fluorescence would be measured and used to calculate the levels of [Ca ]i
in individual cells at various time points. Another method used to measure [Ca2+]j levels
is flow cytometry. However, it would be very difficult to obtain accurate results from
flow cytometry as there is a time delay of several seconds before the sample is loaded
into the machine and read by the detectors. Therefore, this method would be difficult to
adapt for the experiments in this thesis as it is the signalling events of the first 60 sec
that may be critical to activate SOCE. It would also be interesting to use real-time
fluorescent imaging to investigate the effect of pre-incubating neutrophils with soluble
E-selectin, to determine whether every neutrophil was contributing equally to the
prolonged calcium release and identify whether a sub-population of neutrophils was
responsible for causing a delayed Ca2+ signal in response to PAF which causes the
prolonged Ca2+ release. However, all our results so far suggest that the whole
population of neutrophils are acting synchronously. Importantly, in every whole cell
patch clamp experiment the neutrophil responded to stimulation by PAF in a similar
manner each time, which is consistent with this suggestion.
Receptor mediated activation of leukocytes by a number of inflammatory stimuli
requires Ca2+ mobilization and influx as a critical common activation mechanism.
Selective inhibition of distinct components of these Ca2+ signals may represent
potentially attractive strategies for developing anti-inflammatory drugs to attenuate
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leukocyte activation. Data presented in this chapter represents the first demonstration of
soluble E-selectin causing permissive SOCE to occur following activation of neutrophils
by PAF, and that this SOCE most likely occurs through TRPC6. This novel mechanism
of molecular crosstalk relies on signals generated by a pertussis toxin-insensitive Gq
protein being permitted to communicate with a TRPC which has been primed to receive
its signals and cause SOCE. The expression of Ca2+ sensors STIM1 and CRACM1
suggests that these may also be involved in the SOCE pathway in human neutrophils and
2_j_ .
may have a role in soluble E-selectin prolonged PAF induced Ca mobilization. This is
an important observation as at present the role of these proteins in myeloid cells remains
to be defined but it is clear that they are key players in SOCE mechanism and the focus
of future research. The precise order of molecular events is yet to be fully explored (See
figure 3.17). These observations raise the interesting possibility that modulation of TRP
channel function may represent a novel therapeutic target for selective manipulation of















Figure 3.17 Schematic model of intracellular communication between E-selectin
receptor and PAF receptor
PAF binds to its Gq/n-protein coupled receptor resulting in activation of PLC, leading to
cleavage of PIP2 and generation of membrane-retained DAG and cytosolic IP3. DAG
can directly activate TRPC6 (Li et al., 2002). Soluble IP3 activates the IP3R on the
endoplasmic reticulum to release intracellular Ca2+. These responses result in the initial
rapid increase of [Ca2+]j. E-selectin interacts with a receptor on the neutrophil surface,
permitting PAF-induced Ca2+ mobilization to communicate with TRPC6 and allows
"permissive" SOCE to occur. G = G-protein coupled receptor.
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Chapter 4: Regulation of E-selectin mediated SOCE
4.1 Introduction
Recent investigations have extensively studied the regulation of TRPC channel activity.
However, the exact mechanisms and components that activate and regulate TRPCs are
still unknown. It is apparent that G-protein-coupled pathways linked to stimulation of
PLC activity have a profound effect on regulating channel activity and that generation of
DAG is a central event in these signalling cascades. DAG is a triglyceride that has a
pivotal role in gating cation channels via both PKC-dependent and -independent
mechanisms. Although production of DAG is pivotal to the activation ofmany of these
channels, the pathways leading to generation of DAG and mechanisms by which DAG
regulates opening ofchannels varies for different classes of ion channels.
PKC activation
The PKC pathway is a major signal transduction system that is activated upon
stimulation of transmembrane receptors by hormones, neurotransmitters and growth
factors. Key mediators of this pathway are formation of DAG and increased [Ca2+]i
concentrations. The rise in [Ca2+]j combined with the production of DAG causes
activation and translocation of PKC to the plasma membrane where it can phosphorylate
specific effector proteins and enzymes.
PKC comprises a family of serine/threonine kinases, which are activated principally by
signals generated following receptor-mediated hydrolysis of membrane phospholipids
(Nishizuka, 2003). PKC isoforms have been divided into 3 classes which are classified
as calcium-dependent, calcium independent and atypical isozymes according to their
sensitivity to Ca2+ and DAG. The conventional or Ca2+-dependent PKCs (cPKCs: a, |3
and Y) require additional free Ca2+ and DAG for complete activation. The calcium-
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independent novel PKCs (nPKCs: 5, £, r| and 0) are fully activated by DAG only,
whereas the atypical PKCs (aPKCs: £, I and A) are Ca2+- and DAG-independent
(Newton, 2003). Activation of PKC results in the translocation of the enzyme from the
cytosol to membrane compartment where it exerts its function (Nishizuka, 1995).
Despite the extensive sequence and structural homologies between different PKC
isozymes, especially within the catalytic domain, individual PKCs mediate unique
cellular functions (Dempsey et al., 2000; Jaken and Parker, 2000), presumably
determined by the substrates that they phosphorylate (Carpenter et al., 1987; Parker et
al., 1989)
Several proteins have been found to interact with PKCs with isoform selectivity (Poole
et al., 2004). For example among the PKC-interacting proteins, scaffolding/adaptor
proteins termed RACKs (receptor for activated C kinases), bind with isozyme selectivity
to PKC only after activation and translocation of the enzyme close to its relevant
substrates (Mochly-Rosen et al., 1995). Two RACK proteins have been identified and
characterized namely RACK1 which is selective for PKCp and RACK2 which is
selective for PKC£ (Schechtman and Mochly-Rosen, 2001). Localization of activated
PKC isozymes to different subcellular sites confers specific substrate phosphorylation
and different cellular responses. Therefore, binding to its respective RACK can localize
each PKC isozyme next to a subset of protein substrates and away from others, thus
conferring different functional specificity for each activated isoform (Mochly-Rosen et
al., 1995). Specific PKC isozymes can associate with a range of cytoskeletal proteins
including myristoylated alanine-rich C-kinase substrate (MARCKS) and pleckstrin
which are prominent substrates of PKC in many cell types (Hartwig et al., 1992;
Brumell et al., 1997). Another protein suggested to be involved in the regulation of PKC
is the 14-3-3 family of proteins (Aitken et al., 1995; Aitken, 1996). Although 14-3-3
proteins are thought to play important roles generally in the regulation of PKC, it is not
clear whether these two proteins interact in vivo and what the nature of this interaction is.
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Phosphorylation of TRPC channels
Apart from the regulation of TRPC channels by DAG generated from PLC stimulation
through either GPCRs or receptor tyrosine kinases (RTKs), little is known about the
ability of additional signalling pathways downstream of receptor-stimulation to regulate
TRPC activity. Activation via GPCRs or RTKs results in the rapid phosphorylation of
many cellular proteins (Tsai et al., 1997; Babnigg et al., 2003). There are multiple
potential phosphorylation sites for either serine/threonine kinases or tyrosine kinases in
the primary sequence of all TRPCs. It is now clear that critical regulatory elements that
control TRP channel activity include phosphorylation and Src family tyrosine kinases
(Hisatsune et al., 2004). However, few studies have specifically addressed the role of
specific protein kinases in the regulation ofTRPC channel activity.
Previous experiments have demonstrated that Ca2+ mobilization in neutrophils, an early
key event in the control of motility, respiratory burst and degranulation, is prolonged in
the presence of PAF and soluble E-selectin (Ruchaud-Sparagano et al., 2000). PAF
induces an increase in [Ca2+]j which occurs primarily through Ca2+ release from IPs-
sensitive intracellular stores followed by an influx of extracellular Ca2+ via ion channels
• • 2+
expressed in the plasma membrane. However, the mechanism for this prolonged Ca
response is not well defined. There have been a number of recent studies investigating
the mechanisms by which selectins activate signalling pathways. For example, it has
been reported that engagement of selectin receptors activates the MAPK pathway and/or
activation of cell surface receptor-associated protein tyrosine kinases (Simon et al.,
2000). It has also been shown that Src family tyrosine kinases are involved in the
induction of monocyte chemotaxis by soluble E-selectin (Kumar et al., 2001),
suggesting these would be pertinent mechanisms to investigate.
Membrane phospholipids are known to influence the activity of several types of ion
channels, including TRP non-selective cation channels (Tong et al., 2004). PI 3-kinase
is a lipid kinase that phosphorylates phosphatidyl inositol 4-phosphate and PtdIns(4,5)P2
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at the D-3 position producing PtdIns(3,4)P2 and PtdIns(3,4,5)P3 (Fruman et ah, 1998).
Production of these phospholipids via PI 3-kinase signalling and subsequent activation
of a downstream kinase cascade is critical for many cellular processes, including
proliferation and protein synthesis. One of the best characterized targets of PI 3-kinase
products is the protein kinase Akt (also known as protein kinase B) (Hanada et ah,
2004). In quiescent cells, Akt resides in the cytosol in a low-activity conformation.
Upon cellular stimulation Akt interacts with PI 3-kinase generated phospholipids,
causing its translocation to the plasma membrane, where it is phosphorylated and
activated by 3'-phosphoinositide-dependent kinase 1 (PDK1) and 3'-phosphoinositide-
dependent kinase 2 (PDK2) (Fresno Vara et al., 2004). PI 3-kinase signalling regulates
several types of ion channels, via modulation of vesicular movement and/or channel
synthesis (Macrez et ah, 2001). For example, it was reported that growth factor
stimulation requires PI 3-kinase for the rapid translocation of the TRPC5, from vesicles
to the plasma membrane (Bezzerides et ah, 2004) and it has been shown that a TRPV1
and PI 3-kinase signal transduction complex facilitates trafficking of TRPV1 to the
plasma membrane (Stein et ah, 2006). However, the phospholipid products of PI 3-
kinase, PtdIns(3,4)P2, and PtdIns(3,4,5)P3 are not themselves widely considered to be
direct modulators of ion channel activity.
The results in Chapter 3 demonstrated that E-selectin mediated prolongation of PAF-
induced Ca2+ mobilization was PLC-dependent. It is well established that PLC activation
can lead to tyrosine phosphorylation ofmultiple proteins through downstream activation
of tyrosine kinases. In this chapter, experiments were carried out to investigate the role
of tyrosine kinases and PKC in regulating E-selectin induced permissive SOCE and to




E-selectin-induced SOCE is regulated by Src and PI 3-Kinase
Specific protein kinase inhibitors were used to test the involvement of tyrosine kinases
in soluble E-selectin-mediated SOCE. Inhibition of p38 MAP kinase by SB203580
(lOpM) or the negative control SB202474 (lOpM) had no effect on soluble E-selectin-
induced Ca2+ influx following stimulation of neutrophils with PAF (Figure 4.IB).
Similarly, a lack of effect of PD98059 (lOpM) on soluble E-selectin-induced modulation
of Ca2+ influx identified that MEK1 was not involved in mediating these responses
(Figure 4.IB). However, consistent with published data (Hisatsune et al., 2004), the
specific Src family tyrosine kinase inhibitor PP2 (5pM) selectively inhibited the soluble
E-selectin-induced SOCE to control levels of PAF-only stimulated neutrophils (Figure
4.1 A and B). This effect was specific as the inactive analogue, PP3, had no effect on
soluble E-selectin-induced Ca2+ influx. These data suggest either a direct role for Src in
modulating TRPC6 channel activity or a role for Src in the downstream signalling events
following soluble E-selectin binding to its putative receptor on neutrophils.
Western blot analysis of neutrophil protein lysates using a phosphorylation state-specific
antibody (Tyr(P)116), which correlates with Src tyrosine kinase activation, showed
significant phosphorylation above control levels with soluble E-selectin alone treatment
(Figure 4.2A). Interestingly, stimulation of neutrophils with PAF alone had no effect on
the levels of phospho-Src (Figure 4.2A). Pre-treatment of neutrophils with PP2, prior to

























- • E-sel/PAF +
Wortmannin





Figure 4.1 PI 3-Kinase and Src kinase activity are required for soluble E-selectin
Ca2+ mobilization
(A) PD98059 (lOpM), SB203580 (lOpM) and PP2 (5pM) were added concurrently with
E-selectin for 15mins prior to stimulation with lOOnM PAF. The Ca2+ trace shown is
representative of three separate experiments that were performed with similar results.
(B) Bar graph representing area under the curves of graph A, calculated using GraphPad
Prism software. Data expressed as mean ± sem of three independent experiments. (C)
LY294002 (10pM, 5 min pre-incubation) and wortmannin (lOOnM, 15 min pre¬
incubation) were added prior to stimulation with lOOnM PAF. The Ca2+ trace shown is
representative of three independent experiments that were performed. (D) Bar graph
representing area under the curves of graph A, calculated using GraphPad Prism
software. Data expressed as mean ± sem from three separate experiments is shown. *
Statistically different (P<0.05) from PAF/E-selectin-treated controls.
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Since PI 3-kinase is also known to be a key regulator of ion channels in a variety of
other cell types, neutrophils were pre-treated with the specific PI 3-kinase inhibitors
wortmannin (lOOnM) or LY294002 (lOpM) and LY303511 (lOpM), an inactive
structural analogue. LY303511 had no effect on soluble E-selectin-induced Ca2+ influx
(data not shown). In contrast PI 3-kinase inhibition by either LY294002 or wortmannin
inhibited the soluble E-selectin-induced SOCE to control levels (Figure 4.1C&D), thus
identifying PI 3-kinase as an additional key regulator in the signalling pathway which
mediates the effects of soluble E-selectin on Ca influx.
Furthermore, LY294002 (lOpM) had no significant effect on soluble E-selectin-induced
phosphorylation and activation of Src (Figure 4.2A), indicating that PI 3-kinase may be
involved in a parallel pathway or act downstream of Src in regulating Ca influx.
Treatment of neutrophils with soluble E-selectin caused activation of PI 3-kinase as
assessed by a significant increase in phosphorylated Akt, compared with control
untreated cells, whereas PAF did not induce any Akt phosphorylation (Figure 4.2B).
Soluble E-selectin-induced increases in phospho-Akt levels could be inhibited
completely by LY294002, confirming that it is a target of PI 3-kinase. Interestingly, the
Src tyrosine kinase inhibitor PP2 also produced complete inhibition of phospho-Akt
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Figure 4.2 Soluble E-selectin induces Src & Akt activation in neutrophils
Freshly isolated neutrophils were incubated in the presence or absence of PP2 (5pM, 15
min) or LY294002 (10pM, 15 min), with soluble E-selectin (5pg/ml, 15min). Western
blots of neutrophil lysates were carried out as described in Materials and methods, and
probed with a (A) phospho-Src (Tyr 116) antibody (1:500) or (B) anti-phospho-
Aktl/PKBa (Ser473) (1:200). To verify equal loading, the blots were probed with p-
actin (1:10000) or total Akt (1:2000). This figure is a representative blot from 3
independent experiments that were performed with similar results.
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PKC negatively regulates E-selectin mediated SOCE
Endogenous DAG undergoes continual turnover through the combined actions of DAG
kinase and DAG lipase. Several groups have suggested that DAG is able to regulate
TRPC ion channel activity (Hofmann et al., 1999; Venkatachalam et al., 2003).
Therefore, to further investigate the role of DAG in TRPC activation, endogenous DAG
levels were modulated by altering the function of DAG kinase, which actively converts
DAG to phosphatidic acid. R59949 is an effective and specific inhibitor of Ca2+-
activated DAG-kinase (Jiang et al., 2000), the catalytic function of which is very
effective in reducing the elevated levels of DAG resulting from receptor-induced PLC
• . 2+activation (Jiang et al., 2000). Firstly, effect of R59949 on Ca mobilization induced
by PAF or E-selectin and PAF was examined. As shown in figure 4.3A and B, PAF-
9+ •
induced Ca mobilization was not affected, even at high concentrations (lOpM) of
R59949, whereas E-selectin prolonged Ca2+ mobilization following PAF treatment was
sensitive to inhibition of DAG kinase (also see Figure 4.4). Inhibition of DAG kinase
would be predicted to result in prolonged elevation of levels of DAG, activating PKC
and possibly suggests that PKC activity may negatively regulate TRPC activity. These
results could also suggest that elevated DAG levels may be involved in TRPC
regulation. Experiments in Chapter 3 (Figure 3.12 and 3.13) showed that a DAG
anologue (OAG) can cause Ca2+ influx but only when the TRPC channel is first
'primed' by E-selectin or store depletion.
To evaluate a role for PKC in regulating TRPC6 channels, we utilized Ro31-8220,
which is recognized as a selective and potent inhibitor of multiple PKC subtypes (Keller
and Niggli, 1993). Figure 4.5 demonstrates that the PKC inhibitor, Ro31-8220 (lOpM)
did not inhibit soluble E-selectin-induced modulation of Ca2+ influx following
stimulation of neutrophils with PAF. Interestingly, Ro31-8220 significantly enhanced
E-selectin-induced SOCE (P<0.001).
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Figure 4.3 Effect of R59949, a DAG kinase inhibitor, on PAF-induced Ca2+
mobilization
(A) Concentration-dependent effect of R59949 on PAF-induced Ca2+ mobilization,
freshly isolated neutrophils were loaded with Fura-2-AM (2pM) and preincubated with
various concentrations of R59949 for 5 min before stimulation with lOOnM PAF. (B)
2_|_
Concentration-dependent effect of R59949 on E-selectin prolonged PAF induced Ca
mobilization, freshly isolated neutrophils were loaded with Fura-2-AM (2pM) and
preincubated for 15 min with soluble E-selectin (5pg/ml) and with various
concentrations of R59949 for 5 min before stimulation with lOOnM PAF. Data from
three separate experiments that were performed are expressed as mean area under the


























Figure 4.4 DAG kinase activity is required for soluble E-selectin Ca + mobilization
(A) Freshly isolated neutrophils were loaded with Fura-2-AM (2pM) and preincubated
with or without E-selectin (5pg/ml) for 15 min and/or with lOpM R59949 for 5 min
before stimulation with lOOnM PAF. (B) Bar graph representing the area under the
curves of the graph in A and a PAF + R59949 control from the same experiment (not
shown on A), calculated using GraphPad Prism software. Data shown are expressed as
mean area under the curve + sem from three independent experiments. * Indicates
statistically different (P<0.05) from PAF treated controls.
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Figure 4.5 PKC is required for soluble E-selectin Ca2+ mobilization
(A) Freshly isolated neutrophils were preincubated with or without E-selectin (5pg/ml)
for 15 min or with Ro31-8220 (1 pM) for 5 min before stimulation with lOOnM PAF. A
representative Ca2+ trace from three separate experiments that were performed. (B) Bar
graph representing area under the curves of the graph in A plus a PAF + Ro31-8220
control from the same experiment, calculated using GraphPad Prism software. Data
shown are expressed as mean + sem from three separate experiments. * Indicates
statistically different (P<0.05) from PAF treated controls.
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These data suggest either a direct role for PKC in negatively modulating TRPC6 channel
activity or alternatively a role for PKC in the downstream signalling events following
soluble E-selectin binding to its putative receptor on neutrophils.
In order to examine a means of activating PKC that was independent of DAG, the direct
PKC-activator PMA was utilized, which causes pronounced PKC-mediated
phosphorylation of targets at nanomolar levels (Quest et al., 1997). PMA (lOOnM)
selectively inhibited the soluble E-selectin-induced SOCE to control levels of PAF-only
stimulated neutrophils (Figure 4.6) and the PAF-induced Ca2+ release from intracellular
stores was unaffected. Taken together these data show that PMA-induced PKC
activation inhibits channel activity and PKC inhibitors can potentiate the effect of E-
selectin to prolong PAF-induced Ca2+ mobilization, suggesting that PKC negatively
regulates TRPC channels.
TRPC6 channels are phosphorylated by PKC
Three protein kinase C phosphorylation sites that are common to all three TRPs in the
TRPC3, TRPC6 and TRPC7 subfamily have been identified as Thr573, Ser617, and Ser712.
712 •A recent study identified that TRPC3 channels are phosphorylated by PKC on Ser in
the carboxyl-terminal domain (Trebak et al., 2005). Therefore, investigation of the role
of PKC-mediated phosphorylation in E-selectin mediated SOCE was carried out using
an antibody that specifically recognizes any PKC substrates containing phosphoserine
residues such as TRPC channels. Figure 4.7A demonstrates that in whole cell neutrophil
lysates, PMA induced significant serine phosphorylation of a protein at around lOOkDa.
Co-immunoprecipitation techniques were then used to obtain evidence for direct
phosphorylation of TRPC6 by PKC. The ability of the phosphoserine/PKC substrate
antibody to bind TRPC6 channels was examined before and after activation of PKC with
phorbol ester (PMA). In figure 4.7B the upper blot shows that the anti-
phosphoserine/PKC substrate antibody binds to TRPC6 channels immunoprecipitated

















Figure 4.6 PKC activation with phorbol esters inhibits soluble E-selectin Ca
mobilization
(A) Ca2+ traces showing the effect of PMA on the prolonged [Ca2+]j elevation induced
by soluble E-selectin. 5pg/ml E-selectin was added 15 min and/or lOOnM PMA was
added 5 min before stimulation with lOOnM PAF. The Ca2+ trace shown is
representative of three separate experiments with similar results. (B) Bar graph
representing area under the curves of graph C, calculated using GraphPad Prism
software. Data shown is expressed as mean + sem from three separate experiments that

















Figure 4.7 TRPC6 channels are phosphorylated following activation with PMA
(A) Western blotting of PMA (lOOnM for 5min) treated or untreated neutrophil
membrane preparations probed with anti-phospho-Ser PKC substrate antibody (1:500)
revealed a strong band at the predicted molecular weight (80kDa) as indicated. A
representative immunoblot of three different experiments is shown. (B)
Immunoprecipitation (IP) with anti-TRPC6 antibody and western blot analysis of the
immunoprecipitates were performed as described in methods and materials. In the upper
blot, phospho-Ser PKC substrates that coimmunoprecipitated with TRPC6 channels
were detected by probing the transfer membranes with an anti-phospho-Ser PKC
substrate antibody (upper blot). Immunoprecipitation of TRPC6 channels was
confirmed by probing the same samples with an anti-TRPC6 antibody (lower blot). The
results shown are representative of three independent experiments.
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However, PAF and E-selectin did not induce phosphorylation of serine residues in
TRPC6 (Figure 4.7B). The anti-phosphoserine/PKC substrate antibody was able to
detect phosphorylated TRPC6 channels only from cells exposed to PMA and not from
unstimulated cells or cells pretreated with E-selectin and/or PAF (Figure 4.7B).
PKC isoform activation
PKC predominantly resides in the cytosol in an inactive state and upon cell stimulation,
translocates to the cytoskeleton or plasma membrane, where it becomes activated in the
presence of specific lipid co-factors. As previous experiments have indicated a role for
PKC in negatively regulating E-selectin prolongation of PAF-induced Ca2+ mobilization,
experiments were carried out to investigate whether this effect was mediated by a
specific subset of PKC isoforms.
Human neutrophils express the following PKC isoforms: PKCa, PKC(3, PKC5, PKCl,
and RACK1 a PKC-interacting protein, as detected by western blotting in whole cell
lysates (Figure 4.8). The predicted molecular weights for each PKC isoform can be
found in Table 4.1. Figure 4.8 shows several bands for the PKC isoforms present rather
than one single distinct band, this is probably due to proteolysis of proteins by numerous
highly active proteases present in neutrophils despite the presence of various protease
inhibitors in the lysis buffer. Experiments investigating the location of these PKC
isoforms and their translocation in response to different stimuli were carried out. In
untreated neutrophils PKCa, PKC5, PKCl and RACK1 were found in the Triton X-100
soluble fraction and no PKC isoforms were found in the Triton X-100 insoluble fraction
(Figure 4.9). Colloidal gold staining confirmed that protein was present in the Triton X-
100 insoluble fractions. Pre-treatment of neutrophils with soluble E-selectin had no
effect on the presence or location of PKC isoforms (data not shown). However, in
neutrophils pre-treated with soluble E-selectin and stimulated with PAF, both PKC







Figure 4.8 PKC isoforms present in whole cell lysates
Neutrophil lysates were carried out as described in Materials and Methods. Western
blotting of neutrophil lysate fractions with PKC isoform antibodies (1:100) revealed
bands for PKCa, p, 6, I and RACK1 in human neutrophils. A representative
immunoblot of three different experiments is shown.
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Figure 4.9 PKC isoforms present in untreated human neutrophils.
Triton X-100 soluble (A) and Triton X-100 insoluble (B) fractions of neutrophil lysates
were carried out as described in Materials and Methods. Western blotting of neutrophil
lysate fractions with PKC isoform antibodies (1:100) revealed bands for PKCa, 5, l and
RACK1 in the Triton X-100 soluble fraction of human neutrophils. A representative
immunoblot of three different experiments is shown.
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Under these conditions; PKC5 PKCi and RACK1 were found to be present in the Triton
X-100 soluble fraction and PKCa, PKCp, PKC5 and RACK1 were present in the Triton
X-100 insoluble fraction (Figure 4.10). Treatment of neutrophils with PAF alone had
the same PKC isoforms present in the Triton X-100 insoluble fraction but had different
PKC isoforms present in the Triton X-100 soluble fraction, namely PKC|3, PK.C5, PKCl
and RACK1. Table 4.1 summarises PKC isoform expression and location under the
various treatments.
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Figure 4.10 Soluble E-selectin and PAF induce PKC activation in Triton X-100
insoluble fraction of human neutrophils.
Freshly treated neutrophils were pre-incubated with soluble E-selectin (5pg/ml) for
15min before stimulation with lOOnM PAF. Triton X-100 soluble (A) and Triton X-100
insoluble (B) fractions of neutrophil lysates were carried out as described in Materials
and Methods. Western blotting of neutrophil lysate fractions with specific PKC isoform
antibodies (1:100) revealed bands for PKCa, P, 5 and RACK1 in the Triton X-100
insoluble fraction of human neutrophils. This figure is a representative blot from 3
independent experiments.
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PKC Isoform Basal E-sel PAF E-sel/PAF
Name MW Sol Insol Sol Insol Sol Insol Sol Insol
DKG0 110
PKCa 75 + + + +
PKCp 80 + + +
PKCy 80




PKCi 74 + + + +
PKCA. 74
RACK1 36 + + + + + +
Table 4.1 Summary of PKC isotype expression in various neutrophil treatments
Sol = Triton X-100 soluble fraction, Insol = Triton X-100 insoluble fraction
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4.3 Discussion
Despite the existence of multiple potential phosphorylation sites in the primary sequence
of all TRPCs, few studies have specifically addressed the role of kinases in regulating
TRPC channel activity. However, the possibility that tyrosine kinases might play a role
in regulation of TRPCs has recently received some attention. Recent studies have
shown that tyrosine phosphorylation by Src family protein tyrosine kinases represents a
potential regulatory mechanism of TRPC6 channel activity (Trebak et al., 2003;
Hisatsune et al., 2004). It has been suggested that two simultaneous events, coordinated
opening of the channel by DAG and modulation by Src-induced tyrosine
phosphorylation, contribute to the efficient influx of calcium through TRPC6 channels
(Hisatsune et al., 2004). We found that PP2, a selective Src inhibitor, caused specific
inhibition of soluble E-selectin-mediated prolongation of PAF-induced SOCE compared
to that observed in PAF-only stimulated neutrophils. In parallel, soluble E-selectin
caused phosphorylation and activation of Src which was sensitive to inhibition by PP2
but was unaffected by PI 3-kinase inhibition with LY294002. These findings strongly
suggest that Src activity is involved in modulating TRPC6 channel activity to regulate
Ca2+ influx in human neutrophils.
Inhibition of PI 3-kinase also selectively blocked the soluble E-selectin-induced SOCE
in neutrophils. Several potential intracellular regulatory motifs have been identified on
TRPC6 including PI 3-kinase-SH2 recognition domains, suggesting a mechanism by
which these channels might interact with the PI 3-kinase signalling pathway (Hofmann
et al., 1999). Several groups (Li et al., 2002; Tseng et al., 2004) have discovered that
the PI 3-kinase lipid product PIP3 can mediate Ca2+ influx through a mechanism
independent of PLC activity and/or store depletion in several cell lines. Activation of
receptor tyrosine kinase cascades leads to the membrane co-localization of PLCy and PI
3-kinase, both of which utilise PIP2 as a substrate to generate IP3 and PIP3 respectively.
These two signalling intermediates trigger the activation of Ca2+ channels within
different cellular compartments, giving rise to elevated levels of [Ca2+]j. Soluble E-
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selectin was demonstrated to cause an increase in phospho-Akt, a downstream target of
PI 3-kinase, suggesting that PI 3-kinase was activated following exposure of human
neutrophils to E-selectin. Interestingly, phospho-Akt induced by E-selectin was blocked
by PP2 which suggests that PI 3-kinase is regulated by Src and lies downstream of Src.
Therefore, soluble E-selectin's ability to activate PI 3-kinase may be due to its ability to
activate Src rather than to activate PI 3-kinase directly. Together, these data suggest a
role for PI 3-kinase in modulating TRPC6 channel activity and that PI 3-kinase lies
downstream of Src in the regulation of soluble E-selectin-mediated permissive SOCE.
To further define the regulatory role of the Src/PI 3-Kinase pathway in phosphorylation
of TRPC6, immunoprecipitation and western blotting could be used together with the
use of specific pharmacological inhibitors of these signalling pathways (PP2 to inhibit
Src and LY294002 to inhibit PI 3-Kinase). Furthermore, the role of TRPC6
phosphorylation by Src family tyrosine kinases could be examined in neutrophils
isolated from Hck"/"Fgf/~Lyn"/" mice (Meng and Lowell, 1997). As discussed in Chapter
3, using murine neutrophils limits the number of experiments using the methods for
measuring [Ca2+]j in this present study that can be carried out as typical yields from bone
marrow neutrophil and peritoneal neutrophil preparations are approximately 1-2 million
cells in total. However, alternative cell imaging techniques may make these
measurements feasible in murine neutrophils.
Hoffmann et al. (1999) indicated that members of the subgroup TRPC3, TRPC6 and
TRPC7 channels can each be activated in response to DAG through a mechanism
independent of PKC. In the present study, experiments were carried out to investigate
whether OAG, a DAG analogue, regulates TRPC activation. Results in Chapter 3 show
that OAG does not directly activate TRPC channels in neutrophils (Figure 3.12). Further
investigation of DAG-mediated regulation in neutrophils was carried out using R59949,
an inhibitor of DAG metabolism, which inhibits DAG kinase and leads to an increase of
• • 2"h
DAG in the plasma membrane of the cell. Figure 4.4 shows that R59449 inhibited Ca
influx, suggesting that the relative levels of DAG have an important role in controlling
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TRPC channel activity. It should be emphasized that the present experiments do not
show that DAG directly opens the channel but that DAG is the single molecule
identified so far that is closest to the channel.
Protein phosphorylation is not only important for activation mechanisms, but is also
important for inactivation mechanisms of TRPC channels. It is well recognised that
PKC can inhibit the activity of TRPC3 and TRPC6 (Zhang et al., 2001; Trebak et al.,
2003) and that TRPC6 forms a multiprotein complex containing PKC as a regulatory
component (Kim and Saffen, 2005). Experiments investigating the role of PKC in
regulating TRPC6 channel activity indicated that activation of PKC, using phorbol esters
(PMA), resulted in inhibition of E-selectin-mediated Ca2+ influx (Figure 4.6) whereas
inhibition of PKC using Ro31-8220, a PKC inhibitor, enhanced Ca2+ influx (Figure 4.5).
consistent with previous reports showing that TRPC3 can be phosphorylated by PKC
resulting in a negative regulatory manner (Venkatachalam et al., 2003). Overall, these
results indicate that PKC may negatively regulate E-selectin induced SOCE through
TRPC6.
An important area to investigate is the detailed molecular mechanism of PKC-mediated
inhibition on TRPC channels. Recently, Trebak et al. (2005) showed that PKC inhibits
TRPC3 proteins by directly phosphorylating Ser712 on the TRPC3 proteins. The
mechanism by which this phosphorylation inhibits TRPC3 activity is not known but may
cause a conformational change in the channel structure itself to limit ion movement or
that phosphorylation of these key residues blocks a domain on the protein that interacts
with a regulatory protein. These observations are consistent with a recent report
showing that PKC phosphorylates TRPC6 channels on a conserved serine residue,
Ser7'2, in the carboxyl terminal domain (Kim and Saffen, 2005). Ser712 lies just
downstream of the highly conserved TRP domain (Montell, 2001), a proline-rich
sequence that is involved in the interaction of TRP proteins with regulatory proteins
such as the immunophilin FK506 (Goel et al., 2001; Sinkins et al., 2004) and the
scaffolding protein, Homer (Yuan et al., 2003). By using antibodies that specifically
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recognize phosphoserine residues in PKC substrates, experiments demonstrated that
TRPC6 channels themselves are phosphorylated following exposure to PMA (Figure
4.7). In untreated and E-selectin treated cells, a low level of phosphoserine would be
expected to be present to maintain the channel in an inactive state, which was not seen
here. Other groups have also been unable to detect phosphoserine in untreated cells,
which suggests that cellular levels may be below the limit of detection by
immunoprecipitation in neutrophils. Matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry (MALD1-TOF MS) analysis could be carried out to confirm
that phosphorylation is present under unstimulated conditions. E-selectin and PAF
treated samples may affect the phosphorylation of PKC sites on TRPC channel but again
this is difficult to detect at a protein level in human neutrophils. However, the results
show that protein kinase C activation by PMA induces TRPC6 phosphorylation and
completely inhibits TRPC6 channel activity supporting the hypothesis that PKC
negatively regulates TRPC6.
The data presented here also suggests that the negative regulation of TRPC6 channel
represents a potential physiological feedback mechanism associated with G protein-
coupled receptor stimulation and that protein kinase C plays an important role in this
regulatory mechanism. Protein kinase C activators as well as compounds interfering
with the sequence containing Ser712 might be useful in modulating TRPC6 activity and
controlling Ca2+ entry into cells. Of course, identifying cell types in which TRPC6 is a
component of native channels activated via specific physiological stimuli would be very
useful in strategies aimed at selective control of Ca2+ homeostasis during disease.
Understanding how the phosphorylation of Ser712 interferes with TRPC6 activation will
help to unravel the molecular mechanisms of TRPC6 activation and shed light on how
TRPC6 contributes to Ca2+ signalling in cells during physiological functions. To
investigate the role of Ser712 in TRPC6 regulation it would be interesting to construct a
site mutant in the PKC phosphorylation site of TRPC to confirm that PKC was
negatively regulating TRPC6. In a recent study, mutation of Ser712 ofTRPC3 to alanine
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was shown to prevent PKC phosphorylation upon PMA stimulation (Trebak et al.,
2005), confirming that PKC directly phosphorylates TRPC channels.
Recently published studies have suggested that trafficking of TRPC channels is an
important aspect of their regulation (Cayouette et al., 2004; Bezzerides et al., 2004;
Morenilla-Palao et al., 2004; Singh et al., 2004). Therefore, it is possible that
phosphorylation of these ion channels could prevent proper targeting to the plasma
membrane or could cause channels to be internalized. To date, the specific PKC
isoforms involved in regulating the phosphorylation and translocation of TRPC6 in
intact human monocytes and neutrophils have not been identified. It was therefore
important to investigate if E-selectin and PAF acted to recruit PKC isoforms to 'prime'
the TRPC channel in neutrophils. Upon activation, PKC isoforms translocate from
soluble to particulate compartments (plasma membrane, nucleus, and cytoskeleton), in a
similar way as reported for TRPC channels (Cayouette et al., 2004). A variety of PKC
isoforms are found in human neutrophils (Kent et al., 1996; Sergeant and McPhail,
1997). PKC is kept in an inactive "folded" conformation by binding of the
pseudosubstrate sequence to the substrate binding site in resting cells (Tan and Parker,
2003). PKC becomes activated when conformational changes associated with
phospholipid binding displace the pseudosubstrate moiety from the catalytic domain,
thus allowing PKC to phosphorylate its protein substrates.
In this study, we examined the PKC isoforms present in Triton X-100 soluble and Triton
X-100 insoluble fractions of human neutrophils by western blotting analysis with
monoclonal antibodies against PKC isoforms and demonstrated that human neutrophils
express at least two classical PKCs; a, P, one novel PKC, 5, and one atypical PKC; I.
(Figure 4.8). PKC a, P 5 and C, have been shown by numerous groups to be present in
human neutrophils (Dang et al., 1995; Kent et al., 1996; Naucler et al., 2002). The
specificity and biological activity of PKC isoforms are regulated by their subcellular
localization. Thus, after activation, PKC isoforms are often translocated to other
compartments. Translocation of PKC is isoform-, cell type-, and activator-specific, and
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is tightly regulated by various cofactors (Oancea et al., 1998; Shirai et al., 1998). Each
PKC may, therefore, display a distinct subcellular localization and bind to intracellular
proteins that serve as substrates and/or carriers, such as receptors for activated C kinases,
receptors for inactive C kinases, MARCKs, annexins, and cytoskeletal components
(Mochly-Rosen et al., 1995). In resting neutrophils PKC a, [3 and 5 are known to reside
in the cytosol and upon activation they have been shown to translocate to membrane
fractions (Bussolino et al., 1994; Faghiri and Bazan, 2006). Soluble E-selectin alone
had no effect on the distribution of the Triton X-100 soluble and insoluble PKC
isoforms. However, cells stimulated with PAF or E-selectin/PAF induced a sustained
and marked translocation of PKC a, P and 5 from the Triton X-100 soluble to the Triton
X-100 insoluble fraction.
The data shown here indicates that human neutrophils contain members of all three PKC
isoform families and that translocation of cPKC and nPKC to the plasma membrane may
occur in cells in response to PAF as well as to E-selectin/PAF. These results
demonstrate that conventional PKCa and PKC5 translocate to the Triton X-100
insoluble fractions in response to PAF and E-selectin. However, these PKC isoforms
also showed translocation following PAF treatment alone, suggesting that they may not
be involved solely in regulating TRPC. No atypical PKCs moved to the Triton X-100
insoluble fraction upon stimulation which may be due to their Ca2+- and DAG-
independent activation mechanism (Newton, 2003). Unforutantely, in the experiments
carried out in this thesis the Triton X-100 soluble and insoluble fractions probably
contained a mixture of proteins, rather than representing distinct cytoplasmic and
cytoskeletal fraction as orginially intended. The Triton X-100 soluble fraction probably
contained membrane, cytoplasmic and some cytoskeletal proteins and the Triton X-100
insoluble may have contained nuclei and some cytoskeletal proteins. The speed of the
first spin (14,000 g for lOmin) in the Triton X-100 fractions protocol (see section 2.14)
was too low to spin out all the cytoskeletal proteins present in neutrophils lysates. A spin
of approximately 200,000 g for 40mins would be required to pull out all cytoskeletal
proteins. Therefore, blotting for known cytoskeletal, cytosolic and membrane proteins
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needs to be carried out to prove what is present in each fraction before definite
interpretations of these results can be made. The protocol will need to be adapted to
achieve distinct cytoplasmic and cytoskeletal fractions or ultracentrifugation of
neutrophils could be carried out to fractionate out the cytoskeletal and cytoplasmic
proteins if this work was continued.
Further studies are needed to determine if E-selectin and PAF recruits PKC isoforms to
'prime' TRPC channels for activation and if PKC membrane localization is required for
TRPC6 activation. For example, PKC-mediated internalization or redistribution of
fluorescently labelled TRPC6 channels could be examined using confocal microscopy
when the appropriate antibodies become available.
The data presented in this chapter demonstrates that both Src and PI 3-kinase are
required in a common pathway to mediate the soluble E-selectin-induced permissive
SOCE and resulting prolongation of [Ca2+]j. These results also indicate that increased
opening of TRPC6 by E-selectin is negatively regulated by PKC. Several other groups
have also shown PKC to have a negative effect (Trebak et al., 2003; Estacion et al.,
2004). Figure 4.12 shows a schematic model of the role of Src, PI 3-kinase and PKC
phosphorylation in regulating E-selectin induced permissive SOCE by PAF. These
results demonstrate that the Src, PI 3-kinase and PKC pathways mediate the soluble E-
selectin-induced prolongation of [Ca2+], elevation, and raise the interesting possibility
that modulation of TRP channel function may represent a novel therapeutic target for
selective manipulation of potentially pro-inflammatory neutrophil functional responses.
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Figure 4.12 Schematic model of TRPC regulation
PAF binds to its Gq/n-protein coupled receptor resulting in activation of PLC, leading to
cleavage of PIP2 and generation of membrane-retained DAG and cytosolic IP3. DAG
can directly activate TRPC6 (Li et al., 2002) and this study showed that DAG may
possibly directly activate TRPC6 channel when it is primed. Positive modulation of
TRPC6 channel involves Src and PI 3-kinase pathways and PKC negatively regulates
TRPC6.
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Chapter 5 - Functional Consequences of E-selectin mediated
SOCE
5.1 Introduction
In neutrophils, Ca2+ signalling is important for a number of cellular activities, including
adhesion, chemotaxis, phagocytosis, respiratory burst and apoptosis (Jaconi et al., 1991;
Dewitt and Hallett, 2002; Theander et al., 2002; Niggli, 2003). The Ca2+ influx through
SOCs into the cytosol is responsible for many of these neutrophil responses (Dillon et
al., 1988; Lee et al., 2005). Therefore, it is important to understand the functional
consequences of SOCE in neutrophils.
Adhesion
It has been suggested that the binding of neutrophil adhesion receptors plays an
important role in the regulation of neutrophil function and that interactions which occur
between neutrophils and endothelial cells via E-selectin during rolling adhesion may
play a part in regulating subsequent adhesion events (Zimmerman et al., 1992). The
potential for fine regulation of neutrophil adhesion through the fT integrins is clear from
studies that demonstrate functional modulation of these receptors (Hynes, 1992; Takagi
and Springer, 2002). However, the interactions and physiological mechanism
underlying control of neutrophil adhesion has not been fully defined. Several groups
have reported that the selectin family may act to trigger P? integrin-mediated adhesion
(Simon et al., 1995; Bunting et al., 2002). Ruchaud-Sparagano et al. (2000) showed that
exposure of neutrophils to soluble E-selectin and PAF in combination induced a
synergistic effect upon p2-integrin-mediated adhesion.
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Chemotaxis
One of the most important functions of neutrophils is to respond by chemotaxis to a
variety of products released either by the host or by the invading organism (Babior et al.,
2002). Transmigration requires initial contact and adhesion of neutrophils to endothelial
cells through cell adhesion molecules such as E- and P-selectin, followed by active,
chemokine-directed migration of neutrophils through the endothelial cell layer to the site
of injury or infection. Recent studies have suggested that soluble E-selectin is a potent
chemotatic factor for monocytes and that soluble E-selectin mediates monocyte
chemotaxis through Src family tyrosine kinases (Kumar et al., 2001). However, the role
of E-selectin in regulating chemotaxis in neutrophils remains to be fully investigated.
Superoxide Release and Priming
Superoxide production by neutrophils participates in the destruction of invading
organisms and in host defence (Babior, 2000). The inappropriate production of
superoxide can contribute to destruction of normal tissues and to the prolongation of the
inflammatory process and therefore must be tightly controlled. For example as
discussed in Chapter 1 (Section 1.3.1), CGD is a primary immunodeficiency that affects
the oxidative mechanism of microbial killing of phagocytic cells and is characterized by
a lack of, or severely reduced superoxide anion (O2-) production by neutrophils (Barese
et al., 2005). CGD normally results from a gene mutation and/or abnormality of the
NADPH oxidase components, particularly cytochrome b558 (gp91phox and p22phox) in
the membrane and the cytosol factors p47phox, p67phox, p40phox and others present in
neutrophils (Curnutte, 1992).
Neutrophil functional responses are subject to priming (Aida and Pabst, 1991) which is
an alteration in the activation state of the cell that amplifies subsequent responses. Low-
level in vitro exposure of neutrophils to priming agents such as PAF, LPS and TNFa,
does not result in superoxide release but causes shape change, an increase in
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adhesiveness and a decrease in deformability of the cytoskeleton and consequently
chemotactic response. Primed neutrophils show an increased respiratory burst in
response to stimulation with chemotatic factors such as fMLP. Neutrophil priming also
leads to increased vascular sequestration and combinations of priming agents could act
to amplify neutrophil-mediated damage to the endothelium both in vivo and in vitro.
Apoptosis
During in vitro culture, neutrophils undergo spontaneous apoptosis, with characteristic
morphologic alterations (cytoplasmic and nuclear condensation) and intranucleosomal
DNA cleavage (Savill et al., 1989). Neutrophil apoptosis is associated with the marked
down-regulation of a number of neutrophil functions, including phagocytosis, stimulated
granule secretion and chemotaxis (Dransfield et al., 1995), many of which show marked
adhesion-dependency. One study characterizing apoptosis-associated cell surface
changes showed that apoptotic neutrophils have a markedly reduced capacity to bind to
E-selectin (Dransfield et al., 1995). They suggest that this is a consequence of the
reduced availability of the sialyl Lewis" selectin ligands, which are down-regulated on
the apoptotic cell surface.
E-selectin ligands
The first molecular contacts formed between the endothelium and circulating neutrophils
occur via vascular E- and P-selectins expressed by activated endothelium, resulting in
rolling adhesion which probably represents a key event in regulation of neutrophil
function (Lawrence and Springer, 1993; Frenette et al., 1996). Recent studies have
focused on the identification and characterization of glyco-conjugate ligands for the
selectins (Sperandio et al., 2006). Several ligands for E-selectin, which all contain sLex-
type glycans, have been identified including P-Selectin Glycoprotein Ligand-1 (PSGL-
1) (Asa et al., 1995), L-selectin (Picker et al., 1991), CD66 (Kuijpers et al., 1992),
CD44 (Dimitroff et al., 2001) and E-selectin ligand 1 (ESL-1) (Levinovitz et al., 1993)).
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It is probable that other Lex and sLex expressing glycoproteins and glycolipids on the
neutrophil are also capable of mediating interactions with the selectins. However, E-
selectin ligands on neutrophils are less well characterized. PSGL-1, which is found on
leukocytes and platelets, binds to P-, E- and L-selectins in vitro and represents an
important functional ligand for all of these molecules (McEver and Cummings, 1997).
Experiments carried out in Chapter 3 demonstrated that E-selectin binds via the lectin
domain to a ligand present on neutrophils and was required for the prolongation of Ca2+
mobilisation observed in neutrophils in response to PAF. Furthermore, the results in
Chapter 3 demonstrated that soluble E-selectin caused increased [Ca2+]j release
following stimulation with PAF. In this chapter, experiments were carried out to
examine the functional consequence of this increased [Ca2+]j release and the potential
role of TRPC channels in mediating several important neutrophil functional responses.
In addition, the role of the lectin domain in neutrophil responses was investigated and
potential neutrophil E-selectin counter-receptor(s) were investigated.
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5.2 Results
Recombinant E-selectin supports neutrophil adhesion
Figure 5.1 shows that recombinant E-selectin promoted neutrophil adhesion to E-
selectin-coated wells, which was susceptible to inhibition by the monoclonal antibody
ENA2 F(ab')2, confirming the requirement of the lectin domain for E-selectin mediated
adhesion.
Soluble E-selectin inhibits neutrophil chemotaxis towards PAF
Augmentation of (B2 integrin-dependent adhesion by soluble E-selectin (Ruchaud-
Sparagano et al., 2000) raised the possibility that soluble E-selectin may also affect the
potential for p2 integrin-mediated directed migration of neutrophils towards the
chemoattractant PAF. A P2 integrin blocking mAb (TS 1.18) abolished migration
towards PAF (Figure 5.2) confirming the p: integrin-dependent nature of neutrophil
migration. Figure 5.2B shows that the PAF-directed migration of neutrophils was
inhibited by soluble E-selectin, an effect which was reversed when soluble E-selectin
was pre-incubated with ENA2. These data suggest that increased p2 integrin-mediated
adhesive interactions in the presence of soluble E-selectin acts to slow migration
processes, prolonging neutrophil-endothelial cell interactions and may inhibit
transmigration in vivo.
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Figure 5.1 - Neutrophil adhesion to selectin coated plates shown by light
microscopy
Plates were coated with soluble E-, P-selectin or FCS at a concentration of lug/ml
overnight at 4°C. For adhesion blockade using CD62E mAb, wells were preincubated
with 1:50 dilution of ENA2 F(ab')2 for 30 min at 4°C. Wells were washed six times in
assay medium alone and fixed with 3% paraformaldehyde and adhesion of neutrophils
was viewed under a light microscope. A = E-selectin, B = CD62E blockade of E-selectin
adhesion, C = FCS (negative control) & D = commercial recombinant E-selectin
(positive control). All images taken with a Zeiss Axiovert si00 with lOx objective.
Pictures are representative of three separate experiments.
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Figure 5.2 Soluble E-selectin inhibits neutrophil chemotaxis
Chemotaxis of freshly isolated neutrophils was assessed using sub-agarose method (see
section 2.9). Figure A shows images taken with a Zeiss Axiovert si00 with lOx
objective. After staining with Diff-Quick, the distance from the origin to the leading
edge of migrating cells was determined using computer image analysis. Data shown are
the mean + sem from six separate experiments. E-selectin was used at 5pg/ml and
TS1.18 an anti-CD 18 monoclonal Ab was used at 10pg/ml. For blockade of CD62E,
ENA2 F(ab')2 (1:50) and soluble E-selectin were preincubated for 1 h.
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SOCE inhibition reverses E-selectin chemotaxis inhibition
Experiments were carried out to investigate the effect of Ca2+ channel inhibitors on E-
selectin inhibition of PAF-directed chemotaxis. Figure 5.3, shows Gd3+, a SOC and
TRPC channel blocker, reverses the inhibitory effect of E-selectin on chemotaxis,
suggesting a role for E-selectin-mediated SOCE in the inhibition of chemotaxis. As
Gd3+ reverses the effects of E-selectin on chemotaxis, this would further suggest a role
for TRPC channels being involved in this response.
Tyrosine phosphorylation reverses E-selectin effects on chemotaxis
The results in Chapter 4 (Figure 4.1) suggested a role for Src family tyrosine kinases in
soluble E-selectin-induced SOCE. Kumar et al. (2001) have recently shown that Src
family tyrosine kinases are involved in the induction of monocyte chemotaxis by soluble
E-selectin. Therefore, experiments were carried out to investigate the involvement of
tyrosine kinases in neutrophil chemotaxis. To further define the pathways involved in
neutrophil activation following soluble E-selectin treatment, the effects of specific
inhibitors of protein kinases involved in intracellular signaling were tested upon soluble
E-selectin-induced inhibition of chemotaxis. Inhibition of E-selectin-mediated
neutrophil migration in response to PAF was reversed by PP2, a Src family tyrosine
kinase inhibitor (Figure 5.4), suggesting a role for Src kinases in the inhibition of





Figure 5.3 Calcium channel blockers reverse E-selectins inhibition
Chemotaxis of neutrophils was assessed using sub-agarose method (see section 2.9). (A)
Images taken with a Zeiss Axiovert si00 with lOx objective. (B) After staining with
Diff-Quick, the distance from the origin to the leading edge of migrating cells was
determined using computer image analysis. Data shown are the mean + sem from six
separate experiments. E-selectin was used at 5pg/ml and Gd3+ used at lOpM.
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Figure 5.4 Src reverses E-selectin effects on chemotaxis
Chemotaxis of neutrophils was assessed using sub-agarose method (see section 2.9).
Figure A shows images taken with a Zeiss Axiovert si00 with lOx objective. After
staining with Diff-Quick, the distance from the origin to the leading edge of migrating
cells was determined using computer image analysis (B). Data shown are the mean +
sem from four separate experiments. E-selectin was used at 5pg/ml and PP2 was used at
a final concentration of 5pM.
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Soluble E-selectin augments neutrophil respiratory burst
Increased [Ca2+]j release following soluble E-selectin and PAF exposure may influence
the potential for neutrophil-mediated cellular damage. Untreated neutrophils release low
levels of 02~ (Figure 5.5). However, treatment of neutrophils with E-selectin treatment
alone significantly induced 02~ release (Figure 5.5). E-selectin induced superoxide
release was also blocked by ENA2, again indicating that the lectin domain of E-selectin
was required for its functional effects. Analysis of the effects of E-selectin upon
neutrophil superoxide response provides evidence that some of the observed effects of
soluble E-selectin are independent of Ca2+ mobilisation. For example, E-selectin alone
does not induce increased [Ca2+]j but treatment of neutrophils with soluble E-selectin
induces significant amounts of neutrophil 02" release (Figure 5.5) suggesting E-selectin
induced prolongation of Ca2+ mobilisation in response to PAF is not involved in the
effects of E-selectin on superoxide responses. In contrast, increased adhesion following
E-selectin/PAF treatment may parallel prolonged Ca2+ mobilisation.
Soluble E-selectin induced SOCE is not involved in neutrophil priming
Classical priming agents such as PAF or TNF-a have no effect upon neutrophil
superoxide release when used alone, but prime release in response to a second stimulus
such as fMLP or chemokines. Untreated neutrophils release low levels ofOf and fiMLP
stimulation alone leads to a small increase in the level of 02~ production, confirming that
the neutrophils used in these experiments were minimally activated or unprimed (Figure
5.6). Treatment with PAF alone also did not induce neutrophil 02" release (untreated =
0.3 ± 0.1 nmoles O2"/106 cells and PAF alone = 1.3 ± 0.5 nmoles O2~/106 cells), but pre¬
incubation with PAF caused an increase from 3.0 ± 1.0 to 16.0 ± 2.0 nmoles O2"/106
cells in fMLP-induced 02~ release (Figure 5.6).
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Figure 5.5 Soluble E-selectin alone induces O2" release
Neutrophils were preincubated with soluble E-selectin (5pg/ml) for 15 min at 37°C. For
blockade of CD62E, ENA2 (1:50) and soluble E-selectin were preincubated for 1 h.
Cells were then incubated in HBSS in presence of cytochrome c (lmg/ml) for another 15
min at 37°C. Superoxide dismutase-inhibitable reduction of cytochrome c was then
determined by measuring the peak absorbance between 535 and 565nm using a Pye-
Unican scanning spectrophotometer. Data are expressed as nmol of O2 /IO6 cells and are
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Figure 5.6 Soluble E-selectin effect upon (V release involve distinct mechanism
when compared to priming agents such as PAF and TNFa
Neutrophils were preincubated with soluble E-selectin (5pg/ml), PAF (lOOnM) for 15
min at 37°C or with TNFa (0.lng/ml) for 1 h at 37°C. Cells were then incubated in
HBSS of fMLP (lOOnM) in presence of cytochrome c (lmg/ml) for another 15 min at
37°C. Superoxide dismutase-inhibitable reduction of cytochrome c was then determined
by measuring the peak absorbance between 535 and 565nm using a Pye-Unican
scanning spectrophotometer. Data are expressed as nmol of CV/IO6 cells and are shown
as the means + sem of four separate experiments.
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In contrast, soluble E-selectin treatment alone significantly induced O2 release (4.0 ±
1.0 nmoles O2 /IO6 cells) and pre-incubation of neutrophils with soluble E-selectin prior
to fMLP treatment resulted in an increase in O2" release to 20.0 ± 3.0 nmoles (V/IO6
cells, to approximately the same levels as seen with PAF-primed neutrophils treated with
fMLP (Figure 5.6). TNFa alone did not induce neutrophil O2" release but in
combination with fMLP caused an O2" release of 19.0 ± 3.0 nmoles O2/IO6 cells.
Soluble E-selectin does not affect Ca2+ mobilisation in response to fMLP (Figure 3.5,
Chapter 3). However, soluble E-selectin enhances fMLP's ability to act as a secretory
stimulus in terms of O2" release. These data provide evidence that the effects of soluble
E-selectin upon neutrophil superoxide production and release are largely independent of
the effects upon Ca2+ mobilisation.
Soluble E-selectin augments PAF-induced neutrophil survival
The results in Chapter 3 (Figure 3.2), showed that soluble E-selectin prolongs PAF-
• 9+ ... . . 9+ • •
induced Ca mobilization. Recent investigations have suggested that Ca has a critical
regulatory role in neutrophil apopotosis and Whyte et al. (2003), demonstrated that
. • 2~F • .... .transient elevation of [Ca ]j resulted in prolonged inhibition of neutrophil apoptosis. It
has also been previously shown that neutrophil apoptosis characterized by distinctive
alterations in nuclear morphology (Figure 5.7A) is associated with a reduction in E-
selectin binding ability (Dransfield I, Stocks SC, 1995). These data suggest that the role
of soluble E-selectin in neutrophil apoptosis is a pertinent mechanism to investigate.
Therefore experiments investigating the effect of soluble E-selectin on apoptosis were
carried out using surface expression of phosphatidylserine (PS) as an index of apoptosis.
PS exposure is an indicator of apoptosis as following the onset of apoptosis, most
mammalian cell types translocate PS from the inner face of the plasma membrane to the
cell surface (Zhang G, 1997). Following 20 hours in culture, the viability of neutrophils
was determined by flow cytometric analysis of annexin V binding and PI exclusion.
Apoptotic neutrophils were defined as the population of cells, which were annexin V
positive and PI negative and viable neutrophils are annexin V and PI negative.
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Figure 5.7 E-selectin augments PAF-induced survival
(A) In overnight cultured neutrophils, apoptotic nuclei appear condensed whilst viable
cells have multi-lobed nuclei. (B) Viability was determined by flow cytometric analysis
of annexin V binding and PI exclusion. Human neutrophils (5 x 106/ml) were cultured at
37°C in Iscove's DMEM containing 10% autologous serum and were treated with
lOOpM PAF and/or 5pg/ml soluble E-selectin. After 20 h, the cells were incubated with
FITC-labelled recombinant human Annexin-V to determine phosphatidylserine
exposure. All values represent mean + sem of n = 5 experiments, each performed in
triplicate. * Indicated statistically different (P<0.5) from PAF treated controls.
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Annexin V is a marker of apoptotic cells and PI binds to DNA and allows the detection
of necrotic cells rather than apoptotic cells.
PAF has been shown by several groups to prolong neutrophil survival during in vitro
culture (Kuijpers et al., 2001; Khreiss et al., 2004). Figure 5.7 shows that PAF causes a
2 fold increase in the percentage of non-apoptotic neutrophils present after 20 hours
(42.8 ± 6.5 % vs 23.1 ± 4.2%) confirming that treatment with PAF alone promotes
neutrophil survival. In contrast, treatment with soluble E-selectin alone does not affect
neutrophil apoptosis. However, neutrophils cultured with both E-selectin and PAF,
show a significant increase in neutrophil survival when compared with PAF alone.
These data indicate that E-selectin augments PAF-induced neutrophil survival.
Role of E-selectin induced SOCE in PAF-mediated augmentation of apoptosis
To investigate if the effects of soluble E-selectin upon PAF-induced neutrophil survival
9+ • t • •
were dependent or independent of E-selectin prolonged PAF induced Ca mobilisation,
the effect of Ca2+ channel inhibitors on the observed inhibition of apoptosis was
investigated. Figure 5.8, shows that both MRS 1845 and Gd3+, known SOC channel
blockers, inhibited E-selectin effects on PAF-induced neutrophil survival to levels
observed in the presence of PAF alone. These results demonstrate that increased
neutrophil survival observed in the presence of PAF requires E-selectin induced SOCE.
Furthermore, the effects of soluble E-selectin upon neutrophil apoptosis may require a
TRPC channel since Gd3+ also reverses the soluble E-selectin effect.
Role of signaling pathways in neutrophil apoptosis
The results in Chapter 4 (Figure 4.1) suggested a role for Src family tyrosine kinases and
PI 3-kinase, in soluble E-selectin-induced SOCE. Therefore, experiments investigating
the effect of several inhibitors on E-selectin and PAF apoptosis levels were carried out
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Figure 5.8 Effect of Ca2+ channel inhibitors on E-selectin augmentation of PAF-
induced survival
Neutrophil viability was determined by flow cytometric analysis of annexin V binding
and PI exclusion. Human neutrophils (5 x l06/ml) were cultured at 37°C in Iscove's
DMEM containing 10% autologous serum and were treated with lpM PAF and/or
5pg/ml E-selectin. For blockade with Ca2+channel inhibitors lOpM Gd3+ or 2pM MRS
1845 was added. After 20 h, the cells were incubated with FITC-labelled recombinant
human Annexin-V to determine phosphatidylserine exposure. All values represent mean
+ sem of n = 5 experiments, each performed in triplicate. * Indicated statistically
different (P<0.5) from PAF treated controls.
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Figure 5.9 Effect of Src, PI 3-kinase and PKC on apoptosis levels
Neutrophil viability was determined by flow cytometric analysis of annexin V binding
and PI exclusion. Human neutrophils (5 x 106/ml) were cultured at 37°C in Iscove's
DMEM containing 10% autologous serum and were treated with lpM PAF and/or
5pg/ml E-selectin. For blockade of Src, 5pM PP2 was added, for blockade of PI 3-
kinase lOOnM wortmannin and for blockade of PKC, lpM Ro 31-8220 was added.
After 20 h, the cells were incubated with FITC-labelled recombinant human Annexin-V
to determine phosphatidylserine exposure. All values represent mean + sem of n = 5
experiments, each performed in triplicate. * Indicated statistically different (P<0.5)
from PAF treated controls.
154
Treatment of neutrophils with PP2 (Src specific inhibitor), alone augmented neutrophil
survival, whereas wortmannin (PI-3-kinase inhibitor), and Ro31-8220 (specific PKC
inhibitor) alone induced apoptosis (Figure 5.9). Inhibition of these signalling pathways
has direct effects upon neutrophil apoptosis and therefore it is difficult to interpret these
results and due to time limitations further in-depth investigations were not carried out.
CD66 is a potential E-selectin counter-receptor
Previous data in this thesis demonstrates that the binding of soluble E-selectin via the
lectin domain to a counter-receptor present on neutrophils is essential for the
9-4-
prolongation of Ca mobilization in neutrophils in response to PAF. E-selectin is
recognised by receptors that carry sialyl lewis", the principal carbohydrate counter-
receptor for the selectins. One cell adhesion molecule suggested to play a role in
selectin-mediated adhesion is CD66 or carcinoembryonic antigen (CEA). Human
neutrophils are known to express; CEACAM1 (CD66a), CEACAM8 (CD66b),
CEACAM6 (CD66c) and CEACAM3 (CD66d), all of which are highly glycosylated
molecules with multiple sialyl and fucosyl residues (Skubitz et al., 2001). As CD66
may function as an adhesion molecule capable of binding to E-selectin, experiments
• ... 2+
were carried out to examine the effect of CD66 ligation on PAF-induced Ca
mobilization. Pre-incubation of neutrophils with either a monoclonal antibody (Kat4c)
or a CEA polyclonal antibody revealed that both antibodies prolonged PAF-induced
induced Ca2+ mobilization in a similar manner to that caused by soluble E-selectin
(Figure 5.10). These results suggest a possible involvement of CD66 in the PAF-
induced [Ca2+], prolongation effect of soluble E-selectin.
PSGL-1 has been proposed as an important tethering counter-receptor for E-selectin and
has been shown by several groups to support the initial tethering of leukocytes to E-
selectin and is highly expressed on human leukocytes. Therefore, antibodies were used
to investigate whether PSGL-1 was the neutrophil counter-receptor mediating soluble E-
9+ • • •




Figure 5.10 CD66 antibodies prolong PAF-induced Ca2+ mobilisation
Freshly isolated neutrophils were loaded with Fura-2AM (2pM) and pre-incubated with
or without soluble E-selectin (5pg/ml) or CD66 antibodies (1:100), KAT4C F(ab')2 (A)
or CEA (B) for 15 min at 37°C. The cells were then stimulated with PAF (lOOnM) after
60 s of recording. A representative Ca2+ trace from three separate experiments that were
performed.
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Data from preliminary experiments showed that prolongation of Ca2+ mobilisation was
inhibited by the function-blocking anti-PSGL-1 antibody (PL-1) whereas the non-
blocking antibody (PL-2) was without effect, eliminating the possibility of steric effects
of antibody binding to PSGL-1 (data not shown). Although, these results appeared to
demonstrate a requirement for PSGL-1 in mediating the effects of soluble E-selectin
upon neutrophil Ca2+ responses, subsequent experiments using different batches of
antibodies from the same supplier failed to reproduce these findings. Therefore, the role
of PSGL-1 in E-selectin mediated SOCE remains unresolved.
Identification of E-selectin counter-receptors
Several putative glycoprotein selectin counter-receptors have been isolated from
hematopoietic cells using in vitro affinity purification techniques (Steegmaier et al.,
1995; Jones et al., 1997; Dimitroff et al., 2001), but the exact identity and contribution
of physiologic E-selectin counter-receptors on neutrophils is unknown. Precipitation
techniques were used to identify candidate glycoproteins as counter-receptors for E-
selectin. Biotinylation of the neutrophil cell surface was carried out prior to affinity
isolation of potential cell surface counter-receptors for E-selectin (Figure 5.11). IgG
sepharose was then used to pull-down E-selectin or protein A from neutrophil lysates.
As can be seen in figure 5.12 under the conditions used in these experiments E-selectin
pull-downs failed to identify potential counter-receptors. An LFA-1 integrin mAb was
used as a positive control to confirm that the cell surface biotinylation and precipitation
protocol was successful and as can be seen in figure 5.12 the expected bands for LFA-1
were observed at 175 (a subunit) and 95kDa (P subunit). Protein A was used as an
additional control to demonstrate specificity of any potential counter-receptors, as E-
selectin contains a protein A domain which may bind to potential candidate proteins.
This therefore, eliminates the possibility that proteins in the lysate are binding to the
protein A domain. All precipitation samples were also western blotted with an anti-E-
selectin antibody to confirm successful pull-down of E-selectin.
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Figure 5.11 Biotinylation of the cell surface of neutrophils
Fresh neutrophils were incubated with O.lmg/ml biotin and left for 1 h on ice and were
then lysed as described in Materials and Methods (Section 2.12). Western blotting of
unbiotinylated neutrophils (1) and biotinylated neutrophils (2) stained with streptavidin-
HRP revealed numerous bands in the biotinylated neutrophil lane which proves
biotinylation of the neutrophil cell surface has occurred. A representative immunoblot
of three different experiments is shown.
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Figure 5.12B shows that E-selectin was present in the E-selectin pull-down sample and
none of the other precipitation samples as would be expected. Precipitation experiments
can be difficult when using neutrophils, due to the potential for protein breakdown by
the numerous proteases present in neutrophils. Furthermore, the E-selectin counter-
receptor interaction is known to have fast association and dissociation rates, a preferred
requirement for rolling adhesion, which may also make it technically difficult to detect
by standard precipitation techniques. Any potential E-selectin counter-receptors may







Figure 5.12 Precipitation of E-selectin counter-receptor
(A) Freshly isolated neutrophils were incubated with O.lmg/ml biotin and left for 1 h on
ice and were then preincubated with either 5pg/ml soluble E-selectin (lanel), 5pg/ml
Protein A (lane2) or buffer (lane3) for 15 min prior and were then lysed as described in
section 2.12. Cell lysates were then spun with the appropriate antibody for 1 h at 4°C
(lane 1 & 2 no antibody was added & 2pg/ml of LFA1 was added in lane 3) before
addition of the appropriate sepharose (LFA-1 - anti-mouse IgG sepharose and Protein A
& E-selectin - rabbit IgG sepharose). In lanel proteins that coprecipitated with soluble
E-selectin were detected by probing the transfer membranes with an anti-streptavidin
HRP. Lanes 2 & 3 were used as positive controls for precipitation, were also probed
with anti-streptavidin HRP. (B) Pull-down of E-selectin was confirmed by probing the
same samples with an anti-E-selectin antibody, 1:200. The results shown are
representative of three independent experiments.
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5.3 Discussion
Appropriate recruitment of neutrophils to sites of infection or tissue injury is critical for
the initiation and progression of the inflammatory response. A number of studies have
shown the importance of selectins in the orchestration of adhesion and migration of
neutrophils in the initial capture and subsequent rolling on vascular endothelial ligands
(Lawrence and Springer, 1991; Frenette et al., 1996; Crockett-Torabi, 1998). Selectins
also have a more complex regulatory role in inflammatory processes, initiating
intracellular signal transduction cascades that lead to neutrophil activation and altered
functional responses (Simon et al., 1995; Hidari et al., 1997). Many of the effector
functions of neutrophils, such as granule release, phagocytosis and toxic metabolite
production are modulated by the adhesive state of the cell. Engagement of (L-integrins
or matrix receptors serves to amplify the destructive potential of neutrophils in response
to triggering stimuli (Graham et al., 1993; Tyagi et al., 2000a; Tyagi et al., 2000b).
Similarly, several studies have suggested that binding of neutrophils to vascular selectins
may enhance subsequent neutrophil function (Kuijpers et al., 1993; Stocks et al., 1995).
In Chapter 3, it was demonstrated that soluble E-selectin caused prolonged [Ca2+]j
release following stimulation with PAF. In this chapter, the physiological consequence
of this prolonged [Ca2+], release was investigated on a number of important neutrophil
functional responses.
Firstly, neutrophil adhesion was investigated as previous studies reported that soluble E-
selectin specifically potentiates P2-mediated adhesion (Ruchaud-Sparagano et al., 2000).
Experiments were carried out that confirmed soluble E-selectin alone was capable of
supporting neutrophil adhesion (Figure 5.1). Treatment of neutrophils with both E-
selectin and PAF induced a synergistic effect upon P2-integrin mediated adhesion
(Ruchaud-Sparagano et al., 2000). Ruchaud-Sparagano et al. (2000) investigated
whether E-selectin affected the PAF response by altering Ca2+ fluxes within neutrophils
using different Ca2+ inhibitors. Their results showed that blocking the initial
intracellular Ca2+ influx abolished E-selectin and PAF-mediated P2-integrin activation
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suggesting a role for Ca2+ influx in the regulation of neutrophil adhesion. However,
Ca2+ mobilisation may not be involved in the regulation of neutrophil adhesion by E-
selectin alone.
E-selectin's ability to augment p2 integrin-mediated adhesion in response to PAF
(Ruchaud-Sparagano et al., 2000) suggested that soluble E-selectin effects on p2
integrin-mediated directed migration of neutrophils may be an interesting mechanism to
study. Therefore, experiments investigating the role of E-selectin upon neutrophil
migration in response to PAF were carried out. The results showed that soluble E-
selectin is a potent inhibitor of chemotaxis of neutrophils in response to PAF (Figure
5.2). The presence of tightly regulated local changes in [Ca2+]j and transient increases of
9-P • • • 2+ • •
[Ca ]j in migrating neutrophils suggests that modulation of [Ca ]; may play a critical
role in chemotaxis (Marks and Maxfield, 1990; Verploegen et al., 2002). Therefore,
Ca2+ influx mediated by E-selectin may be involved in inhibition of neutrophil migration
by E-selectin. Figure 5.3 shows that MRS 1845, a SOC inhibitor, reversed E-selectin
effects on migration suggesting that Ca2+ influx may be involved. The prolonged
elevation of [Ca2+]j may interfere with the dynamic activation/deactivation of integrin
ligand binding that are necessary for efficient migration (Lawson and Maxfield, 1995;
Leitinger et al., 2000). Figure 5.3 also shows Gd3+, a TRPC inhibitor also reverses E-
selectin's inhibitory effect on neutrophil migration implying that TRPC channels may be
responsible for E-selectin's inhibitory effects.
One of the primary mechanisms by which neutrophils are activated is through the
activation of protein tyrosine kinases at the plasma membrane (Berton, 1999; Fumagalli
et al., 2007). Among the tyrosine kinases, Src family kinases are activated upon
stimulation of several cytokine and G-protein-coupled receptors in neutrophils (Yan et
al., 1995; Berton et al., 2005) and therefore might play an important role in neutrophil
signalling and effector functions. Data obtained using knock-out mice of different Src-
family members demonstrate that these kinases are involved in degranulation (Mocsai et
al., 1999) and migration (Lowell and Berton, 1998). Src family tyrosine kinases are also
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known to play a role in P2 integrin-mediated adhesion (Giagulli et al., 2006) and
recently, Src family tyrosine kinases have been demonstrated to be involved in
promoting P2 integrin adhesiveness in neutrophils tethered by E-selectin (Totani et al.,
2006). Inhibitors of Src family tyrosine kinases may be useful in the treatment of
several inflammatory diseases including ischemia-reperfusion injury, sepsis or acute
lung injury due to the critical role that they play in the regulation of neutrophil activation
and inflammatory responses (Korade-Mirnics and Corey, 2000; Okutani et al., 2006).
Data in Chapter 3 showed that soluble E-selectin induced activation and tyrosine
phosphorylation of Src and that Src was involved in E-selectin prolonged Ca2+
mobilisation, suggesting that the Src family tyrosine kinases may be important
regulators in soluble E-selectin-mediated signalling in neutrophils. Therefore, the role
that Src family kinases play in soluble E-selectin mediated signalling in chemotaxis was
investigated. PP2, a Src family specific inhibitor, reversed soluble E-selectin effects on
chemotaxis, returning chemotaxis to basal levels (Figure 5.4). These data indicate that
Src family kinases play a role in the signalling events responsible for E-selectin
inhibition of neutrophil chemotaxis. Kumar et al. (2001) showed soluble E-selectin
mediated monocyte chemotaxis via Src family tyrosine kinases and soluble E-selectin-
induced angiogenesis is predominantly mediated through the Src-P13K pathway (Kumar
et al., 2003). Taken together, these results suggest that soluble E-selectin may inhibit
chemotaxis through the Src pathway and this could thus be a potential target for
modulating neutrophil or monocyte recruitment-driven diseases.
Figure 5.5 shows that soluble E-selectin significantly increases superoxide release when
used alone, unlike conventional priming agents such as PAF or TNFa. Flowever, in
combination with stimuli that do not normally trigger 02" release from unprimed
carefully prepared neutrophils (e.g. fMLP), soluble E-selectin potentiates O2" production.
Previous work has shown that when interleukin-8 or PAF was used in combination with
soluble E-selectin, the effect was the same as seen with fMLP (Ruchaud-Sparagano et
al., 2000). In Chapter 3, it was observed that soluble E-selectin specifically prolongs
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2+Ca mobilisation in response to PAF but not fMLP or LTB4 whereas soluble E-selectin
in combination with fMLP significantly induces production of O2". Differential
regulation of Ca2+ influx by fMLP and PAF has been well studied (Chen et al., 2000).
PAF and fMLP are also known to affect signalling pathways differently, for example
neutrophil MAPK signalling pathways mediated by fMLP and PAF are known to be
different (Chen et al., 2005). This difference in signalling pathway activation may be
the reason that PAF and fMLP produce different functional outcomes in neutrophils.
The difference between augmentation of 0{ and Ca2+ mobilisation in response to PAF
indicates that altered Ca2+ mobilisation following PAF receptor ligation does not
regulate the synergistic action of PAF and E-selectin upon 02" release.
Neutrophil death by disintegration or necrosis has the potential to inflict cellular damage
by release of granule contents (Simon, 2003), stimulating resident phagocyte
populations and prolonging the inflammatory reaction. While neutrophils undergo
apoptosis constitutively, the rate of apoptosis can be modulated. For example it is
known that inflammatory mediators, such as fMLP or C5a (Colotta et al., 1992;
Perianayagam et al., 2002), as well as other receptor-mediated stimuli associated with
2~E ... . 2+ •Ca mobilisation and elevation of [Ca ]j during neutrophil activation (Kuijpers et al.,
2001) can affect apoptosis. Elevation of [Ca2+], has been reported to induce apoptosis in
a number of cell types (Jiang et al., 1994; Chiu et al., 2007; Sasaki et al., 2007).
•*> 1
However, a recent report showed that incubation of neutrophils with Ca ionophores
dramatically inhibited neutrophil apoptosis without inducing cell necrosis and concluded
that transient elevation of [Ca2+]j resulted in prolonged inhibition of neutrophil apoptosis
(Whyte et al., 1993). Therefore, these results raise the interesting possibility that
apoptosis in the neutrophil is inhibited by stimuli increasing [Ca2+]j, whilst this event has
been shown to trigger apoptosis in other cell types. It has also recently been
demonstrated that Ca2+ influx is shutdown during apoptosis in neutrophils (Ayub and
Hallett, 2004). This suggests that a failure of the shut-down mechanism could give rise
to inappropriately prolonged activity, which may result in inflammatory tissue damage.
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The results presented here showed that PAF significantly augmented neutrophil survival
whereas soluble E-selectin alone failed to affect the rate of apoptosis at the time points
examined. However, soluble E-selectin and PAF caused a subsequent significant
prolongation of neutrophil survival when combined in vitro. To investigate if E-
selectin's prolonged Ca2+ influx was involved in this process, the SOC inhibitors
MRS 1845 and Gd3+ were used. These SOC inhibitors did not affect basal levels of
apoptosis but abolished the increased neutrophil survival observed following E-selectin
and PAF co-treatment to levels observed with PAF alone, indicating that E-selectin-
mediated SOCE may be involved in the augmented neutrophil survival. The ability of
Gd3+, a TRPC channel inhibitor, to reverse E-selectin's augmentation of PAF induced
neutrophil survival implies there may be a role for TRPC channels in this response.
The data presented here suggests that transient rises in [Ca2+]i can have profound and
lasting effects upon on the apoptosis signalling pathway. PAF and E-selectin may be
involved in inhibition of the pro-apoptotic signal in neutrophils. This study suggests a
mechanism may exist for the inhibition of constitutive apoptosis, which is mediated, at
least in part by elevation of [Ca2+]j. Apoptosis provides a neutrophil clearance
mechanism in tissue and would tend to limit inflammatory tissue injury and promote
resolution rather than persistence of inflammation. These observations may have some
relevance for the development of novel approaches to anti-inflammatory therapy, as with
increasing knowledge of the mechanism of apoptosis; it may be possible to specifically
induce apoptosis in certain inflammatory cells at critical stages in the pathogenesis of
inflammatory disease by inhibiting E-selectin and PAF's effects. It is therefore
important to understand the signalling pathways involved in the Ca2+ influx during
apoptosis in neutrophils before this knowledge may be useful in the future.
Investigation of the downstream signalling events involved in modulation of apoptosis
was undertaken to identify roles for distinct pathways. The effects of several well
characterised inhibitors on E-selectin and PAF modulation of apoptosis was determined.
Treatment with PP2, the Src specific inhibitor alone augmented neutrophil survival
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(Figure 5.9). In contrast the PI-3-kinase inhibitor wortmannin, and Ro31-8220, a
specific PKC inhibitor alone induced apoptosis (Figure 5.9). Alteration of basal levels
of apoptosis by these inhibitors makes investigation of the role of Src, PI 3-kinase and
PKC in E-selectin's effect on PAF-induced apoptosis difficult.
Tyrosine kinases, PI-3-kinase and PKC isoforms have been shown by several groups to
be important in inhibition of neutrophil apoptosis (Wei et al., 1996; Webb et al., 2000;
Petrin et al., 2006). PKC isoforms have been shown to be differently involved in
regulation of apoptosis (Deacon et al., 1997). For example PKCa has been
demonstrated to be predominantly anti-apoptotic whereas PKC8 and PKC0 are pro-
apoptotic (Pongracz et al., 1999; Cataisson et al., 2003). PI-3 kinase activity has also
been shown to delay neutrophil apoptosis (Wang et al., 2003). Unfortunately, in the
experiments carried out here, inhibitors of these signalling pathways alone affected basal
neutrophil apoptosis and did not allow definition of the role of signalling pathways
involved in the effect of E-selectin on PAF-induced apoptosis. However, alternative
approaches could be investigated to define the role of signalling pathways involved in
the E-selectin regulation of PAF inhibition of apoptosis. For example to investigate the
role of PKC signalling, specific PKC isoform inhibitors could be used to determine the
role of each PKC isoform in neutrophil apoptosis and various concentrations of these
inhibitors could be tested to find an optimal concentration that didn't affect basal
apoptosis. The effect of PAF and E-selectin on triggered cell death by Fas of TNFa
could also be tested, to see if they still promoted cell survival.
In Chapter 3 (Figure 3.9) TRPC channels were identified to be involved in the
generation of soluble E-selectin induced SOCE. The results in this chapter demonstrate
that TRPC channels may also be involved in mediating the Ca2+ fluxes that are
responsible for the inhibitory effect of E-selectin on chemotaxis (Figure 5.3) and soluble
E-selectin's augmentation of PAF induced neutrophil survival (Figure 5.8). However,
neither of these experiments definitively identifies which TRPC channels regulate these
responses. Therefore, to determine the role ofTRPC in modulating neutrophil migratory
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potential and neutrophil apoptosis, it would be interesting to carry out these functional
assays using neutrophils isolated from wild type and TRPC6 7 mice. As discussed in
Chapter 3, experiments to confirm that E-selectin and PAF cause permissive SOCE in
neutrophils from mice, in the same way as human neutrophils would need to be carried
out first. If neutrophils from TRPC6"A mice treated with soluble E-selectin showed
normal migration and no augmentation of PAF-induced neutrophil survival it would
confirm the involvement of TRPC6 in these functional responses. It would also be
interesting to investigate if failure to limit tyrosine kinase activation underlies generation
of a 'pro-inflammatory' neutrophil response following selectin ligation resulting in
altered chemotaxis, degranulation and survival by using murine neutrophils from Src
kinase knockout mice. However, we still have to confirm if soluble E-selectin causes
the same effects in murine neutrophils. As discussed in previous chapters, using murine
neutrophils imposes constraints on the number of experiments that can be carried out as
typical yields from bone marrow neutrophil and peritoneal neutrophil preparations are
approximately 1-2 million cells in total.
Elevated levels of soluble E-selectin are found in patients with inflammatory conditions
including septic shock (Kayal et al., 1998), rheumatoid arthritis (Koch et al., 1993;
Yildirim et al., 2005), juvenile idiopathic arthritis (Bloom et al., 2005), ARDS (acute
respiratory distress syndrome) (Ruchaud-Sparagano et al., 1998), hepatitis B (Yan et al.,
2006), asthma (Janson et al., 2005) and in uveitis (Lee et al., 2007). However, the
consequences of elevated levels of soluble E-selectin at inflamed sites and the
mechanism of action of soluble E-selectin are still poorly understood. The results in this
chapter suggest that the presence of high local concentrations of soluble E-selectin
would have the potential to influence cellular recruitment patterns and may exert pro¬
inflammatory effects upon neutrophil behaviour. Soluble E-selectin specifically
augmented p2 integrin-mediated adhesion decreased PAF-directed migration of
neutrophils and triggered O2" release, which would result in tissue damage in vivo.
Alterations in Ca2+ mobilisation in response to soluble E-selectin and PAF
synergistically augment neutrophil survival, which could lead to prolonged survival of
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destructive neutrophils at sites of inflammation. These results may suggest that soluble
E-selectin may act to prolong neutrophil-endothelial contact and trigger oxidant-
mediated cellular damage. They also imply that there is potential to selectively block
some of soluble E-effects by inhibiting Ca2+ influx, leaving other Ca2+ mediated
responses intact, which may allow some host defence functions to be maintained and
could be very useful clinically.
The lectin domain of E-selectin plays a major role in counter-receptor recognition and
binds to sialyl Lex on neutrophils. Importantly, we have shown a requirement for the
lectin-binding domain in several E-selectin mediated functional responses including
adhesion, chemotaxis and superoxide production. It is also required for the prolongation
of Ca2+ mobilization in neutrophils in response to PAF. Therefore, identification of the
neutrophil counter-receptors for E-selectin is a critical issue, as they could represent
useful pharmacological targets for inflammatory diseases. There are a number of
potential counter-receptors for E-selectin present on neutrophils, including PSGL-1,
CD44 and a number of proteins that express sialyl Lex, including CD66.
E-selectin was shown to require a lectin-binding domain for several of its functional
responses and CD66 is known to bind to lectin-binding domains. In neutrophils CD66a
is the major membrane glycoprotein that binds sLex antibodies (Stocks and Kerr, 1993).
Thus CD66a may be an endogenous ligand for C-type lectins, such as E-selectin.
Recently, several different Lewis x glycan epitopes were identified on CD66a that may
function as specific binding structures for other proteins, such as C-type lectins using
MALDI-TOF MS analysis (Lucka et al., 2005). CD66 family members also contain a
sequence similar to immunoreceptor tyrosine-based activation motifs (ITAM) and these
motifs are known to be involved in activation of leukocyte responses. CD66a and
CD66d have been shown to contain one ITAM motif in their cytoplasmic domain (Nair
and Zingde, 2001; McCaw et al., 2003). CD66a contains a YstL sequence and CD66d
contains a YeeL sequence. The tyrosine residues within the ITAM motif are necessary
and sufficient for ITAM signalling activity and, when phosphorylated, bind to SH2
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domains of Src kinases (e.g. Fyn, Lck) and of other tyrosine kinases (e.g. Syk and ZAP-
70) which can phosphorylate recruited adaptor proteins (Pitcher and van Oers, 2003). It
has recently been shown that integrin signalling in neutrophils and macrophages requires
adaptors containing ITAM motifs (Mocsai et al., 2006). Therefore, one possibility is
that the presence of an ITAM-like sequence in the CD66 cytoplasmic domain may
provide a mechanism for regulation of neutrophil function following E-selectin binding.
The data presented here strongly implicates CD66 in the response to E-selectin, as CD66
ligation with antibodies caused prolonged PAF-induced Ca2+ mobilization in a similar
manner to that caused by soluble E-selectin. It would be critical to demonstrate that
CD66 functions as a receptor for E-selectin on neutrophils. Immunofluorescence or
immunoprecipitation techniques could be used to show association of E-selectin with
membrane CD66. To date, preliminary experiments with biotinylated neutrophil surface
receptors and immunoprecipitating potential counter-receptors were unsuccessful,
probably due to the high dissociation rates between E-selectin and it's ligands. It would
have been interesting to use an unbiased cross-linking approach to identify neutrophil
surface receptors that bind to soluble E-selectin. Neutrophil surface receptors would be
biotinylated and reversible cross linkers such as 3,3'-
Dithiobisjsulfosuccinimidylpropionate] (DTSSP) or disuccinimidyl suberate (DSS)
could be used to cross link closely associated molecules. Specific immunoprecipitation
of E-selectin followed by reversal of cross-linking would allow the identification of
neutrophil molecules that bind E-selectin by SDS-PAGE together with immunoblotting.
As a control, P-selectin could be used as it binds to neutrophils but fails to affect
neutrophil functional responses examined here. Direct binding of recombinant purified
CD66 to the selectins used in this study could also be tested using surface plasmon
resonance techniques. Experiments using monoclonal antibodies could be used to
selectively engage specific CD66 family members, and define their contribution to
prolongation of Ca2+ and augmentation of neutrophil functional responses. A number of
proteins would be anticipated to associate with E-selectin, binding either independently
or as a complex. Examination of the binding of E-selectin and co-localisation of
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molecules identified as E-selectin counter-receptors using confocal microscopy might
also provide additional insight into whether receptor complexes are involved.
If CD66 was an E-selectin counter-receptor the ITAM-like sequences, YstL or YeeL,
present in the CD66 cytoplasmic domains may recruit Fyn or Lck and these may target
the TRPC channel directly. By using a series of fusion proteins with mutations in key
tyrosine residues, it would be possible to determine the contribution of specific regions
of the CD66 cytoplasmic domain in the regulation of TRPC activity.
Interestingly, a recent study has shown that G-CSF directly induces E-selectin
expression on human myeloid cells (Dagia et al., 2006). They found that G-CSF
treatment consistently resulted in up-regulation in expression of HCELL (a specialized
sialofucosylated glycoform of CD44) and PSGL-1 and suggested that these ligands
prime neutrophils to adhere to inflamed endothelium. On the basis of these results it
would be interesting to investigate the effect of G-CSF treated neutrophils in
immunoprecipitation experiments to investigate if HCELL is a candidate as an E-
selectin counter-receptor. A cell line which expresses the components required for this
system to work, for example the PAF receptor, TRPC6 and CD66, could be used to
determine if CD66 was an E-selectin counter-receptor or used to identify potential E-
selectin counter-receptors.
The results in this chapter have shown that binding of E-selectin via the lectin domain,
through an as yet unidentified E-selectin counter-receptor present on neutrophils, is
required for E-selectin to mediate several of its functional responses. The data presented
in this study suggest that CD66 antigens may be involved in events that regulate E-
selectin-mediated prolongation of PAF-induced [Ca2+];. One possibility is that CD66
antigens contain a binding site for soluble E-selectin or CD66 and other adhesion
receptors need to co-engage via soluble E-selectin to regulate Ca2+ signalling in response
to PAF.
170
Exposure of neutrophils to soluble E-selectin alters the capacity for production of
damaging reactive oxygen species in a manner that is distinct from classical priming
agents but is not dependent on the alteration of Ca mobilisation seen in response to E-
selectin and PAF. Neutrophil (32-integrin-mediated chemotaxis is significantly inhibited
following exposure to E-selectin and E-selectin augments PAF-induced neutrophil
survival. These results demonstrate a requirement for E-selectin induced SOCE and
TRPC channels therefore suggest that E-selectin mediated Ca2+ mobilisation may affect
neutrophil apoptosis and migration. In conclusion, soluble E-selectin levels are elevated
in many chronic inflammatory conditions and soluble E-selectin promotes neutrophil
destructive function, which could influence progression of inflammation. Therefore
understanding mechanisms by which selectins influence signalling pathways may reveal
a novel therapeutic target for the treatment of inflammatory disease.
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Chapter 6 - Summary & Future Directions
6.1 Summary
• • • 2+The main aim of this thesis was to study the effects of soluble E-selectin on Ca
mobilization in neutrophils, and the signalling events involved in its regulation. The
• •••• # 2~b
principal finding of this thesis was that soluble E-selectin does not mobilize [Ca ];
directly, but that signalling via E-selectin receptors allows molecular crosstalk with
receptors for specific inflammatory mediators (e.g. PAF) to occur, permitting a novel
form of Ca2+ influx through TRPC channels and modulation of neutrophil responses. I
have demonstrated that soluble E-selectin induced modulation of TRPC channel activity
occurs through phosphorylation and activation of Src-family tyrosine kinases in
neutrophils, via activation of PI 3-kinase. I have also shown a potential role for PKC in
regulating TRPC6 channel activity. This study provides the first evidence for
intracellular communication between receptors for E-selectin and Gq/n-coupled
inflammatory mediator receptors and suggests this response is mediated through
regulation of TRPC channels (Figure 6.1). Another important finding was that E-
selectin triggered alterations in TRPC channel function acts to promote adhesion, reduce
migratory capacity and augment neutrophil destructive potential and neutrophil survival.
Preliminary data also suggested that CD66 has the potential to act as a counter-receptor
























E-selectin triggered alterations in TRPC channel
function acts to:
- Promote adhesion
- Reduce migratory capacity
- Augment neutrophil destructive potential &
neutrophil survival
Figure 6.1 - A novel mechanism of molecular cross-talk between an adhesion
receptor and an inflammatory mediator.
The results presented in this thesis predict the above model for intracellular
communication between an adhesion receptor and inflammatory mediator at a molecular level,
through activation of permissive soce by selectin receptor ligation following paf stimulation
of human neutrophils and present the functional outcomes of this process.
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6.2 Why is this work important?
Inappropriate recruitment and adhesion-dependent degranulation of neutrophils
contributes to the progression of several inflammation diseases including rheumatoid
arthritis, ARDS, COPD and asthma (Stockley, 1999; Puneet et al., 2005; Eyles et al.,
2006). Soluble E-selectin levels are elevated in many chronic inflammatory conditions
and soluble E-selectin has been suggested to promote neutrophil destructive function
which could influence progression of inflammation. Inhibition of neutrophil 'rolling'
adhesion by blocking selectins has been shown to affect the accumulation of neutrophils
in many experimental settings (Xia et al., 2002; Mocco et al., 2002) and consequently
the possibility that inhibiting selectin activity might provide a treatment for
inflammatory disorders has attracted much attention. However, pre-clinical trials and
clinical trials using drugs that block selectin activity has proven disappointing as
inhibiting adhesion receptors in neutrophils can lead to the loss of vital anti-microbial
defences. Whilst therapeutic blockade of adhesion receptors may place patients at risk
of life-threatening infections due to inadequate recruitment of inflammatory cells,
selective targeting of adhesion receptor signalling pathways could be exploited to
attenuate the destructive responses of neutrophils. Thus, understanding the mechanisms
by which selectins influence signalling pathways may be very important in the discovery
of novel drug compounds for inflammatory diseases.
In particular, Ca2+ is known to play a central role in the functional activities of
neutrophils that are important for host defence (Nathan, 2006). Recent exciting reports
have shed new light on the components and regulators of store-operated Ca entry (Liou
et al., 2005; Spassova et al., 2006; Peinelt et al., 2006) and disruption of their underlying
control mechanisms may lead to inappropriate cell activation, contributing to
development of major life threatening diseases including atherosclerosis, rheumatoid
arthritis, COPD and allergic reactions (Tian et al., 2004; Steel and Anderson, 2004). The
work presented in this thesis aims to define the mechanisms involved in Ca2+ signalling,
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which may ultimately allow specific uncoupling of neutrophil function to limit their
impact on disease progression.
There are over 300 ion channels identified in humans and defects in ion channel function
are widely suspected to be the cause of various diseases (Vincent et al., 2006; Nilius et
al., 2007). Abnormal regulation of ion channel function is especially interesting in all
forms of inflammation and in systemic diseases, such as neurodegenerative,
cardiovascular, and respiratory diseases. However, only a few ion channels have been
directly linked to human disease and less than 10% of known Ca2+ channels have been
successfully used as therapeutic targets. In particular, TRP channels are often activated
by multiple and diverse gating stimuli and act as molecular integrators of these external
and/or internal signals. Indeed, five diseases associated with defects in genes encoding
the TRP channels have been identified to date (Nilius et al., 2007). Perturbation of
physiological functions mediated by ion channels can also contribute more subtly to the
genesis of disease as a consequence of changes in channel abundance, or channel
sensitization, or desensitization, resulting in exaggerated, or diminished, responses to
important pathological stimuli.
The TRPC6 gene has been linked to hereditary kidney disorder, focal & segmental
glomerulosclerosis (FSGS), which leads to renal failure. Six families with six different
TRPC6 gene mutations have been identified (Winn et al., 2005; Reiser et al., 2005).
These mutations lead to a kidney disease with late onset and a variable rate of
progression to FSGS. Three of the identified mutations of the TRPC6 gene are missense
mutations that result in enhanced signalling (gain of function) by TRPC6 via specific
amino acid substitutions. In the nephron, TRPC6 is expressed in the podocytes in the
kidney glomerular filter (Winn et al., 2005; Reiser et al., 2005). Podocyte foot processes
and the glomerular slit diaphragm form the glomerular filter and are an essential part of
the permeability barrier in the kidney, which is defective in FSGS (Kriz, 2005;
Durvasula and Shankland, 2006). The defect in the filter function results in proteinuria
and end-stage renal failure (Kriz, 2005; Gudermann, 2005). It is uncertain how the
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mutations in TRPC6 translate into the development of FSGS. However, for the
mutations that result in gain of function, enhanced Ca2+ entry may constitute a
pathogenic trigger, such as a Ca2+ overload of the podocyte that initiates cell death by
apoptosis, or causes dysregulation that compromises the integrity of the permeability
barrier (Reiser et al., 2005). Alternatively, mutations in TRPC6 may impair the ability
of the podocyte to adapt to the normal physiological demands of maintaining the
functional glomerular filter, such as responding to changes in glomerular filtration
pressure.
The presence of several TRPC genes and proteins in airway smooth muscle cells
products has also been demonstrated, for example TRPC1 mRNA in rat bronchial
smooth muscle cells (Sweeney et al., 2002) and TRPC4 and TRPC6 mRNA in myocytes
isolated from human trachea (Corteling et al., 2004). The potential role of TRPC6 in
airway smooth muscle cells has been identified from studies in vascular smooth muscle
where RNA-knockdown of endogenous TRPC6 protein expression reduced spasmogen-
activated increases in [Ca2+]j and myogenic tone (Inoue et al., 2001; Welsh et al., 2002).
Increased TRPC6 expression has been reported in patients with idiopathic pulmonary
hypertension (IPAH) (Yu et al., 2004). Inhibition of endogenous TRPC6 expression by
using siRNA markedly attenuated IPAH-pulmonary artery smooth muscle cell
proliferation, which suggests that overexpression of TRPC6 in pulmonary artery smooth
muscle cell may play an important role in the development of pulmonary medial
hypertrophy (Yu et al., 2004). TRPC6 has also been demonstrated as a key regulator of
hypoxic pulmonary vasoconstriction (HPV), which occurs in ventilatory disorders
including chronic pulmonary hypertension (Weissmann et al., 2006). The TRPC
channels have also been suggested to be involved in the development of many
neurological diseases and a recent study suggested a role for TRPC6 in Alzheimer's
disease (Lessard et al., 2005). TRPC channels have also been shown to be involved in
numerous other diseases which affect the cardiovascular, endocrine, gastrointestinal and
reproductive systems (Nilius et al., 2007).
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In light of the data presented in this thesis relating to the role of TRPC6 in regulation of
inflammatory cell functions, investigating the mechanism of inter-receptor
communication that results in altered gating of TRPC channels in neutrophils could be
very important for the development of anti-inflammatory drugs to attenuate leukocyte
activation. Selective modulation of distinct components of these Ca2+ signals may be a
potential target. Unfortunately, our knowledge of the detailed mechanisms through
which TRP channels function is still elementary. Such a situation impairs both our
understanding of the mechanistic role of TRP channels in human disease and the
development of drugs to target TRPs and their specific functions. The more we learn
about fundamental TRP channel physiology and the potential role of TRPs in disease,
the closer we come to the development of novel therapies.
6.3 Future studies
A key focus of any future studies would be to define the molecular mechanism of
communication between E-selectin receptors and TRPC channels responsible for
augmenting neutrophil responses. The development of a model system would be
instrumental in further unravelling this molecular mechanism of communication
between an adhesion receptor and a Ca2+ channel. A cell line which expresses the
components required for this system to work, for example the PAF receptor, TRPC6 and
potential E-selectin counter receptors would be required. A cell line with these
properties could also be used to determine if CD66 was an E-selectin counter-receptor or
used to identify other potential E-selectin counter-receptors such as PSGL-1 or CD44.
Preliminary screening of various human leukemic cell lines e.g. THP-1, HL-60, U937
cell lines suggests that a cell line with expression of the required receptors is not
available but it would be possible to develop a model system by transfecting in the
required components into a cell line such as Rat basophilic leukemia cells (RBL-2H3),
which have been used extensively as a model cell system for chemoattractant receptor
signalling. RBL-2H3 cells are also a well established model for Ca2+ signalling as they
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have been used in CRAC and SOC channel studies (Liu et al., 2004; Csutora et al.,
2006; Tani et al., 2007). The presence of TRPC6 has also been demonstrated in RBL-
2H3 cells (Garcia and Schilling, 1997). RBL-2H3 cells contain small secretory
granules, the majority of which stain with alcian blue and lack electron-dense material
(Seldin et al., 1985). These granules, however, reproduce the secretory process, which
occurs in basophils and mast cells when stimulated through an IgE receptor-mediated
mechanism or by a variety of non-immunological stimuli. IgE-mediated degranulation
is an energy-requiring secretory event that occurs in the absence of cell lysis and
depends on a number of signalling pathways resulting in a rise of cytosolic calcium ions
(Beaven and Metzger, 1993). RBL-2H3 cells are also easily transfected and can be
induced to degranulate as a readout for cell activation making them ideal as a model
system for this project. Establishment of a model system also has the advantage that
individual signalling pathways can be investigated more systematically by either
studying the effect of knocking out specific components in the cell line or changing the
combination of molecules that are transfected into the cell line.
Other important work that should be carried out to extend the studies reported here
would be to investigate the role of TRPC channels in the processes of neutrophil
adhesion, migration and release of neutrophil enzymes and reactive oxygen species.
Established assays could be used for neutrophil adhesion, apoptosis, degranulation,
superoxide generation and a combination of sub-agarose, transwell and trans-endothelial
assays to determine the role of TRPC in modulating neutrophil migratory potential using
neutrophils isolated from wild type and TRPC6_/" mice. In Chapter 5, I demonstrated
that soluble E-selectin can augment neutrophil survival induced by the inflammatory
mediator PAF (Figure 5.7). As un-regulated prolonged survival of destructive
neutrophils at sites of inflammation will exacerbate tissue damage, the onset and rates of
neutrophil apoptosis could be examined by flow cytometry from control and TRPC6~A
mice, to establish the potential of targeting this as an effective treatment to reduce
neutrophil recruitment and survival at these inflamed sites.
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Further functional characterizations of the signalling pathways that regulate TRPC are
required. The results presented here indicate that multiple signalling events regulate
TRPC activity in neutrophils. E-selectin was shown to induce activation of Src in
neutrophils and E-selectin was also proven to alter the gating of TRPC channels. It
would be interesting to determine whether tyrosine phosphorylation and altered protein-
protein interactions acts to regulate TRPC channel activity in neutrophils.
Immunoprecipitation and western blotting techniques combined with the use of specific
inihibitors of individual components of these pathways could be used to determine the
role of the Src/PI 3-kinase pathway in phosphorylation of TRPC6. Neutrophils from
Hck'Fgr^Lyn"'" mice (Totani et al., 2006) could be used to investigate any potential
molecular crosstalk between Src family kinases and TRPC6 channels. The role of PKC
in TRPC phosphorylation also needs to be studied in further detail. Future experiments
could be carried out to determine whether there are distinct sites for phosphorylation that
can modulate TRPC6 channel opening, one of which (PKC targeted) that causes
negative regulation and another (Src and/or Akt targeted) that modulates the channel in a
positive manner. Immunoprecipitation and phosphopeptide analysis together with
MALDI/TOF mass spectrometry could be used to identify and confirm roles for distinct
phosphorylation sites of TRPC6 in neutrophils. A key aspect of these studies would be
to determine the interplay between Src/PI 3-kinase pathway and PKC in control of
neutrophil adhesion, migration and degranulation responses to soluble E-selectin and
thus the potential for therapeutic modulation of neutrophil destructive potential.
STIM1 and CRACM1 have recently been identified as regulators of SOCE. Therefore, a
key area of interest would be to investigate the role of STIM1 and CRACM1 in E-
selectin regulation of TRPC channels. Data in Chapter 3 showed that neutrophils
contain mRNA for STIM1 and CRACM1. Recent reports suggest that adaptor proteins
recruiting other signalling molecules could promote communication to occur through
protein/protein interactions. Formation of STIM1 homo-aggregates may be expected to
appear as distinct punctuate regions close to the plasma membrane and by using single
cell imaging with real-time confocal microscopy the localisation of STIM1, CRACM1,
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E-selectin receptors and TRPC6 channels following E-selectin receptor ligation in the
presence or absence of PAF could be determined. Together these studies would allow
identification of protein/protein interactions with TRPC6 following stimulation of
neutrophils with E-selectin and PAF. Huang et al. (2006) have recently shown that
ST1M1 co-immunoprecipitates with TRPC1, TRPC2 and TRPC4 but not with TRPC3,
TRPC6 or TRPC7. This suggests that STIM1 is a key regulator of activity rather than a
channel component. Therefore, I would expect phosphorylation events to underlie the
'priming' of TRPC6 that occurs, allowing it to interact with a Gq/n-derived signal that
generates interaction sites on the channel itself or recruitment of adaptor proteins for
ST1M1 or other Ca2+ sensors.
Another key focus of any future studies would be to investigate the role of Gq in
communication with TRPC channels. Previous results demonstrated that E-selectin
permitted Ca2+ influx to occur in response to PAF but not fMLP of LTB4 (Ruchaud-
Sparagano et al., 2000). Experiments in Chapter 3 where neutrophils were pre-treated
with pertussis toxin identified that the PAF receptor was coupled to PLC through a PTX-
insensitive Gq/u pathway. This observation may, at least in part, explain the specificity
of the observed effect of soluble E-selectin as fMLP and LTB4 receptors are coupled
through PTX-sensitive G proteins. Direct phosphorylation of TRPC6 alone appears to
be insufficient to cause channel opening and Ca2+ influx and that a Gq/i i-derived signal
is also an essential requirement to permit the channel to open following Ca2+ store
depletion. Thus, E-selectin receptor ligation may 'prime' the TRPC channels for a
specific G protein signal which is supplied following stimulation of neutrophils with
PAF at sites of tissue injury and inflammation. Therefore, it would be interesting to
examine the association of aq/u or (3y subunits with TRPC6 by cross-linking and
immunoblotting techniques and by using specific peptide inhibitors such as GP
antagonist 2A (inhibits Gq) and mSIRK (Py subunit binding peptide) in reversibly-
permeabilised neutrophils loaded with Fura2-AM and under whole cell patch clamp
conditions to ascertain the role of G protein subunits in initiating TRPC6 channel
opening.
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In summary, the work in this thesis revealed a novel communication between an
adhesion receptor and an inflammatory mediator receptor that could provide new
opportunities for modulation of neutrophil function.
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E-selectin permits communication between PAF receptors and TRPC channels
in human neutrophils
Sarah R. McMeekin, Ian Dransfield, Adriano G. Rossi, Christopher Haslett, and Trevor R. Walker
The selectin family of molecules (L-, P-,
and E-selectin) mediates adhesive interac¬
tions between leukocytes and endothelial
cells required for recruitment of leuko¬
cytes to inflammatory sites. Soluble E-
selectin levels are elevated in inflamma¬
tory diseases and act to promote
neutrophil p2-integrin-mediated adhe¬
sion by prolonging Ca2+ mobilization. Al¬
though soluble E-selectin alone was un¬
able to initiate Ca2+ signaling, it allowed a
novel "permissive" store-operative cal¬
cium entry (SOCE) following the initial
platelet-activating factor (PAF)-induced
release of Ca2+ from inositol 1,4,5-
Introduction
trisphosphate (IP3)-sensitive stores. This
induction of permissive SOCE in re¬
sponse to soluble E-selectin and PAF was
shown to act through a G protein-coupled
receptor (GPCR) coupled to pertussis
toxin-insensitive Gq/11. Furthermore, we
demonstrated that permissive SOCE was
mediated by canonical transient receptor
potential channel (TRPC) due to its sensi¬
tivity to specific inhibition by MRS1845
and Gd3+ and that TRPC6 was the princi¬
pal TRPC family member expressed by
human neutrophils. In terms of mecha¬
nism, we demonstrated that soluble E-
selectin activated Src family tyrosine ki¬
nases, an effect that was upstream of
phosphatidylinositol 3'-kinase in a signal¬
ing pathway that regulates permissive
SOCE following exposure of neutrophils
to PAF. In summary, this report provides
the first evidence for communication be¬
tween an inflammatory mediator and ad¬
hesion receptors at a molecular level,
through selectin receptor ligation allow¬
ing permissive SOCE to occur following
PAF stimulation of human neutrophils.
(Blood. 2006;107:4938-4945)
© 2006 by The American Society of Hematology
Dysregulation of neutrophil granulocyte function has been impli¬
cated as having a key role in the initiation and progression of a
number of inflammatory diseases. The control of events involved in
leukocyte recruitment is critical for development of effective
antimicrobial defenses and also for efficient wound healing.
However, excessive inflammatory-cell recruitment or inappropriate
cell activation leads to the development of chronic inflammation
that favors fibrotic repair and, ultimately, loss of organ function.
The selectin family of molecules (L-, P-, and E-selectin) mediate
adhesive interactions between leukocytes and endothelial cells,
representing one of the earliest events in the recruitment of
inflammatory cells. Studies in vitro and in vivo have revealed the
critical role of the selectin family of molecules in the initial capture
and subsequent rolling adhesion on vascular endothelial ligands1
before neutrophils firmly adhere and undergo diapedesis at sites of
tissue injury and inflammation. In terms of structure, the selectins
are type I transmembrane receptors that contain an amino terminal
Ca2+-dependent (C-type) lectin domain that has been shown to be
important in ligand recognition and is directly involved in mediat¬
ing cell-to-cell contact through Ca2 " -dependent interactions with
cell-surface carbohydrates.2
Several ligands for E-selectin, which all contain sialyl Lewis"-
type glycans, have been identified including P-selectin glycopro¬
tein ligand 1 (PSGL-1),3 L-selectin,4 CD66,5 CD44,67 and
E-selectin ligand 1 (ESL-1).8 However, E-selectin ligands on
neutrophils have not been fully characterized to date. The best
characterized selectin ligand is PSGL-1, which is found on
leukocytes and platelets. PSGL-1 binds to P-, E-, and L-
selectins in vitro and represents an important functional ligand
for all of these molecules.9
Recent studies using double or triple selectin knockout mice
revealed that selectins have both overlapping and distinct func¬
tions.10 Single-selectin knockout mice showed only minor deficien¬
cies in leukocyte recruitment in response to tumor necrosis factor a
(TNF-a) or thioglycollate, suggesting distinct roles for the selectins
in the inflammatory process. In contrast, double-mutant mice
displayed more profound defects in neutrophil recruitment. For
example, E- and P-selectin double-mutant mice showed an in¬
creased susceptibility to bacterial infection, with the majority of
animals developing chronic inflammatory lesions of the oral
mucosa and skin, suggesting that E- and P-selectin may function
cooperatively." The most severe deficiencies in neutrophil recruit¬
ment were found in E-, L-, and P-selectin triple-knockout mice,
which had impaired neutrophil emigration, neutrophil rolling, and
significant leukocytosis.12
Although the role of selectins in leukocyte recruitment is well
established, it is now becoming clear that pathways engaged in
response to E-selectin receptor engagement may trigger cell
activation even though the molecular mechanisms remain to be
defined. Engagement of selectin receptors has been reported to
activate the mitogen-activated protein kinase (MAPK) pathway or
activate cell-surface receptor-associated protein tyrosine kinases.13
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Recent findings from a number of studies suggest that soluble
E-selectin may also engage selectin receptors. Soluble E-selectin
levels are elevated in many chronic inflammatory conditions, including
rheumatoid arthritis and asthma.214 In addition, soluble forms of
selectins are rapidly released from activated endothelial cells.14 One
possibility is that receptor shedding may represent a mechanism for
limiting further inflammatory-cell recruitment by decreasing the
availability of endothelial ligands for inflammatory cells. However,
it is becoming clear that soluble E-selectin may activate inflamma¬
tory cells15 and exert potentially proinflammatory effects.16
Early studies have suggested that selectin and platelet-
activating factor (PAF) signaling act cooperatively to induce
neutrophil adhesion to the endothelium.17 E-selectin is known to
reduce the rolling velocity of neutrophils in vitro.18 In vivo work by
Kanwar et al19 found that low concentrations of exogenous PAF
induced an increase in neutrophil adhesion in slow-rolling cells,
whereas fast-rolling cells were unresponsive to the same concentra¬
tion of PAF. Similarly, P-selectin has been shown to slow the
rolling cells so that they are able to firmly adhere in the presence of
lower concentrations of PAF.20 These findings would suggest that
reduced neutrophil rolling velocity following adhesion to selectins
confers a higher ability to adhere in the presence of an appropriate
stimulus. However, one possibility is that selectin receptor engage¬
ment may facilitate integrin-mediated "firm" adhesion following
exposure to a second stimulus and that there could be communica¬
tion between receptors for inflammatory mediators and those
involved in adhesion at a molecular level.
We have previously demonstrated that Ca2+ mobilization
induced by PAF in neutrophils, an early key event in the control of
motility, respiratory burst, and degranulation, is prolonged in the
presence of soluble E-selectin.21 Neutrophil adhesion to p2-integrin
ligands (albumin-coated latex beads) induced by PAF but not by
leukotriene B4 (LTB4) or formyl-Met-Leu-Phe (fMLP) was pro¬
moted by soluble E-selectin and this adhesion required PAF-
induced Ca2+ mobilization from inositol 1,4,5-trisphosphate (IP3>—
sensitive intracellular stores. In this paper, we provide biochemical




Hanks balanced salt solution (HBSS) was obtained from Life Technologies
(Paisley, United Kingdom). Dextran T500 was obtained from Amersham
Pharmacia Biotech (Buckinghamshire, United Kingdom). PAF, pertussis
toxin, gadolinium(III) chloride, and wortmannin were obtained from
Sigma-Aldrich (Poole, United Kingdom). ENA2 was purchased from
Abeam (Cambridge, United Kingdom) and MRS1845 and ruthenium red
from Tocris (Bristol, United Kingdom). U73122, U73343, LY294002
hydrochloride, LY303511, Fura2-AM, PP2, PP3, SB203580, SB202474, and
PD98059 were purchased from Calbiochem (Nottingham, United King¬
dom). Enhanced chemiluminescence (ECL) Western blotting detection
reagents were obtained from Amersham Pharmacia Biotech.
Antibodies
Anti-TRPC6 was purchased from Alamone Labs (Jerusalem, Israel).
Phospho-Src family (Tyr416) was purchased from Cell Signaling (Hertford¬
shire, United Kingdom) and anti-phopho-Aktl/PKBa (Ser473), clone
11E6, was obtained from Upstate Biotechnology (Milton Keynes, United
Kingdom). Monoclonal anti-fl-actin antibody was purchased from Sigma-
Aldrich. Goat anti-mouse and -rabbit horseradish peroxidase (HRP)-
conjugated antibodies were obtained from Dako (Ely, United Kingdom).
Expression and purification of E-selectin
Recombinant proteins of E-selectin were obtained using a baculovirus
expression construct kindly provided by Dr Mike Bird (GlaxoSmithKline,
Stevenage, United Kingdom). Recombinant human E-selectin, lacking the
last 2 consensus repeats, was produced in a baculovirus insect-cell
expression system as a C-terminal chimera with 2 protein A domains in
tandem. High Five cells (BT1-TN-5B1-4 cell line, Invitrogen, Paisley,
United Kingdom) were used to express recombinant E-selectin. High Five
cells were cultured in Express Five serum-free media supplemented with
L-glutamine and penicillin/streptomycin. High Five cells (9 X 106/75-cm2
flask) were seeded into cell-culture flasks and left to adhere for 20 minutes.
After attachment of the cells, the medium was removed and the cells were
infected with recombinant virus at 2 PFU/cell. Three hours later, the
medium was replaced with fresh medium. After 72 hours of incubation at
27°C, the culture supernatant was collected and stored at 4°C for further
purification.
Recombinant proteins were then purified from High 5 insect-cell culture
supernatants using IgG affinity column chromatography using the protein A
domain in the recombinant protein. A column containing IgG-agarose was
equilibrated with 5 column volumes of 0.1 M phosphate buffer, pH 8.0. The
supernatant was applied to the affinity column, the column was washed with
2 column volumes of 0.1 M phosphate buffer, and eluted with 100 mM
glycine in 500- p.L fractions. Fractions were analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for protein con¬
tent. The eluted proteins were then dialyzed against PBS (Ca2+ and Mg2+
free) overnight. A typical yield was 1.5 to 2.0 mg protein/250 mL
supernatant.
Neutrophil isolation
Polymorphonuclear leukocytes were isolated from peripheral blood of
healthy donors as described previously.22 After centrifugation of citrated
whole blood at 300g for 20 minutes and removal of platelet-rich plasma,
leukocytes were separated from erythrocytes by dextran sedimentation
using 0.6% (wt/vol) dextran T500. Polymorphonuclear leukocytes were
then separated from mononuclear leukocytes using discontinuous isotonic
Percoll gradients. Polymorphonuclear leukocytes were 95% to 98% neutro¬
phils using morphologic criteria and cell viability was assessed by trypan
blue exclusion.
Measurement of [Ca2+]i
Freshly isolated leukocytes were resuspended at 107/mL in HBSS (Ca2"
and Mg2+ free) and were incubated with 2 pM Fura2-AM at 37°C for 30
minutes in the dark. The cells were then washed twice to remove Fura2-AM
and resuspended at 4 X 107/mL in HBSS (containing Ca2" and Mg2+).
Intracellular calcium was monitored by Fura-2 emission fluorescence at 510
nm using 340/380-nm dual wavelength excitation in a Perkin Elmer
(Beaconsfield, CA) luminescence spectrometer at 37°C with constant
stirring. Calibration was performed after each experiment using 100 pL
0.1% (vol/vol) Triton X (Rraax) and 10 mM EGTA (Rmj„). [Ca2+]j was
calculated from the 340:380-nm fluorescence ratio.23
RT-PCR analysis
Total RNA was extracted from freshly isolated neutrophils using the TRIzol
reagent method per the manufacturer's instructions (Invitrogen, Life
Technologies). Ofigo(dT)-primed first-strand cDNA synthase was per¬
formed with Moloney murine leukemia virus reverse transcriptase (RT;
Superscript II, Promega, Madison, WI) using 500 ng mRNA as template in
a total volume of 20 pL. The cDNA was then used for polymerase chain
reaction (PCR) with Taq polymerase (Promega). Two pairs of specific
primers each were used to detect the canonical transient receptor potential
channel (TRPC) 1,3,4, and 6 and one primer pair was used forTRPC2 and
5; primers were synthesized by MWG Biotech (Ebersberg, Germany). The
sequence of the printer pairs used along with the predicted size of their
expected amplicons are as follows: TRPC1: forward 5'-ATGTATACAAC-
CAGCTCTATCTTG-3' and reverse 5'-AGTCTTTGGTGAGGGAAT-
GATG-3' (525 bp); TRPC1: forward 5' -TTCTGTGGATTATTATTGG-
GATGA-3' and reverse 5 '-CAGAACAAAGCAAAGCAGGTG-3' (505
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bp); TRPC2: forward 5 '-TCTGGACCATGTTCGGTATG-3' and reverse
5'-GCTACCTCGCTTTGCAGTC-3' (565bp); TRPC3: forward 5'-CTG-
CAAATGAGAGCTTTGGC-3' andreverse 5'-AACTTCCArTCrACATCACT-
GTC-3' (388 bp); TRPC3; forward 5'-GCGAATTGTTAACTTTC-
CCAAATGC-3' and reverse 5 '-TCTTCCAAAAGTTCATAACGAAGGC-3'
(300 bp); TRPC4: forward 5' -ATTCATATACTGCCTTGTGTTG-3' andreverse
5'-GGTCAGCAATCAGTTGGTAAG-3' (329 bp); TRPC4: forward 5'-
TTGCCTCTGAAAGACATAACATAAG-3' and reverse 5'-CTACTAACACA-
CATTGTTCACTGAG-3' (300 bp); TRPC5: forward 5'-ACTTCTATTAT-
GAAACCAGAGC-3' and reverse 5'-GCATGATCGGCAATAAGCTG-3' (289
bp); TRPC6: forward 5'-AAGACATC11CAAGTTCATGGTC-3' and reverse
5'-TCAGCGTCATCCTAATrrCCC-3' (322 bp); TRPC6: forward 5'-ACA-
GATAATGCAAAACAGCTG-3' and reverse 5'-ATGATGCTCTGGGCTTTG
-3' (244 bp); and GAPDH: forward 5'-TGCCTCCrGCACCACCAAGTG-3'
and reverse 5'-AATGCCAGCCCCAGCGTCAAAG-3' (450 bp).
The reaction solution (50 pJL) contained 0.4 pM ofeach primer (forward and
reverse), 2 mM MgCL, 0.2 mM dNTPs, 1.25 U Tag polymerase, and 1 pL
cDNA. The PCR conditions were: 95°C for 10 minutes, followed by 35
cycles, each consisting of denaturation at 95°C for 1.5 minutes, annealing at
63°C for 2 minutes and extension at 72°C for 2 minutes, and a final
extension at 72°C for 10 minutes. After PCR amplification, the reaction
mixtures were applied to 1% (wt/vol) agarose gel for electrophoresis and
















Neutrophils (5 X 10'° cells/L/sample) were lysed, following stimulation as
detailed in the figure legends, in lysis buffer containing Tris HC1 (100 mM,
pH 8.0), NaCl (100 mM), EDTA (2 mM), Nonidet NP-40 (1% vol/vol),
NajV04 (5 mM), NaF (50 mM), and protease inhibitor cocktail (Sigma-
Aldrich) for 30 minutes at 4°C. Samples were centrifuged for 20 minutes at
15 OOOg at 4°C and supernatants were reduced with electrophoresis sample
buffer containing Tris HC1 (0.25 M, pH 6.8), SDS (8% wt/vol), fS-mercapto-
ethanol (10% wt/vol), glycerol (30% vol/vol), and bromophenol blue
(0.02% wt/vol). Each sample was loaded onto a 10% SDS-polyacrylamide
gel and proteins were separated and electrophoretically transferred to
nitrocellulose. The membranes were then blocked for 1 hour in 5% (wt/vol)
dried milk and probed with primary antibody overnight. After washing with
Tris-buffered saline containing 0.1% (vol/vol) Tween 20 (TBST), blots
were incubated with goat anti-mouse HRP (1:2500) or with goat anti-rabbit
HRP (1:2500) antibodies for 1 hour at room temperature. The membranes
were incubated with ECL reagent (Amersham Biosciences, Buckingham¬
shire, United Kingdom), placed under BioMax MS-1 x-ray-sensitive film,
and processed through an x-ray developer (X-Ograph Imaging Systems,
Wilts, United Kingdom).
Statistical analysis
Statistical analysis was carried out using the one-way ANOVA test with a
Newman-Keuls multiple comparison posttest analysis, with statistical
significance being achieved when P was below .05.
Results
Soluble E-selectin prolongs PAF-induced Ca2+ mobilization
Incubation of human neutrophils in the presence of soluble
E-selectin did not induce Ca2+ mobilization (Figure 1 A). However,
in agreement with our previous studies,21 preincubation of neutro¬
phils with soluble E-selectin caused a subsequent sustained in¬
crease in [Ca2+]j in response to PAF without affecting the initial
increase of [Ca211, (Figure 1A). To facilitate comparison of
experimental data, we have calculated the area under the Ca2+
curve to provide a measure of the Ca2+ mobilization observed.
Inhibition of soluble E-selectin interaction with neutrophils by
ENA2, an anti-E-selectin monoclonal antibody that binds to the
lectin domain of E-selectin, inhibited the sustained Ca2+ levels
Figure 1. Soluble E-selectin prolongs PAF-induced Ca2+ mobilization. (A)
Freshly isolated neutrophils were loaded with Fura2-AM (2 pM) for 30 minutes at 37°C
in Ca2' - and Mg2 -free HBSS, then washed and resuspended in HBSS containing
Ca2+ and Mg2+, and then preincubated with or without soluble E-selectin (E-sel, 5
pg/mL) for 15 minutes at 37°C as indicated. For blockade of CD62E, ENA2 (1:50) and
soluble E-selectin were preincubated for 1 hour before being added to neutrophils.
Neutrophils were stimulated with PAF (100 nM) after recording "baseline" Ca2+ levels
for 60 seconds. Data are shown as a representative trace of 5 separate experiments
showing similar results and are expressed as percent of peak [Caz+]i following PAF
stimulation (typically from 50 nM control levels to 2.5 pM following stimulation). (B)
Traces from panel A have been integrated to calculate area under each curve using
GraphPad Prism software (GraphPad, San Diego, CA) to compare the effects of
various inhibitors. Data from 5 separate experiments that were performed and
expressed as mean ± SEM. "Statistically different (P<.05) from PAF-treated
controls.
without affecting the initial rapid rise in [Ca2+]j observed in
response to PAF treatment (Figure IB). These data demonstrate
that binding of soluble E-selectin via the lectin domain to a
counterreceptor present on neutrophils is required for the prolonga¬
tion of Ca2+ mobilization in neutrophils in response to PAF.
Using a range of preincubation times with soluble E-selectin, it
was demonstrated that the effects of soluble E-selectin on prolonga¬
tion of [Ca2+]i in neutrophils were maximal by 15 minutes (Figure
2A), suggesting that downstream signaling pathways may be
involved to induce prolonged Ca2+ mobilization in response to PAF
rather than a rapid and direct physical interaction causing conforma¬
tional changes. Furthermore, the effects of soluble E-selectin on
prolongation of [Ca2+]j levels were maintained whether soluble
E-selectin was present or removed by washing; no significant
difference was evident between samples (Figure 2B). Thus, the
effects of soluble E-selectin are unlikely to be attributed to
nonspecific effects such as sequestration/buffering of extracellular
Ca2+ or changes in associated molecules that affect Ca2+ ion
movements. These data suggest that soluble E-selectin triggers
intracellular signaling pathways to modulate Ca2+ entry. We have
previously shown that soluble E-selectin promotes Ca2+ mobiliza¬
tion and adhesion selectively to PAF but not to stimulation by
fMLP or LTB4.21 Pretreatment of neutrophils with pertussis toxin,
which ADP ribosylates G, and G0, was found to inhibit fMLP- and
LTB4-induced Ca2+ mobilization but had no effect on Ca2+
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Figure 2. Effect of soluble E-selectin is time-dependent. (A) Freshly isolated
neutrophils were loaded with Fura2-AM (2 |xM) as for Figure 1 and preincubated with
E-selectin (5 jig/mL) for various times as indicated. The cells were then stimulated
with 100 nM PAF after 60 seconds of recording. Data from 3 separate experiments
that were performed are expressed as mean area under the curve ± SEM.
"Statistically different (P< .05) from PAF-treated controls. (B) Freshly isolated
neutrophils were preincubated with soluble E-selectin and samples were either
washed to remove E-selectin (WO) or used after 15 minutes of incubation. Data
shown are expressed as mean area under the curve ± SEM from 3 independent
experiments.
responses (Figure 3A), thereby suggesting a role for a pertussis
toxin-insensitive G protein in mediating the effects of PAF.
E-selectin causes Ca2+ influx through a TRPC
PAF-induced Ca2+ mobilization is dependent on activation of
phospholipase C and release of IP3 because this response is
sensitive to complete inhibition by U73122, a specific phospho¬
lipase C inhibitor (Figure 3B), whereas the inactive analog U73343
had no effect. Our previous studies also demonstrated that the
initial PAF-induced [Ca2+]i spike was abolished by TMB-8, which
blocks Ca2+ release from intracellular stores, and that a relatively
small second phase ofCa2+ mobilization was sensitive to inhibition
by the receptor-operated channel inhibitor SKF96365.21 Impor¬
tantly, soluble E-selectin-induced promotion of Ca2+ mobilization
in this latter phase was insensitive to SKF96365,21 suggesting it
occurs through distinct ion channels. We therefore sought to further
define the molecular mechanism by which soluble E-selectin
induced prolonged elevation of [Ca2+]j. Neutrophils treated with
ruthenium red, an inhibitor of Ca2+-induced Ca2+ release from
ryanodine-sensitive stores, had no effect on mobilization of Ca2+ in
response to PAF in the presence of E-selectin (Figure 3C).
Chelation of extracellular Ca2+ by EGTA showed that only the
E-selectin-mediated prolongation of [Ca2+]i was sensitive to
blockade and that PAF-induced Ca2+ release from stores was
unaffected, indicating that soluble E-selectin affected Ca2+ influx
rather than release from an intracellular store. The initial elevation
of [Ca2+]j in response to PAF, known to be due to release of Ca2+
from IP3-sensitive stores, was unaffected by MRS1845, a store-
operated channel inhibitor; however, soluble E-selectin-induced
sustained [Ca2+]i following stimulation with PAF was sensitive to
inhibition by MRS 1845 (Figure 3D). These results indicate that
soluble E-selectin was allowing activation of a store-operated
channel by PAF-induced Ca2+ store emptying, an effect we have
termed "permissive" store-operated Ca2+ entry (SOCE). We next
tested whether Gd3+, a specific transient receptor potential family
of cation channels (TRPC) inhibitor, would affect the E-selectin-
induced [Ca2+]j response to PAF. As shown in Figure 3C, the
prolonged rise in [Ca2+]j observed in the presence of soluble
E-selectin was sensitive to Gd3+, which is consistent with a role for
TRPC in this response.
TRPC expression in polymorphonuclear leukocytes
To determine the profile of TRPC expression in human neutrophils,
multiple specific primer pairs were used to screen for the presence
of TRPC1-TRPC6 mRNA species in highly purified human
neutrophils. The expression profile for members of the TRPC
family is illustrated in a representative gel of RT-PCR products
shown in Figure 4A. PCR products for TRPC6 were found in all
neutrophil samples (n = 10), whereas TRPC3 was only found in
20% of samples. We did not observe signals for TRPC1, 2, 4, and 5
in any of the preparations, despite positive RT-PCR controls
demonstrating that these PCR conditions were optimal. To confirm
TRPC6 protein expression, we assayed crude membrane prepara¬
tions from freshly isolated human neutrophils using Western
blotting techniques. A specific antibody for TRPC6 revealed a
strong band in the appropriate 90- to 100-kDa range, which could
be blocked by a TRPC6-blocking peptide (Figure 4B), confirming
the presence of protein and the RT-PCR data.
S 300000
Figure 3. TRPCs mediate soluble E-selectin prolongation of
PAF-induced Ca2+ mobilization. (A) Freshly isolated neutro¬
phils were incubated with pertussis toxin (2 pg/mL) for 1 hour,
washed, and then loaded with Fura2-AM (2 pM) for 30 minutes at
37°C prior to stimulation with 100 nM PAF. Data shown are
expressed as mean area under each curve ± SEM from 3
separate experiments. "Statistically different (P < .05) from PAF/
LTB4- or fMLP-treated controls, n.s. indicates not significant. (B)
U73122 (5 pM) and U73343 (5 pM) were added 5 minutes and
EGTA (1.25 mM) was added 10 minutes before stimulation with
100 nM PAF. A representative Ca2' trace from 3 separate
experiments that were performed is shown. (C) Calcium traces
showing the effect of calcium channel inhibitors on the prolonged
[Ca2+]i elevation induced by soluble E-selectin. Ruthenium red
(RR; 20 nM), MRS1845 (2 pM) were added 5 minutes and
Ga3+CI3 (10 pM) was added 3 minutes before stimulation with
100 nM PAF. The calcium trace shown is representative of 3
separate experiments with similar results. (D) Bar graph represent¬
ing area under the curves of the graph in panel C, calculated using
GraphPad Prism software. Data shown are expressed as mean ±
SEM from 3 separate experiments that were performed. "Statisti¬

























Figure 4. TRPC6 expression in human neutrophils. (A) Expression of TRP family
members in isolated human neutrophils. Representative results of RT-PCR analysis
with mRNA from a single isolation and cDNA preparation of neutrophils with each of
the indicated primers are given and GAPDH was used as a positive control. Lanes
are indicated as: M, markers; 1, TRPC1; 2, TRPC2; 3, TRPC3; 4, TRPC4; 5, TRPC5;
and 6, TRPC6. (B) Western blotting of neutrophil (N) or mononuclear cell (M)
membrane preparations stained with anti-TRPC6 antibody (1:400) revealed a strong
band at the predicted molecular weight (100 kDa) as indicated. Specificity was
demonstrated by incubation of the TRPC6 antibody with a 4-fold excess of the
antigenic peptide exhibited no signal. Nonspecific binding was assessed using an
IgG control stained with rabbit anti-IgG antibody (1:400). A representative immuno-
blot of 3 different experiments is shown.
E-selectin-induced SOCE is regulated by Src and PI-3K
It is now clear that critical regulatory elements that control TRPC
activity include phosphorylation and Src family tyrosine kinases in
particular.24 We therefore used specific protein kinase inhibitors to
test their involvement in soluble E-selectin-mediated SOCE.
Inhibition of p38 MAPK by SB203580 (10 p.M) or the negative
control SB202474 (10 pM) had no effect on soluble E-selectin-
induced Ca2+ influx following stimulation of neutrophils with PAF
(Figure 5B). Similarly, a lack of effect by PD98059 (10 pM) on
soluble E-selectin-induced modulation of Ca2+ influx identified
that MEK1 was not involved in mediating these responses (Figure
5B). However, the specific Src family tyrosine kinase inhibitor PP2
(5 pM) selectively inhibited the soluble E-selectin-induced SOCE
to levels observed in PAF-only stimulated neutrophils (Figure
5A-B), whereas PP3, the inactive analog, had no effect on soluble
E-selectin-induced Ca2+ influx. These data suggest either a direct
role for Src in modulating TRPC6 channel activity or potentially a
role for Src in the downstream signaling events following soluble
E-selectin binding to its putative receptor on neutrophils. Because
PI 3-kinase is known to be a key regulator of ion channels in a
variety of other cell types, we pretreated neutrophils with the
specific PI 3-kinase inhibitors wortmannin (100 nM) or LY294002
(10 pM) and LY303511, an inactive structural analog. PI 3-kinase
inhibition also inhibited the soluble E-selectin-induced SOCE
to controls levels (Figure 5C-D), the inactive analog having no
effect, thus identifying PI 3-kinase as a key regulator in the
signaling pathway, which mediates the effects of soluble E-selectin
on Ca21 influx.
Western blot analysis of neutrophil protein lysates using a
phosphorylation state-specific antibody (Tyr(P)416), which corre¬
lates with Src activation, showed significant phosphorylation above
control levels with soluble E-selectin treatment (Figure 6A).
Interestingly, stimulation of neutrophils with PAF alone had no
effect on the levels of phospho-Src. Pretreatment of neutrophils
with PP2, prior to stimulation with soluble E-selectin, inhibited
active phospho-Src to below control levels. In addition, LY294002
(10 pM) had no significant effect on soluble E-selectin-induced
phosphorylation and activation of Src (Figure 6A), indicating that
PI 3-kinase may be involved in a parallel pathway or acts
downstream of Src in regulating Ca2+ influx. Soluble E-selectin
caused activation of PI 3-kinase as assessed by a significant
increase in phosphorylated Akt, a downstream target ofPI 3-kinase,
compared with control untreated cells, whereas PAF did not induce
any Akt phosphorylation or activation (Figure 6B). Soluble E-
selectin-induced increases in phospho-Akt levels could be inhib¬
ited completely by LY294002, confirming that it is a target of PI
3-kinase, and interestingly the Src tyrosine kinase inhibitor PP2
also showed complete inhibition of phospho-Akt accumulation
following treatment with soluble E-selectin (Figure 6B). These data
would support the hypothesis that the pathway that regulates
permissive SOCE induced by soluble E-selectin is mediated
primarily by Src with PI 3-kinase acting downstream.
Discussion
The selectin family of receptors is critical for the appropriate
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Figure 5. PI 3-kinase and Src kinase activity are required for
soluble E-selectin Ca2+ mobilization. (A) PD98059 (10 jaM),
SB203580 (10 jiM), SB202474 (10 ^M), PP2 (5 fiM), and PP3 (5
p.M) were added concurrently with E-selectin for 15 minutes prior
to stimulation with 100 nM PAF. The Ca2f trace shown is
representative of 3 separate experiments that were performed
with similar results. (B) Bar graph representing area under the
curves of graph in panel A, calculated using GraphPad Prism
software. Data expressed as mean ± SEM of 3 independent
experiments. 'Statistically different (P < .05) from PAF/E-selectin-
treated controls. (C) LY294002, LY303511 (10 jiM, 5-minute
preincubation), and wortmannin (100 nM, 15-minute preincuba¬
tion) were added prior to stimulation with 100 nM PAF. The Ca2+
trace shown is representative of 3 independent experiments that
were performed. (D) Bar graph representing area under the
curves of graph in panel C, calculated using GraphPad Prism
software. Data expressed as mean ± SEM from 3 separate
experiments is shown. "Statistically different (P < .05) from PAF/
E-selectin-treated controls.
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Figure 6. Soluble E-selectin induces Src and Akt activation in neutrophils.
Freshly isolated neutrophils were incubated in the presence or absence of PP2 (5
nM, 15 minutes) or LY294002 (10 p.M, 16 minutes), with soluble E-selectin (5 pg/mL,
15 minutes). Western blots of neutrophil lysates were carried out as described in
"Materials and methods," and probed with (A) phospho-Src (Tyr 116) antibody (1:500)
or (B) antiphospho-Aktl/PKBa antibody (Ser473; 1:200). To verify equal loading, the
blots were probed with p-actin (1:10 000) or total Akt (1:2000). This figure is a
representative blot from 3 independent experiments that were performed with
similar results.
the initiation and progression of the inflammatory response. We
have previously shown that soluble E-selectin acts to promote
neutrophil adhesion, inhibit migration, and amplify destructive
responses,21 raising the possibility that elevated levels of soluble
E-selectin in patients with inflammatory diseases, such as rheuma¬
toid arthritis, and associated with tumor growth, have a proinflam¬
matory effect.25
In leukocytes, PAF acts through a specific G protein-coupled
receptor to induce chemotaxis. Neutrophil activation by PAF has
been shown to be insensitive to pertussis toxin, implicating a Gq/ll
family member. Neutrophil responses to stimulation by LTB, and
fMLP are sensitive to pertussis toxin, suggesting Gc or G,
involvement.26 28 (L-Integrin-mediated neutrophil adhesion to albu¬
min-coated latex beads induced by PAF but not fMLP and LTB4
was promoted by soluble E-selectin.21 Furthermore, we have also
shown that soluble E-selectin specifically prolongs elevation of
[Ca2+]j in response to PAF but not fMLP or LTB4.21 We have
demonstrated that pertussis toxin does not affect PAF-induced Ca2+
mobilization but abolishes fMLP- and LTB4-induced Ca2+ mobili¬
zation. Taken together, this would indicate that only signals from a
pertussis toxin-insensitive Gq/u-coupled receptor such as the PAF
receptor are able to communicate through a G protein-derived
signal to allow prolonged Ca2+ signaling to occur in the presence of
soluble E-selectin.
We provide important new information relating to the mecha¬
nism by which soluble E-selectin prolongs PAF-induced Ca2+
signaling in neutrophils. Stimulation of neutrophils with PAF
causes primarily a rapid release of Ca2+ from IP3-sensitive stores
and a relatively minor influx of Ca2+ through SKF96365-sensitive
channels, most likely receptor-operated channels.21 Soluble E-
selectin alone does not cause release of Ca2+ from intracellular
stores or via Ca2+ influx but acts to prolong Ca2+ signals induced
by PAF receptor ligation in a novel manner by allowing "permis¬
sive" SOCE. We have demonstrated that prolongation of PAF-
induced Ca2+ signaling by E-selectin is due to Ca2+ influx due to its
sensitivity to blockade by EGTA rather than further release from
ryanodine-sensitive intracellular stores. Furthermore, an obligate
requirement for IP3-mediated release of Ca2+ from intracellular
stores to act as a trigger for the Ca2+ influx permitted by soluble
E-selectin was demonstrated by inhibition of phospholipase C
causing a complete loss of any Ca2+ signaling. In addition, the
susceptibility of E-selectin-permitted Ca2+ influx to blockade by
MRS 1845, a store-operated channel (SOC) inhibitor, identified this
as SOCE. A role for TRPCs as candidates for mediating this novel
SOCE was proposed based on the ability ofGd3+ to cause selective
inhibition of prolonged Ca2+ entry following PAF stimulation in
the presence of soluble E-selectin. Proteins homologous to the
Drosophila transient receptor potential gene (trp) Ca2+ channels
that assemble into tetrameric ion channels are known to be
involved in the generation of store-operated Ca2+ entry (SOCE).
Our RT-PCR studies found that only TRPC3 and TRPC6 mRNA
were expressed in polymorphonuclear leukocytes (Figure 4A), in
agreement with Heiner et al.29 TRPC6 appears to represent the principal
TRPC family member presenL being detected at both the level of
mRNA and protein.
Thus, soluble E-selectin acts to promote a novel form of
molecular cross-talk involving TRPCs that allow a putative E-
selectin receptor to influence PAF-induced signaling pathways. Our
data also suggest that both Gq/U- and soluble E-selectin-mediated
signals are required to communicate with TRPC6 before release of
Ca2+ from intracellular stores can trigger SOCE. We are currently
investigating potential mechanisms for this effect, for example,
whether a regulatory protein becomes recruited to TRPCs to permit
SOCE, or promotion of a physical interaction between IP3 channels
in the endoplasmic reticulum (ER) with TRPC in the plasma
membrane, or alternatively, TRPCs may become sensitized to the
signals that mediate SOCE, such as calcium influx factor (CIF).30 It
has recently been shown that TRPC6 is externalized to the plasma
membrane by the stimulation of a Gq protein-coupled receptor,31
and it has also been shown that expression of TRPC6 in COS cells
increases Ca2+ entry in response to stimulation of a Gq protein-
coupled receptor.32We are therefore currently investigating whether
soluble E-selectin preincubation leads to the up-regulation of
TRPC6 on the cell surface and if this is sensitive to activation via
Gq-coupled receptor-induced signals specifically.
The recent finding that diacylglycerol directly activates TRPC3
and TRPC6 may represent an alternative mechanism for activation
of these channels via phospholipase C-linked receptors,33 allowing
regulation to occur through a lipid mediator. Recent studies have
shown that tyrosine phosphorylation by Src family protein tyrosine
kinases represents a potential regulatory mechanism of TRPC6
activity.24 It has been suggested that 2 simultaneous events,
opening of the channel by DAG and modulation by Src-induced
tyrosine phosphorylation, contribute to the efficient influx of
calcium through TRPC6. We found that PP2 specifically inhibited
soluble E-selectin-mediated SOCE without affecting PAF-induced
responses. In parallel, soluble E-selectin caused phosphorylation
and activation of Src, which was sensitive to inhibition by PP2 but
was unaffected by PI 3-kinase inhibition. These findings strongly
suggest that Src activity is involved in modulating TRPC6 activity
to regulate Ca2+ influx in human neutrophils.
Inhibition of PI 3-kinase selectively blocked the soluble E-
selectin-induced SOCE in neutrophils. Several potential intracellu¬
lar regulatory motifs have been identified on TRPC6 including
PI3K-SH2 recognition domains, suggesting amechanism by which
these channels might interact with the PI 3-kinase signaling
pathway.34 Several groups35'36 have discovered that the PI 3-kinase
lipid product phosphatidylinositol 3,4,5-trisphosphate (PIP3) medi¬
ates calcium influx through a mechanism independent of phospho¬
lipase C (PLC) activity or store depletion in several cell lines. The
activation of receptor tyrosine kinase cascades leads to the
membrane colocalization of PLC-y and PI 3-kinase, both of which
use phosphatidylinositol 4,5-bisphosphate (PIP2) as a substrate to
generate IP3 and PIP3, respectively. These 2 signaling intermediates
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trigger the activation of calcium channels at different cellular
compartments, giving rise to elevated levels of [Ca2+]j. Soluble
E-selectin was demonstrated to cause an increase in phospho-Akt, a
downstream target of PI 3-kinase. We would speculate that PI
3-kinase acts to modulate TRPC6 activity and that PI 3-kinase lies
downstream of Src in the regulation of soluble E-selectin-mediated
permissive SOCE.
Several putative glycoprotein selectin ligands have been iso¬
lated from hematopoietic cells using in vitro affinity purification
techniques, but the exact identity and contribution of physiologic
E-selectin ligands on neutrophils is unknown.37 In this paper, we
have demonstrated that E-selectin binds via the lectin domain to
cause permissive SOCE in neutrophils in response to PAF, presum¬
ably through a putative E-selectin receptor present on neutrophils.
A cell-adhesion molecule suggested to play a role in E-selectin
adhesion is CD66 or carcinoembryonic antigen (CEA). Neutrophils
are known to express several CEA family members, which are all
highly glycosylated molecules with multiple sialyl and fucosyl
residues. In preliminary experiments, CD66 ligation with antibod¬
ies caused prolonged PAF-induced Ca2+ mobilization in a similar
manner to that caused by soluble E-selectin (data not shown). We
are currently investigating the possibility that CD66 and other
adhesion receptors need to coengage via soluble E-selectin to
regulate Ca2+ signaling in response to PAF.
Receptor-mediated activation of leukocytes by inflammatory
stimuli requires Ca2+ mobilization and influx as a critical common
activation mechanism. Selective modulation of distinct compo¬
nents of these Ca2+ signals may represent potentially attractive
strategies for developing anti-inflammatory drugs to attenuate
leukocyte activation. Our report is the first demonstration of
soluble E-selectin causing permissive SOCE to occur following
activation of neutrophils by PAF and that this SOCE most likely
occurs through TRPC6. We have identified a novel form of
permissive SOCE induced by soluble E-selectin in human neutro¬
phils, which occurs through a Src/PI 3-kinase-dependent pathway
and also requires a Gq/n-derived signal to sensitize or prime TRPCs
to open on increased intracellular Ca2+ and depletion of Ca2+
Figure 7. Schematic model of intracellular communication between E-selectin
receptors and PAF receptor. PAF binds to its G^n protein-coupled receptor
resulting in activation of PLC, leading to cleavage of PIP2 and generation of
membrane-retained DAG and cytosolic IP3. DAG can directly activate TRPC6.34
Soluble lnsP3 activates the IP3R on the endoplasmic reticulum to release intracellular
Ca2+. These responses result in the initial rapid increase of [Ca2+]i. E-selectin
interacts with E-selectin receptors on the neutrophil surface, permitting PAF-induced
Ca2+ mobilization to communicate with TRPC6 and allowing permissive SOCE to
occur. Modulation of this Ca2+ channel involves Src and PI 3-kinase pathways. ROC
indicates receptor-operated channel; G, G protein-coupled receptor.
stores, but the precise order of these molecular events is yet to be
fully explored (Figure 7). This novel mechanism of molecular
cross-talk integrates signals from pertussis toxin-insensitive Gq/n-
coupled receptors and TRPCs and could be critical for fine tuning
adhesion and migratory responses during neutrophil recruitment
during inflammation.
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